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Abstract  
This thesis describes novel features in the generation and shaping of the primary B cell receptor 
repertoire. By high-throughput sequencing, we have obtained 9969 unique DJH-rearrangements and 
5919 unique VHDJH-rearrangements obtained from CD19+ cells from 110 healthy adult blood 
donors. We found that DJH-rearrangements and non-productive VHDJH-rearrangements had many 
features in common but differed significantly in their use of D-genes. During D- to JH-gene 
rearrangement, the D-genes proximal to the JH-locus were rearranged more frequently than JH-locus 
distal D-genes while VH-locus proximal D-genes were observed more frequently in non-productive 
VHDJH-rearrangements than VH-locus distal D-genes. We further demonstrated that the distance 
between VH-, D- and JH-gene segments influenced their ability to rearrange within the human 
immunoglobulin locus.  
In the attempt to identify structural differences in N regions we studied the nucleotide 
composition of N regions within 668 unique and unmutated non-productive human VHDJH-
rearrangements and 9832 unique DJH-rearrangements containing one D-gene. We demonstrated that 
the composition of N regions was highly compatible with a model in which N regions were 
generated by two concatenating 3’-overhangs and that the net result of N addition was an 
overweight of C in the 3’-overhangs of gene segments. During joint formation this surplus 
generated a positive G/C ratio gradient across the N regions. Surprisingly, this G/C gradient differed 
in N regions between VH-D and D-JH gene segments and was highly dependent on gene segment 
trimming.  
Mouse studies have suggested that B cells with a non-productive VHDJH-rearrangement or 
autoreactive antigen receptors may be rescued by performing a secondary rearrangement called VH-
gene replacement. The presence of a cryptic RSS (5’-TACTGTG-3’) located at the 3’-end of ~80% 
of all VH-genes enables an upstream positioned VH-gene to replace the VH-gene within an already 
rearranged IgH locus. After VH-gene replacement, an identifiable five to ten nucleotide footprint 
may remain as a remnant of the first VH-gene. Demonstrating the contribution of VH-gene 
replacement in the generation of the human B cell receptor repertoire has however been 
controversial. We have previously failed to demonstrate a significant contribution of VH-gene 
replacement in humans while others have found them to occur at a frequency of 5%. Previous 
studies have been limited by the size of the datasets studied. In order to find evidence for rare 
occurring events such as VH-gene replacement it is vital to have large datasets. We have in this 
thesis investigated 29802 unique human VHDJH-rearrangements downloaded from NCBI for the 
presence of footprints after VH-gene replacement. We did not find any evidence of footprints after 
VH-gene replacement in N-additions ranging from 5-15 nucleotides in length in either mutated or 
unmutated VHDJH-rearrangements.  
The recombination-activating genes (RAG) 1 and 2 are only expressed in lymphocytes and 
they are the main facilitators of V(D)J-rearrangement. Their mechanisms are similar to many other 
DNA binding and cleaving enzymes such as transposons that cut semi-randomly within the genome. 
Transposons have been domesticated and their functions have successfully been modified for the 
purpose of gene therapy. We have in this thesis explored the opportunity of using RAG1 and RAG2 
to introduce a transgene into the human immunoglobulin heavy chain loci. These enzymes 
   MARCH 2013 
 
4 
 
recognize specific recombination signaling sequences (RSS) that could act as potential integration 
sites for transgenes. We have designed and generated a prototype for a non-viral two-plasmid 
targeted gene intergrational system consisting of one vector containing both RAG1 and RAG2 
(RAGVec1.0) and one vector containing the gene of interest, in this case RFP, (GeneVec1.0) 
flanked by 23-spacer RSS. We have used the model cell line HEK293T for testing the expression 
potential of both plasmids and achieved high mRNA expression of both RAG1 and RAG2 and 
demonstrated translation into protein for RAG1. We further demonstrated that RFP was expressed 
within 72 hours of transfection. Taking the so-far accumulated data together, it has not been 
possible to demonstrate targeted gene integration yet using the current vector design.
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Dansk resumé 
Denne afhandling beskriver hidtil ukendte træk i genereringen af det primære B-cellereceptor 
repertoire. Ved hjælp af pyro-sekventering har vi erhvervet 9969 unikke DJH-rearrangementer og 
5919 unikke VHDJH-rearrangementer fra CD19+ B-celler fra 110 raske voksne bloddonorer. Vi 
fandt at DJH-rearrangementer og ikke-produktive VHDJH-rearrangementer havde mange træk til 
fælles, men adskilte sig signifikant i deres brug af D-gener. Under D- til JH-gen rekombination blev 
JH-locusnære D-gener oftere brugt end VH-locusnære D-gener. Vi opdagede at afstanden mellem 
VH-, D- og JH-gensegmenterne påvirkede deres evne til at rekombinere på immunglobulinlocus i 
voksne mennesker.  
Med det mål for øje at identificere strukturelle forskelle i de to N regioner i VHDJH-
rearrangementet studerede vi nukleotidsammensætningen af 668 unikke og umuterede ikke-
produktive humane VHDJH-rearrangementer og 9832 unikke humane DJH-rearrangementer. Vi 
demonstrerede at N regionerne blev genereret af to sammenkædede overhængende 3’-ender og at 
nettoresultatet af nukleotidsammensætningen var en overvægt af C i de overhængende 3’-ender. 
Efter dannelsen af N regionen førte denne overvægt til en positiv G/C gradient henover N regionen. 
Til vores overraskelse var G/C gradienten forskellig i N regionen mellem VH-D og den mellem D-
JH gensegmenterne. En forskel vi fandt afhængig af niveauet af nukleasetrimning af 
gensegmenterne. Forskellen mellem de to N regioner på nukleotidniveau påvirkede også deres 
aminosyrekompositionen. Efter selektion var denne forskel dog betragtelig reduceret.   
Musestudier har antydet at B-celler med ikke-produktive VHDJH-rearrangementer eller 
autoreaktive receptorer kan reddes fra programmeret celledød ved at udføre et sekundært 
rearrangement i form af VH-genserstatning. Tilstedeværelsen af en kryptisk 
rekombinationssignalsekvens (5’-TACTGTG-3’) i 3’-enden af 80% af alle VH-gener gør det muligt 
for et opstrøms VH-gen at erstatte VH-gensegmentet i et allerede rekombineret tungkæde-locus.  
Efter erstatning af VH-genet vil en 5 til 10 nukleotider lang sekvens, kaldet et footprint, forblive 
efter det tidligere VH-gen. Det er kontroversielt om VH-genserstatning har en betydning for 
dannelsen af B-cellereceptorrepertoiret i mennesket. Vi har tidligere ikke fundet belæg for et 
væsentligt bidrag mens et andet studie har indikeret at mekanismen har dannet 5% af 
rearrangementerne i et materiale bestående af 343 VHDJH-rearrangementer. For at kunne finde 
belæg for sjældne begivenheder i forbindelse med dannelsen af B-cellernes receptorer, såsom VH-
genserstatning, er det essentielt at have store mængder data til rådighed. Med en ny og forbedret 
footprint-analyse har vi undersøgt 29802 unikke humane VHDJH-rearrangementer hentet fra The 
National Center for Biotechnology’s hjemmeside for tilstedeværelsen af footprints efter VH-
genserstatning. Vi fandt ingen evidens for VH-gen erstatning i N-nukleotidsekvenser på mellem 5 
og 15 nukleotider.  
De to rekombination-aktiverende gener, RAG1 og RAG2, er under normale omstændigheder 
kun udtrykt i lymfoide celler og de er hovedansvarlige for V(D)J-rekombinationsmekanismen. 
Deres molekylære mekanisme minder meget om andre DNA-interagerende og kløvende enzymer, 
såsom transposoner, som kløver semi-specifikt i genomet. Funktionen af transposoner er blevet 
modificeret med formål for anvendelse til genterapi. Vi har undersøgt muligheden for at benytte 
RAG1 og RAG2 til at introducere et transgen i det humane immunoglobulintungkædelocus.  
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Rekombinationssignalsekvenser kan fungere som potentielle positioner for genintegration. Vi 
har designet og genereret en prototype for et non-viralt dobbelt-plasmid lokalisationsspecifikt 
genintegrationssystem. Det ene plasmid bestod af RAG1 og RAG2 (RAGVec1.0) og det andet af 
transgenet, i dette tilfælde et rødt fluoreserende protein (RFP), (GeneVec1.0) flankeret af 
rekombinationssignalsekvenser. Vi benyttede cellelinjen HEK293T til at teste 
ekspressionspotentialet for de to plasmider og opnåede et højt udtryk af mRNA for både RAG1 og 
RAG2. Vi demonstrerede yderligere at RAG1 var udtrykt på proteinniveau. RFP var funktionelt og 
udtrykt indenfor 72 timer efter transfektionen. Om vi er i stand til at indsætte transgenet ved hjælp 
af det nuværende plasmid-design er endnu ikke påvist.   
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Aims and Hypotheses 
 
Aim 1: Learning about the basic V(D)J rearrangement mechanism prior to selection. 
 
Hypothesis:  
• DJH-rearrangements are a better source for studying the basic 
rearrangement mechanism than non-productive VHDJH-
rearrangements. 
• The D-gene and JH-gene usage and the junction in between are 
similar in DJH- and non-productive VHDJH-rearrangements. 
Methods: 
• Next-generation sequencing 
• Resolution of DJH and VHDJH sequences by VDJsolver  
 
Aim 2:  Establishing whether the N regions between VH-D and D-JH gene segments 
are constructed similarly. 
 
Hypothesis: 
• There are specific structural patterns in nucleotide composition of 
N regions. 
• The N region in between VH-D and D-JH gene segments are 
similarly composed. 
Methods:  
• Next-generation sequencing 
• Resolution of DJH and VHDJH sequences by VDJsolver  
 
Aim 3:  Establishing the frequency of VH-gene replacement and its contribution to 
the generation of the human B cell receptor repertoire. 
 
Hypothesis: 
• VH-gene replacement does not contribute to the generation of the 
human B cell receptor repertoire. 
 
Methods: 
• Down loading all VHDJH-rearrangements available on NCBI. 
• Data weeding 
• Identifying footprints from 5-10 nucleotides in length in N 
regions of varying length using a specially designed footprint 
identifier program.  
 
  MARCH 2013 
8 
 
Aim 4:  Demonstrating that recombination-activating genes can mediate gene 
integration into the immunoglobulin locus. 
 
Hypothesis: 
• RAG1 and RAG2 in a dual-expression vector will be highly 
expressed in non-lymphoid cell lines. 
• Transgenic RAG1 and RAG2 are capable of rearranging an 
artificial rearrangement substrate in non-lymphoid cells. 
• Transgenic RAG1 and RAG2 are capable of rearranging the 
immunoglobulin locus of non-lymphoid cells. 
• Transgenic RAG1 and RAG2 are capable of integrating a gene of 
interest flanked by 23-spacer RSS in between two D-genes on the 
immunoglobulin locus within five days. 
 
Methods: 
• Molecular cloning 
• Non-viral gene delivery 
• Real time PCR 
• ELISA 
• DNA sequencing 
• Fragment analysis
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BACKGROUND 
Immunoglobulin Generation 
 
 
ABSTRACT 
The immune system is capable of recognizing and responding to a nearly infinite number of 
different antigens. This is possible due to the great repertoire of specific cell surface receptors 
found on lymphocytes which are generated by stepwise rearrangement of gene segments. The 
B cell receptor is generated by rearranging the immunoglobulin heavy chain loci and a λ or κ 
light chain locus. Rearrangement occurs between gene segments called variable-, diversity- 
and joining-gene segments and each have several copies containing discrete differences. 
Many enzymes are involved in this mechanism but the two lymphoid-specific recombinases 
recombination-activating genes 1 and 2 are considered to be the main facilitators. Here I will 
focus on B cell development and in detail describe the primary rearrangement of the 
immunoglobulin heavy chain locus. 
 
 
The origin of adaptive immunity. 
In higher organisms the immune system is 
divided into the innate and adaptive immune 
systems (AIS). The first line of defence 
meeting an invading microorganism or toxin is 
the innate immune system (IIS) 1-3. The cell 
receptors in the IIS are encoded in the germ 
line as functional ready-to-use receptors that 
have evolved to recognize highly conserved 
patterns distinct to certain microorganisms and 
toxins 4, 5. Components of the IIS are found in 
multi-cellular organisms throughout the animal 
kingdom and is the oldest mechanism of 
defence against pathogens seen from an 
evolutionary perspective (Figure 1)6-9. 
However, pathogens’ ability to escape the IIS 
has evolved in parallel. As lifeforms became 
larger and more complex a more 
comprehensive immune system was required 
to ensure survival. The AIS arose around 500 
million years ago in jawed vertebrates and is 
capable of recognizing a vast majority of self 
and non-self antigens. More importantly the 
AIS remembers the encounter with pathogens, 
thus protecting the host from the intruder later 
in life10, 11. From having only innate immunity 
to having both innate and adaptive immunity 
occurred within 50 million years, which is an 
extremely short period of time within the 
course of evolution 12. 
 
The immunoglobulin locus. 
Lymphocytes are the main players in the AIS 
and their high specificity against antigens is 
addressed to their cell surface receptors and 
the mechanism by which these are generated. 
They are constituted of a variable domain 
involved in antigen recognition and a constant 
domain conveying the signal after antigen 
binding13, 14. The variable part is distinctive to 
all immature lymphoid cells enabling the cells 
to literally recognize an unlimited number of 
antigens of foreign and self origin. This part of 
the receptor is generated by assembling a 
variable (V), a diversity (D) and a joining (J) 
gene segment by the force of the two 
recombinases called recombination-activating 
genes 1 and 2 (RAG1 and 2).  
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All jawed vertebrates rearrange their V-, D- 
and J-gene segments and the basic mechanism 
of V(D)J rearrangement is highly conserved 
across species. The number of gene segments, 
loci, chromosomal location and configuration 
do however vary among species. There are two 
configurations identified: Translocons and 
clusters (Figure 2). In a translocon, the V-, D- 
and J-gene segments are grouped together in 
their own respective loci, and the constant 
regions follow after the J-gene locus. In a 
cluster one V-gene segment, one or more D-
gene segments and one J-gene segment are 
clustered together followed by one constant 
region (Figure 2). Higher vertebrates have 
their immunoglobulin (Ig) genes organised as 
translocons15-19 while lower vertebrates have 
them in clusters20-22. 
In humans the B cell receptor is 
generated from segments belonging to three 
different loci: The immunoglobulin heavy 
chain (IgH) locus located on chromosome 14 
23, 24
 and the two immunoglobulin light chain 
(IgL) loci Igκ and Igλ located on 
chromosomes 2 and 22, respectively25. The 
different receptor gene segments arose early in 
 
Figure 1. The innate immune system has been found in the three kingdoms Fungi, Plantae and Metazoa. Adaptive 
immunity is however only found in cartilaginous fish (Chondrichthyes), bony fish (Osteichthyes), amphibians 
(Amphibia), reptiles (Reptilia), birds (Aves) and mammals (Mammalia). Cartilaginous fish are the oldest jawed 
vertebrate and the adaptive immune system arose in the steps of becoming a jawed vertebrate. The class Agnatha does 
thus not have an adaptive immune system as we know it in higher vertebrates. 
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the jawed vertebrate history by gene 
duplications founding the beginning of the 
extremely complicated mechanism of 
lymphoid receptor generation. Searching for 
traces after an ancestral lymphoid receptor in 
jawless fish has led to the discovery of a gene 
specifically expressed in their lymphoid cells. 
This gene is composed of a V- and J-gene 
segment resembling today’s T cell receptors 
and only exists as one copy in the genome of 
the jawless fish. Gene duplications could have 
given rise to the many V-, D- and J-gene 
segments found in higher vertebrates today26. 
 
Generating B cell receptor variety. 
The immunoglobulin molecule is composed of 
two identical heavy chain subunits and two 
identical light chain subunits (Figure 3). It can 
be either membrane bound and function as the 
B cell receptor (BCR) or secreted as antibodies 
in a humoral response. It is the N-terminal of 
each heavy and light chain that is involved in 
antigen binding and the C-terminal that 
determines the class of antibody and the 
effector functions13, 14. Within the variable part 
of both heavy and light chains, three regions 
are especially important for antigen 
recognition. These regions are termed 
complementarity-determining region (CDR) 1, 
2 and 3. The nucleotide sequence encoding the 
CDRs is particularly variable compared to the 
surrounding nucleotide sequence which is 
 
Figure 2. The gene segments within the IgH locus can be organised as translocons or clusters. A translocon is 
characterized by having VH, D, JH and constant segments placed in their own respective loci. In a cluster one VH-gene 
is followed by one or more D-genes that are followed by one JH-gene and one constant gene segment. In lower 
vertebrates, fish and sharks, the gene segments are organised in clusters while in higher vertebrates, mice and humans, 
they are organised in translocons. 
 
 
Figure 3. The B cell receptor is composed of two 
identical heavy chains and two identical light chains 
and a transmembrane domain anchoring it in the 
membrane. Without the transmembrane domain the 
molecule is secreted as an antibody.  
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termed framework regions27. CDR1 and 2 are 
encoded within the VH-gene segment. CDR3 
comprises the entire joint region spanning 
from the conserved cysteine in the 3’-end of 
the VH-gene to the conserved tryptophan in 5’-
end of the JH-gene. The CDRs form three 
loops that project outward from the variable 
domain and interact with the antigen. The 
variable part of the Ig molecule is generated 
early in B cell development in the bone 
marrow. RAG1 and RAG2 initiate V(D)J 
rearrangement and they are generally only 
expressed in short time intervals during B cell 
development. They bind and cleave specific 
recombination signalling sequences (RSS) 
flanking each VH-, D- and JH-gene segment28-
30
. The RSS is composed of a relatively 
conserved heptamer (5’-CACAGTG-3’) 
separated from a conserved nonamer (5’-
ACAAAAACC-3’) by a non-conserved spacer 
region of either 12 or 23 nucleotides31. 
Generally, a gene segment flanked by a 23-
spacer RSS only joins with a gene segment 
flanked by a 12-spacer RSS. This is known as 
the 12/23 rule32. On the IgH locus VH- and JH-
gene segments are flanked by 23-spacer RSS, 
while D-gene segments are  
 
Figure 4. In adults, B cell development starts in the bone marrow. The first step in receptor generation is initiated in 
the pro-B cell by rearranging the IgH chain. First checkpoint in B cell development is successful pairing of the 
rearranged IgH chain with the surrogate light chain and expression of the resulting pre-BCR at the cell surface. CD34 
is a hematopoietic stem cell marker that is lost in the transition from pro- to pre-B cell. In the pre-B cell rearrangement 
continues on the IgL chain. CD10, CD20 and sIgM (pre-BCR) are specific markers for the pre-B cell stage. Transition 
into the immature B cell is achieved when the IgH and IgL chains are paired and IgM is expressed at the cell surface.  
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A 
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C 
 
 
Figure 5. A) A representative example of an RSS B) The RAG complex nicks the DNA at the 3’-end of the heptamer. 
The freed hydroxyl group attacks the phosphate group on the opposite DNA strand causing a double stranded DNA 
break C) A hairpin is created at the coding-end while the heptamer-end also called the signal-end remains as a double 
stranded DNA break.  
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flanked by 12- spacer RSS. This arrangement 
ensures that the gene segments are associated 
in the correct VHDJH configuration. First step 
of rearrangement occurs between a D- and a 
JH-gene segment and takes place on both 
chromosomes simultaneously. Next, a VH-
gene segment rearranges to the DJH-
rearrangement. This only occurs on one 
chromosome at the time33. If the initial 
VHDJH-rearrangement is functional, meaning 
that the VHDJH-rearrangement has an open 
reading-frame and is translatable, 
rearrangement will stop and the second 
chromosome will be left with a DJH-
rearrangement. This mechanism is known as 
allelic exclusion and prevents a B cell from 
expressing more than one type of BCR. 
Chromatin structures and nuclear position of 
the locus is thought to regulate this process33-
36
. When a VHDJH-rearrangement is 
transcribed it will pair with a surrogate light 
chain, until a rearranged λ or κ light chain is 
available. This surrogate hybrid receptor, pre-
BCR, is transcribed and expressed at the cell 
surface providing survival signals37-41. 
Expressing pre-BCR at the cell surface is the 
first vital checkpoint in B cell development 
and marks the transition from pro- to pre-B 
cell (Figure 4). The variable part of the light 
chain is composed of a VL- and JL-gene 
segment. The VL-gene segments are flanked by 
23-spacer RSSs and JL-gene segment by 12-
spacer RSSs. If the VLJL-rearrangement is 
translatable, it will replace the surrogate IgL 
chain in the pre-PCR. This step constitutes the 
second checkpoint in early B cell development 
and marks the transition from pre-B cell to 
immature B cell.  
 
RAG specificity and cleavage of RSS. 
V(D)J rearrangement is dependent on the 
union of RAG1 and RAG2 in a hetero-dimeric 
RAG-complex. RAG1 is capable of binding to 
RSS by itself but it does not have any catalytic 
activity outside the RAG-complex. RAG2 
does not by itself have any DNA binding 
capacity but it enhances the preference 
towards the 12-spacer RSS and it has been 
suggested that RAG2 is responsible for the 
site-specificity of the RAG-complex42. After 
binding, the RAG-complex cleaves at the 3’-
end of the heptamer. This generates a free 3’-
OH that will attack the opposite DNA strand in 
a transesterification reaction forming a hairpin 
structure at the coding end43 (Figure 5). The 
freed heptamer, also called the signal-end 
remains as a double stranded (ds) DNA break 
and ligates with the signal-end created at the 
pairing gene segment forming an excision 
circle44, 45. The heptamer sequence within the 
RSS is under normal circumstances essential 
for RAG cleavage and the two first positions 
within the heptamer are specifically important 
for hairpin formation. The nonamer is 
involved in the initial recognition and binding 
process but is dispensable for the actual 
enzymatic reaction. Its absence does however 
reduce cleavage 7-fold46. Even though the 
heptamer and nonamer are the conserved and 
important elements within the RSS for binding 
and cleaving, it has been demonstrated that the 
composition of the spacer region also 
influences recombination47. Alignment studies 
even reveal that some nucleotides within the 
spacer do display conservation across species 
however not to the same extent as for the 
heptamer and nonamer. The first 5 nucleotides 
in both the 12RSS (5’-ATACA-3’) and 23RSS 
spacers (5’-ATGCA-3’) have sequence 
conservation of 36-67% across various species 
and loci31.  
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Joining coding-ends. 
After RAG has cleaved between the heptamer 
and gene segment and sealed the coding-end 
with a hairpin, the coding-end hairpin is 
reopened by an ATP dependent mechanism 
performed by the Artemis/DNA-PKCS 
complex. Artemis is strongly dependent on 
phosphorylation and interaction with DNA-
PKCS and does not have hairpin opening 
activity outside this complex. After hairpin 
opening, the Artemis/DNA-PKCS complex has 
been demonstrated to process the resulting 
single stranded DNA overhang by exonuclease 
activity (Figure 6)48.  
Terminal deoxynucleotidyltransferase 
(TdT) subsequently adds non-templated 
nucleotides, better known as N-additions, to 
the 3’ overhangs (Figure 7). TdT is a template-
independent polymerase that has both 
transferase and exonuclease activity. It is 
structurally similar to other polymerases 
except for the presence of a loop structure 
preventing the interaction with a template 
strand. Three isoforms of TdT exists in 
humans: One short and two long. The short 
TdT performs the transferase activity while 
two long TdTs have been shown to have 
exonuclease activity in addition to 3’ to 5’ 
exonuclease activity on the 3’-overhangs49. 
The exonuclease activity of TdT is thought to 
complement the Artemis/DNA-PKcs-complex 
during joint formation. Non-homologous end 
joining (NHEJ) is a mechanism involved in 
repairing dsDNA breaks and this mechanism 
 
 
Figure 6. The Artemis/DNA-PKCS-complex is responsible for opening the hairpin generated by the RAG–complex. 
The figure illustrates the joining between a VH-gene and a DJH-rearrangement. Artemis/DNA-PKCS nicks the DNA at 
a random position near the hairpin-end generating 3’-overhangs that are futher processed by the exonuclease activity 
of the Artemis/DNA-PKCS-complex or TdT. USusally the Artemis/DNA-PKCS-complex nicks the non-sense strand as 
illustrated, but it may also nick the sense strand87. Opening of the hairpin will in some cases generate a palindromic 
sequence that will remain in the junction between the different gene segments if not removed by exonuclease activity.   
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also joins the two coding-ends. A heterodimer 
composed of ku70/ku80 forms a ring that 
wraps around the two coding-ends holding 
them together50. Microhomology within the 3’-
overhangs guides the joining of the two gene 
segments. Non-pairing nucleotides are 
subsequently removed by exonuclease activity 
and the gaps are repaired by DNA synthesis. 
The DNA repair protein, XRCC4, associates 
with DNA ligase IV and together these 
molecules ligate the residual nick in the DNA 
strand after gap filling51. 
 
Regulation of the RAG-complex. 
Regulation of RAG1 and RAG2 is highly 
complex and occurs at many levels. RAG 
expression is up-regulated in short periods 
during early B cell development in the bone 
marrow but studies have also shown that their 
expression may be up-regulated in B cells 
located in secondary lymphoid tissues 
promoting secondary rearrangement52-54. 
Down-regulation of RAG1 and RAG2 
expression upon signalling through the BCR is 
a main regulatory mechanism of these 
enzymes55. As the formation of the RAG-
complex is essential for V(D)J rearrangement, 
another level of regulation is preventing 
complex formation. When over-expressing 
RAG1 and RAG2 separately in mouse 
 
 
Figure 7. Terminal deoxynucleotidyl transferase adds non-templated nucleotides to the 3’-overhangs (represented by 
small letters). This N addition may vary greatly in length ranging from 1 to 30 nucleotides. The two 3’-overhangs are 
joined by non-homologous end joining (NHEJ).  Annealing is guided by microhomology between the two 3’-
overhangs. DNA polymerase and XRCC4/DNA ligase IV repair the gap and completes rearrangement. 
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embryonic fibroblasts both enzymes localise 
around the periphery of the nucleus. However, 
co-expression of RAG1 and RAG2 changes 
their nuclear distribution. RAG1 then localises 
primarily at sites high in RNA content such as 
the nucleoli within the nucleus, while RAG2 
spreads throughout the nucleus bypassing the 
nucleoli56. This suggests that when the activity 
of the RAG-complex is unwanted RAG1 and 
RAG2 resides in different nuclear 
departments.   
 
Somatic hypermutations and Class Switch 
Recombination. 
When B cells have successfully rearranged 
their IgH and IgL loci and express a BCR they 
will leave the bone marrow as immature B 
cells and become transitional B cells that 
migrate to secondary lymphoid tissues. In the 
lymphoid tissues B cells may be exposed to 
antigen and the initial antigen encounter will 
initiate a dynamic cascade of cell signalling 
events that ultimately promotes cellular 
activation and proliferation57-60. In the 
secondary lymphoid organs this area of B cell 
expansion is a visible structure and termed the 
germinal centre (GC)61. As B cells divide, 
their receptor undergoes somatic 
hypermutation (SHM); a mechanism whereby 
the IgH and IgL genes are hypermutated and 
fine tuned to have higher affinity towards the 
antigen to which the B cell was presented62-64. 
Further, class switch recombination (CSR) will 
replace the default IgH Cµ-gene segment by 
another CH-gene segment providing an Ig 
molecule with different effector functions65. 
Both SHM and CSR are executed by 
activation-induced cytosine deaminase 
(AID)66, 67; a cytosine deaminase that 
enzymatically converts cytosine into uracil in 
antigen stimulated B cells. SHM occurs by two 
mechanisms: 1) DNA replication reads the 
uracil as a thymidine and pairs it with an 
adenine which results in a C to T or G to A 
transition. This type of mutation only requires 
AID activity68, 69. 2) Uracil is a pyrimidine 
normally found in RNA and the base-excision 
repair system will therefore attempt to correct 
the mistake by removing the uracil. This 
creates an abasic site in the DNA strand. The 
removal of the uracil is executed by an enzyme 
called uracil N-glycosylase (UNG)70, 71. In the 
abasic site a random nucleotide may be 
inserted leading to both transitions (G:C into 
A:T) and transversions (G:C into C:G)68. 
Ultimately, for both mechanisms it is the 
misreading of a low fidelity polymerase that is 
responsible for the introduction of the point 
mutation72, 73. AID only binds single stranded 
(ss) DNA and thus only functions on actively 
transcribed alleles where transcription 
temporarily separates of the two DNA strands 
within the transcription bubble74-76. 
Sequencing studies support this in that 
mutations only occur downstream of the VH-
gene promoter suggesting the importance of 
this promoter for AID activity. It is 
hypothesized that AID is recruited to the Ig 
region by the transcriptional machinery77, 78. 
Chaudhuri and colleagues demonstrated in 
2004 that AID interacts strongly with 
replication protein A (RPA), a protein with an 
extremely high affinity towards DNA. This 
interaction is dependent on AID 
phosphorylation and the AID-RPA complex is 
targeted to the transcription bubble 
surrounding the DNA motif RGYW (R = 
purine, Y= pyrimidine, W = A or T). After 
deamination, AID exits the transcription 
bubble leaving a potential site for the base-
excision repair system to enter76.  
Upstream of each constant gene segment 
on the IgH locus is a region called the switch 
region. This region contains numerous target 
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sites for AID and is 1-12 kb in length79. The 
abasic site remaining after UNG activity also 
acts as a target site for the APE1 
endonuclease, which nicks the DNA at the 
abasic site and triggers CSR. It is believed that 
the mismatch repair system then generates a 
double stranded (ds) DNA break from the 
ssDNA break80. However, the possibility of 
ssDNA breaks being located closely together 
on opposite strands could also facilitate a 
spontaneous dsDNA break. The recombination 
mechanism that joins two switch regions 
resembles that of homologous recombination. 
The intervening DNA including the previous 
CH-gene segment is excised as a circle and the 
downstream CH-gene segment is now adjacent 
to the VHDJH-rearrangement and a different 
class of antibody is expressed81. 
 
PERSPECTIVE 
 
Much of the detailed information regarding 
normal B cell development and differentiation 
available today has been derived from in vitro 
cell culture studies or in vivo studies in mice. 
The murine model system is the main choice 
when studying human immunological 
mechanisms and genome sequencing has 
demonstrated that the human and mouse 
genomes differ by 300 genes82. Studies on 
bone marrow, tonsils and peripheral blood 
have illustrated that both early and late B cell 
development in man and mouse are rather 
similar83. Differences are however identified in 
the B cells’ ability to respond to specific 
cytokines84, 85 and the expression of certain 
lymphoid cell surface markers such as CD38, 
CD5 and CD2386. The murine model is thus 
not a perfect system for studying human 
immunology. In order to obtain information 
about the human immune system and B cell 
development, studies should be performed on 
human B cells. In this thesis, I will focus on 
the mechanisms involved in generating and 
shaping the primary B cell receptor repertoire 
of human adults.  
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ABSTRACT 
V(D)J rearrangement is the mechanism responsible for the stochastic generation of antigen 
receptors in B and T cells. Rearrangement is guided by recombination signaling sequences 
(RSS) consisting of regularly spaced nonamers and heptamers which constitute target sites for 
the recombination-activating genes (RAG). Less complete RSS (cryptic RSS or cRSS) are 
present in many immunoglobulin genes and may even be found outside the immunoglobulin 
locus. It is well documented that occasional engagement of these cRSS may lead to RAG-
induced double strand DNA breaks, translocations and cancer. However, the function within 
the immune system may also allow secondary rearrangement that may potentially rescue a 
non-productive VHDJH-rearrangement or change the antigen specificity of an autoreactive 
antigen receptor, by replacing the VH-gene by a new one (receptor editing). Because 
autoreactivity is a common feature of newly formed B cells, the latter mechanism might 
contribute significantly to the peripheral repertoire. While the technical feasibility of this 
mechanism is well known from studies in mice and humans, the quantitative impact of VH-
gene replacement on the B cell receptor repertoire remains unclear. Here we briefly evaluate 
the existing evidence for and against a significant contribution to the repertoire in humans.    
 
 
Discovering VH-gene replacement in murine 
cell lines and mouse models. 
VH-gene replacement was initially discovered 
in a pre-B cell line derived from murine bone 
marrow in the mid 1980’s1. This cell line 
originally carried a DJH-rearrangement on 
both IgH loci and thus had no µH-chain 
expression. However, while growing in 
culture the cells continued to rearrange their 
IgH loci forming VHDJH-rearrangements. The 
culture was sub-cloned and interestingly it 
was observed that sub-clones initially 
containing a non-productive VHDJH-
rearrangement up-regulated their µ-chain 
expression after 4 weeks of culture. 
Sequencing demonstrated that the VH-gene 
from the non-productive VHDJH-
rearrangement had been replaced by an 
upstream VH-gene and was now productive. 
The existence of an internal heptamer 
designated a cryptic recombination signaling 
sequence (cRSS) located in the 3’-end of most 
VH-genes had been known for a while (Figure 
1). Reth and colleagues suggested that this 
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heptamer functioned as a pairing element 
enabling a VH-gene to VHDJH rearrangement1. 
A few years later Kleinfield and colleagues 
demonstrated the same tendency in a murine 
lymphoma cell line, NFS-5. They further 
noticed that after the secondary 
rearrangement, a stretch of 9 nucleotides had 
emerged in the N region. They suggested that 
these nucleotides, not encoded by the current 
VH-gene, could have been remnants of the 
previous VH-gene and thus could be used as 
an indicator of the event of VH-gene 
replacement2. This remnant was later entitled 
a footprint.  
In vitro studies using Glutathione S-
transferase (GST)-tagged core RAG1 and 
RAG2 have demonstrated that human RAG 
enzymes are capable of binding and cleaving 
cRSS at a frequency only 5-fold lower than 
the conventional RSS3. It is therefore likely 
that VH-gene replacement in the mouse is 
executed through a RAG-dependent 
mechanism just as the primary 
rearrangements3. Both in mice and humans, 
RAG enzymes are primarily expressed during 
B cell development in the bone marrow, but it 
has been shown that RAG expression can be 
up-regulated in some lymphoid cells in 
secondary lymphoid tissues as well4. VH-gene 
replacement could therefore potentially take 
place in both primary and secondary 
lymphoid tissues4. In the bone marrow, 
studies have indicated that VH-gene 
replacement only occurs in pro-B cells5. This 
is the developmental stage at which primary 
rearrangement of the immunoglobulin heavy 
chain takes place, suggesting co-occurrence of 
the two types of rearrangement. Likewise, 
VH-gene replacement on the IgLκ locus only 
takes place in murine pre-B cells, which is the 
developmental stage that primary 
rearrangement of the immunoglobulin light 
chains normally occurs6. Secondary 
rearrangement of the kappa light chain locus 
is well established, and it usually comprises 
leap-frogging in which a new rearrangement 
 
Figure 1. A schematic overview of VH-gene replacement. The N region between VH and D is defined as N1 and the N 
region between D and JH is defined as N2. The  cryptic RSS (cRSS) is located in the 3’-end of the VH-gene and 
RAG1/2 are attracted to this signalling sequence and facilitates a second rearrangement into the allready rearranged 
IgH locus. This VH-gene replacement will remove the previous VH-gene leaving only a short stretch of 5-9 
nucleotides behind as a footprint (FP). This footprint may, however, become modifyed during joint formation by 
exonuclease and TdT activity and in activated B cells by somatic hypermutation. 
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between an unused upstream Vκ–gene and an 
unused downstream Jκ-gene segment deletes 
the previous VκJκ-gene.  However, Vκ-genes 
also feature embedded cRSS distributed 
among three locations throughout the Vκ-
gene. Ligation-mediated (LM) PCR has 
revealed that double stranded DNA breaks 
readily occur at embedded cRSS as well, 
suggesting that VL-gene replacement is a 
potential mechanism for receptor editing just 
as leap-frogging6.  
Transgenic mouse models have been 
really useful when demonstrating the potential 
of the VH-gene replacement mechanism in 
rescuing autoreactive B cells and B cells with 
non-productive rearrangements7-9. Chen and 
colleagues inserted a VHDJH sequence 
encoding the VH domain of an anti-DNA 
autoantibody, 3H9, into the JH-locus of mice. 
VH-gene replacement rescued the B cells from 
apoptosis due to autoreactivity7. A closer look 
at the manipulated locus revealed that three 
situations had occurred. 1) An upstream D-
gene segment had rearranged to the 3H9 
VHDJH generating a D-DJH hybrid and the 
3H9 VH-gene segment had been removed, 2) 
An upstream VH-gene segment had 
rearranged to the D-DJH hybrid creating a VH-
D-DJH hybrid and 3) an upstream VH-gene 
segment had rearranged to the 3H9 VHDJH 
replacing most of the 3H9 VH-gene segment 
and generating a VHDJH-rearrangement with 
different antigen specificity. The latter 
mechanism was consistent with the upstream 
VH-gene attacking a cRSS (5’-TTCTGTG-3’) 
present in the third frame work region of the 
3H9 VH gene. In another study, transgenic 
mice homozygous for a non-productive 
VHDJH-rearrangement were completely 
dependent on VH-gene replacement in order to 
generate a B cell receptor repertoire. These 
mice were in fact capable of producing large 
numbers of peripheral B cells by VH-gene 
replacement. Sequence analysis did, however, 
reveal that VH-gene replacement only 
occurred three times more often than a direct 
VH to JH rearrangement which is usually rare 
as it violates the 12/23 rule. Interestingly, 
though the majority of VHDJH-rearrangements 
in these transgenic mice had been generated 
by VH-gene replacement, only 20% of the 
sequences contained footprints suggesting 
that exonuclease activity is involved in the 
process as it is during primary V(D)J 
rearrangement10. 
VH-gene replacement is thus a well 
documented and characterized mechanism in 
murine cell lines and model systems11, 12. 
However when studying VH-gene replacement 
in mouse models it should be taken into 
account that these systems are driven by 
strong selection pressures that will favor the 
survival and proliferation of cells that have 
been rescued by VH-gene replacement. 
Therefore these systems do not describe the 
biological relevance or contribution of this 
mechanism during the generation of the 
normal murine B cell receptor repertoire.   
 
VH-gene replacement in the generation of the 
human B cell receptor repertoire. 
Much less is known about VH-gene 
replacement in human B cells. It is known 
that approximately 80% of all human VH-gene 
segments do contain a cRSS close to the 3’-
end. Zhang and colleagues have demonstrated 
that the human RAG enzymes are capable of 
binding and cleaving at the site of cRSS in 
vitro3. This ability to recognize and execute 
catalytic activity at motifs similar to the 
conventional RSS has also been implicated in 
the ontogeny of human B and T cell 
malignancies13-15. By recognizing and 
cleaving at poorly conserved cRSS located in 
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both tumor suppressor- and proto-oncogenes 
such as LMO2, Ttg-1, SIL, TAL1, RAG can 
mediate chromosomal translocations. These 
translocations can either take place between 
two non-antigen receptor loci (NARL) or 
between an antigen receptor locus and a 
NARL16. NARL cRSSs only contain the first 
3 or 4 nucleotides of the conventional RSS 
heptamer. Sequence analysis has revealed that 
these translocations are characterized by 
containing N additions and also show signs of 
exonuclease activity during the joining event. 
This indicates that illegitimate rearrangements 
must have been acquired through a similar 
mechanism as conventional VHDJH-
rearrangements under influence of RAG and 
TdT. These enzymes are primarily expressed 
in pro- and pre-B cells in the bone marrow, 
but also to some extent in lymphoid 
progenitor cells present in extra-follicular 
secondary lymphoid tissues17, 18. However, 
the affinity of RAG towards various NARL 
cRSSs has been studied and found to range 
between 30 and 20,000 fold less than the 
affinity towards the conventional RSS. 
Cleavage occurs at all NARL cRSSs 
identified, however hairpin formation does 
not always occur19, which is a vital step for 
segment joining20. While these data clearly 
points to a role for illegitimate RAG-induced 
rearrangements in the development of cancer, 
it is also likely that cRSSs will occasionally 
be targeted during the normal B cell 
ontogeny. It has been suggested that it plays a 
role in receptor editing in autoreactive B cells 
either in the bone marrow or elsewhere3. 
Because autoreactivity by newly formed B 
cells is quite common, such a function might 
have a substantial impact on the general B 
cell repertoire. To which extent this occurs 
remains to be established.  
Evidence that VH-gene replacement 
occurs commonly enough to affect the 
repertoire significantly is difficult to acquire, 
because the junctions after the second 
rearrangement are subject to modifications by 
adding, deleting and mutating the nucleotide 
sequence7. Only two studies so far have 
provided estimates for the frequencies at 
which VH-gene replacement contributes 
during the generation of the normal B cell 
receptor repertoire. One study suggested a 5% 
contribution3 while we suggested no 
significant contribution21. Zhang and 
colleagues searched for footprints in a sample 
of 343 unique VHDJH-rearrangements 
obtained from infants. The N region between 
the VH- and D-gene segments is often 
designated as N1 and the one between the D 
and JH-gene segment as N2. There should be 
no footprints after VH-gene replacement in N2 
and thus this N region was used as negative 
control. Zhang and colleagues observed a 5 
percentage points difference in the prevalence 
of footprints identified in N1 compared to N2. 
This difference was consequently interpreted 
as the frequency at which VH-gene 
replacement contributes to the normal B cell 
receptor repertoire. In Zhang and colleagues’ 
study, 11 footprints were excluded from the 
analysis as they were evaluated to match D-
gene sequences and thus would increase the 
number of irrelevant hits in the analyses in 
case unrecognized D-gene segments would be 
present in the presumed N regions. In Ohm-
Laursen and colleagues’ study, more than 
3600 unique VHDJH-rearrangements in which 
a D-gene segment was identified were 
analyzed for footprints in N1. In the same 
study, no evidence of direct D-gene to D-gene 
rearrangement was found in productive 
VHDJH-rearrangements making it irrelevant to 
exclude specific footprints from the analysis. 
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When searching for a broad spectrum of 
footprints no significant difference was found 
in the number of hits between N1, N2 or 
artificially permutated N1 sequences21.  
So how come a mechanism so easily 
induced in cell lines and mouse models is so 
difficult to find evidence for in the normal B 
cell receptor repertoire? One explanation 
could be that footprints contribute little to the 
peripheral repertoire. Another possibility is 
that footprints are lost during the secondary 
joint formation due to exonuclease activity. 
By estimating the average exonuclease 
activity during joint formation based on the 
truncation of the 3’-end of VH-gene segments 
and 5’ end of D-gene segments in thousands 
of VHDJH-rearrangements, the chance of 
finding a footprint of at least 5 nucleotides 
after a heptameric germline footprint is in fact 
only 18.7% (Manuscript III). This frequency 
correlates well with the previously mentioned 
mouse-model study, where only 20% of the 
rearrangements generated by VH-gene 
replacement were found to contain 
footprints10. At the same time, the 
identification of motifs stochastically 
simulating footprints in the control materials 
may be very high, sometimes exceeding 30%. 
This imposes severe difficulties in the 
statistical analyses of the data and these 
problems may be the main explanation for the 
discrepancy between the two studies. Safe 
detection of a 5% prevalence of true 
footprints given 15% random hits in the 
control group requires more than 1200 
VHDJH-rearrangements per group given the 
conventional type 1 error rate of 2α=5% and  
a type-2 error rate of 10%*. To date, only the 
study of Ohm-Laursen and colleagues meet 
                                                 
*
 Comparison of two proportions: N1=N2=(1.28√[p1(1-
p1)+p0(1-p0)]+ 1.96√[2p¯ (1-p¯ )]/(p0-p1)2 
this requirement (n>3600) and, as mentioned 
above, failed to find evidence of VH-gene 
replacement  using a P value of 1% as a 
correction for testing multiple lengths of 
footprints (Bonferroni correction). Zhang only 
used N2 as a negative control for VH-gene 
replacement while Ohm-Laursen also used an 
artificially permutated N1. Even though N2 
cannot contain true footprints after VH-gene 
replacement, the use of N2 as a control is 
based on an assumption that N1 and N2 are 
structurally alike. Patterns within the 
nucleotide sequence of N1 and N2 have been 
difficult to demonstrate due to limited 
numbers of VHDJH-rearrangements. It is 
therefore unknown whether N2 is a suitable 
control for N1. Similarly, it may be argued 
that permutated N regions not necessarily 
have the relevant microstructure needed for 
establishing a suitable control. Large-scale 
studies on datasets generated by high-
throughput sequencing may however 
demonstrate discrete differences within the 
structure of N1 and N2. This knowledge may 
be used for fabricating negative controls by 
computer algorithms that imitate the natural 
structure of N1. Large-scale analysis for 
footprints and reconsideration of the analysis 
method, may in the future establish the 
contribution of VH-gene replacement in the 
generation of the human B cell receptor 
repertoire. 
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Materials & Methods 
 
 
NEXT-GENERATION SEQUENCING 
 
Next-generation sequencing is a powerful 
method for obtaining large amounts of 
sequence data in a time-efficient manner. We 
used the GS Junior System provided by 
Roche for sequencing thousands of DJH- and 
VHDJH-rearrangements obtained from healthy 
adult donors. This sequencing system is based 
on the technique of emulsion PCR, where   
DNA fragments are ligated to small DNA-
capture beads in a water-in-oil emulsion. Here 
we describe the process we went through to 
obtain our results.    
 
Peripheral blood mononuclear cell. 
Peripheral Blood Mono-nuclear Cells 
(PBMCs) were isolated from blood obtained 
from 110 healthy adult donors using 
lymphoprep solution. By taking advantage of 
the different densities of the cells present in a 
blood sample is it possible to separate the 
erythrocytes and granulocytes from the 
PBMCs using the density gradient medium 
lymphoprep. The PBMCs have the lowest 
density of all the blood cells and therefore 
these cells will be retained at the 
sample/medium interface as a fussy white 
layer known as the buffy coat. The blood 
samples were diluted 1:1 with PBS and then 
loaded on top of lymphoprep (ratio 2:3) in a 
50 ml tube and spun at 600g for 60 min. The 
buffy coat (Figure 1) was subsequently 
transferred to a new tube and washed three 
times in PBS prior to counting. After counting 
we pooled cells from 5 donors into one 
sample contributing 10 million PBMCs each. 
This yielded a total of 22 samples containing 
 
 
 
Figure 1. Lymphoprep isolation of PBMCs. A) 110 bags of fractionated blood were each diluted 1:1 in PBS. B) Each 
diluted sample was loaded on top of the lymphoprep C) After centrifugation the PBMCs have settled on top of the 
lymphoprep and are easily collected using a disposable Pasteur pipette. 
 
SECTION 2.0 MATERIALS & METHODS MARCH 2013 
34 
 
50 million cells. We did this to prevent clonal 
B cell populations in individual donors from 
dominating the samples and thus affecting the 
sequencing outcome. 
 
CD19+ cell separation. 
The B cell specific marker CD19+ was used 
for extracting all developmental stages of B 
cells from Pro- to Mature B cells. 50 µl anti-
CD19-coated magnetic beads (Invitrogen) 
were dissolved in 10 ml ice-cold PBS 
supplemented with 1% heat inactivated FBS 
and separated on a magnetic separation device 
(MSD) suitable for 15 ml tubes. Beads were 
washed 3 times prior to use. The washed 
beads were added to 50 million PBMCs in a 
final volume of 5 ml and incubated rotating at 
4°C for 30 mins. Cells were washed 3 times 
in 10 ml PBS using the MSD. After final 
wash, cells were resuspended in 200 µl PBS 
 
 
Figure 2. CD19+ cells conjugated to anti-CD19 coated Dynal beads. The number of cells isolated can be estimated 
based on the Burket counter chamber. The Bürker counter chamber is divided into 9 squares that each are divided 
into 16 squares. The number of cells per ml is estimated by calculating the average number of cells within 1 of the 9 
squares and multiplying it by 10,000. In this case there were ~60 cells within the red lines and accordingly the cell 
density was ~106 cells/ml. 200 µl of bead conjugated B cells (2x106 cells) were following subjected to DNA 
extraction.   
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and counted using a Bürker counting chamber 
(Figure 2).  
 
Genomic DNA extraction. 
DNA was extracted from samples containing 
a maximum 5x106 CD19+ B cells 
resuspended in 200 µl PBS by QIAamp ® 
DNA Mini and Blood Kit according to 
manufacturer. This is a silica membrane-
based purification kit where the negatively 
charged nucleotides are adsorbed to the 
positively charged silica membrane in the 
presence of a high salt concentration and low 
pH. The DNA is eluted from the silica 
membrane by increasing the pH and lowering 
the salt concentration which occurs when 
water is added to the membrane.  
 
Amplicon Library preparation. 
We amplified DJH- and VHDJH-
rearrangements from the DNA extracted from 
CD19+ B cells. During this PCR, PCR 
products are conjugated to a linker sequence 
provided by Roche. This linker enables the 
fragments to be linked to capture beads in an 
emulsion PCR (Figure 3). Linker conjugated 
PCR fragments are generated in an amplicon 
library PCR, using target specific primers 
with 3’-overhanging multiplex identification 
codes (MID) and linker sequences. During 
amplicon library preparation we had 
attempted to obtain an equal distribution of V 
and D-gene families in VHDJH and DJH-
rearrangements, respectively. Using 
frequencies provided by the literature, we 
calculated the amount of template to add 
during the amplicon PCR. Table 1 illustrates 
the figures that we based the template 
concentrations on. The frequencies indicate 
the usage of the respective gene family in 
blood. Template is the number of templates 
added per PCR reaction. This number was 
Forward primer: 
5'-CGTATCGCCTCCCTCGCGCCATCAG-MID-template specific sequence-3’ 
 
Reverse primer : 
5'-CTATGCGCCTTGCCAGCCCGCTCAG-MID- template specific sequence-3’ 
 
Figure 3. DNA sequence of primers used for amplicon library preparation.  
 
Table 1. Based on the usage frequencies of VH-gene 
and D-gene families in the peripheral BCR repertoire 
and the fraction of B cell carrying DJH-, non-
productive and productive VHDJH-rearrangments we 
estimated the concentration of template to be added 
per PCR template reaction.  
Family Percent template cells ng/well 
D1 7 117 2671 17 
D2 22 117 886 6 
D3 39 117 503 3 
D4 7 117 2708 18 
D5 8 117 2600 17 
D6 17 117 1147 7 
D7 1 N/A N/A N/A 
     
VH1 15 100 933 6 
VH2 4 100 3500 23 
VH3 36 100 389 3 
VH4 15 100 933 6 
VH5 12 100 1167 8 
VH6 3 100 4667 30 
VH7 15 100 933 6 
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estimated based on the level of sequences that 
one sequencing provides (70,000 reads). Each 
template should ultimately be sequenced 10 
times which theoretically enabled us to 
sequence 7000 unique templates per 
sequencing. These 7000 templates had to be 
distributed among 6-7 gene families and 10 
samples yielding 60 PCRs (117 
templates/reaction) for the D-gene families 
and 70 PCRs (100 templates/reaction) for the 
VH-gene families. The number of cells was 
calculated based on the number of templates 
required and the gene family frequency. The 
amount of DNA (ng/well) was calculated 
based on the number of cells and that each 
cell roughly contains 6 pg of DNA. 60% of 
the B cells contain one DJH-rearrangement 
and one VHDJH-rearrangement template, 
while the final 40% contain two VHDJH-
rearrangement templates.    
Roche recommends purifying the 
library by AMPure magnetic beads (Figure 4). 
Other companies such as Promega and Health 
Care also provide PCR purification solutions, 
but in our hands the AMPure beads most 
efficiently removed short fragments and 
primer dimers (data not shown). The PCR 
fragments were incubated with the magnetic 
AMPure beads for 10 min. The bead-
conjugated PCR products were subsequently 
extracted using a 96-well magnetic ring stand. 
The beads were washed twice in ethanol and 
after the last wash the bead pellet was allowed 
to dry completely. The purified PCR 
fragments were eluted by adding 10 µl TE 
buffer to the wells. 
 
PicoGreen concentration estimation. 
Picogreen is a compound manufactured by 
Invitrogen capable of binding double stranded 
DNA. After mixing 1 µl of purified PCR 
fragments with PicoGreen diluted 1:100 in 
TE-buffer, the OD was measured. Based on a 
standard curve, the concentrations of the 
purified PCR samples were estimated and 
diluted to contain 108 amplicons/µl and all 
samples were pooled 1:1.  
 
Bioanalyzer concentration estimation. 
After pooling the samples 1:1, the pooled 
sample was further diluted to 105 
amplicons/µl. To confirm that the library was 
 
 
Figure 4. AMPure beads from Agencourt were used for purifying PCR product. The entire procedure took 
approximately 30 min. Even though the procedure was fast and very efficient at removing primer dimers and other 
short PCR products, we lost a large part of DNA product during purification as well. Fortunately, the Picogreen 
concentration estimation kit detected as little as 2 ng/µl. (Figure from Beckman Coulter Inc.) 
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free of short fragment, the sample w
on a High-sensitivity DNA chip run on the 
Agilent 2100 Bioanalyzer. This analysis 
further validated the quality of the amplicon 
library prior to sequencing. It was imp
that the sample was completely free of short 
redundant fragments as these diffuse more 
easily into the emulsion bubbles of the 
emulsion PCR (emPCR). A large part of the 
resulting beads would then be covered by 
short fragments and ultimately interfer
the sequencing outcome.  
 
454-sequencing. 
454-sequencing relies on attaching single 
stranded amplicons to small DNA
beads in a water-in-oil emulsion 
A PCR reaction then amplifies the amplicon 
within each emulsion bubble 
covering the entire surface of the bead. Each 
DNA-bound bead is placed into a ~29 
 
Figure 5. A) Schematic illustration of the emPCR reaction which is the basic principle of 454
stranded amplicons are conjugated to the capture beads through a linker sequence. The PCR reaction then copies the 
amplicon within the emulsion bubble and ultimately the capture bead is entirely covered by a single amplicon clone. 
(Figure from TRENDS in Genetics) B
without DNA are washed away and the remaining conjugated beads are
to estimate the number of beads recovered. No more than 2,000,000 
recovered. Less than 500,000 beads will lead to too few reads and exceeding 2,000,000 will lead to mixed reads 
during sequencing. 
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µm 
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and luciferase are also packed into the well
The fluidics sub-system 
delivers sequencing reagents (containing 
buffers and nucleotides) across the wells of 
the plate. A CCD came
emissions resulting from the incorporation of 
one or more dNTP. Over a course of 10 hours 
70,000 wells are sequenced.
The amount of amplicon library added 
to the emPCR had to be optimized. In order to 
ensure that only a single ampli
each emulsion bubble, the company has 
provided a formula to calculate the optimal 
amount of amplicons added to the emPCR. 
Using this formula we did however obtain a 
concentration that oversaturated the capture 
beads and as a consequence the
covered by more than one type of amplicon. 
This led to undesirable mixed reads during the 
) After the emulsion PCR, the beads are purified through several steps. Beads 
 counted in a counting device that allows you 
and no less than 500,000 beads should be 
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sequencing procedure. In our hands, 5 µl of 
library 105 amplicon/µl yielded the best 
results. The emPCR was run over night and 
next day subjected to an extensive washing 
procedure according to the manufacturer. 
Empty beads were removed by magnetic bead 
purification. Ultimately the amount of beads 
recovered was between 500,000-2,000,000 
beads which were estimated using a small 
counting device provided by Roche (Figure 5 
B). 
 
Data analysis. 
We used a suite of programs developed by 
Torben Barington for analyzing the 
rearrangements as described in Manus I. 
Briefly, chip sequences were qualified by the 
presence of primer and MID sequences, 
reverse complementary sequences were 
reverse complemented, and identical reads 
were clustered. Clusters from the same PCR 
could be identified based on the primers and 
MIDs and were analyzed separately in the 
Figure 6. A) The length of D-genes in DJH-rearrangements with mutated and unmutated VH3-23. We found that 
there was no difference between the length of D-genes when analysing DJ-rarrangements with mutated and 
unmutated VH3-23. B) The length of N-addition in between the D- and JH-gene segment, did not differ between DJH-
rarrangements with mutated and unmutated VH3-23. 
 
 
Figure 7. The level of frame shifting deletions and 
insertions were significantly higher in non-productively 
rearranged compared to productively rearranged VDJ 
rearrangements. The level of sequence credibility was 
1.6% when accepting sequences with at least 1 forward 
and 1 reverse sequence and 1% when accepting 
sequences with at least 2 forward and 2 reverse 
sequences. This increase in credibility was however not 
significant.   
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following. Clusters were ordered after 
declining number of members. The sequence 
of the largest cluster (≥2 members) was 
accepted if the cluster had an acceptable 
balance of forward and reverse sequences. If 
not accepted, the algorithm continued to the 
next cluster. Once a sequence was accepted, it 
was compared with all smaller clusters and 
these were discarded if their sequence did not 
deviate by a certain number of substitutions or 
delins from the index sequence. The number 
depended on the cluster sizes and was 
selected to account for Taq errors and other 
common sequencing artefacts that allowed 
clonal sequences to diverge. When all smaller 
clusters had been dealt with, the process 
reiterated from the largest of the remaining 
clusters and this process continued until all 
clusters were either accepted or discarded. 
The accepted sequences were analyzed with 
an improved version of the VDJsolver 
algorithm as described elsewhere (Ohm-
Laursen et al 2006).   This program is capable 
of identifying a vast array of features within 
the rearrangements; from identifying the 
germ-line genes used including the D 
segment, the degree of trimming of the 
segments to the number of N-additions added. 
These features are identified based on a 
complex algorithm that analyses the 
rearrangements thoroughly by a maximum 
likelihood algorithm. A VHDJH-rearrangement 
was considered productive when it had 
rearranged in an open reading frame (no stop 
codons) prior to somatic hypermutation, while 
sequences considered non-productive had 
rearranged out of reading frame or contained 
one or more stop codons prior to somatic 
hypermutation. The somatic hypermutation 
status of the rearrangement was based on the 
level of substitutions indentified within the 
VH-gene segment. Rearrangements containing 
more than 3 substitutions in the VH-gene 
segment were considered somatic 
hypermutated. Those with less than 3 
substitutions were considered un-mutated. 
 
Detecting somatic hypermutations in VHDJH-
rearrangements. 
As the program was developed for studying 
VHDJH-rearrangements we had to modify the 
DJH-rearrangements to be able to analyze 
them in the program. We did this by adding a 
known VH3-23 sequence to all DJH-
rearrangements prior to the analysis. VHDJH-
rearrangements can be either mutated or un-
mutated dependent on the developmental 
stage of the B cells they derived from. The 
program used for analyzing VHDJH-
rearrangements evaluated the level of 
mutations in the D- and JH-genes based on the 
number of mutations identified within the VH-
genes. If the VH-gene was heavier mutated the 
program would allow a higher level of 
mutations in the D and JH-gene segments. 
This may subsequently influence the length of 
the identified D-gene and the length N-
additions. If the VH-gene was unmutated the 
program might not accept a mutation in the 
beginning or the end of a D-gene, but instead 
categorize the unmatched nucleotide(s) to the 
N-addition. This had to be taken into account 
when the program was used for analyzing 
DJH-rearrangements that do not have an actual 
VH-gene.  
We therefore analyzed DJH-
rearrangements conjugated to either a mutated 
(15 mutations) or unmutated VH3-23 gene 
segments (Figure 6). We found, however, that 
the outcome was almost identical for both 
datasets of DJH-rearrangements and therefore 
decided to use DJH-rearrangements joined 
with unmutated VH3-23 gene segments. 
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Distinguishing Taq-errors from somatic 
hypermutation. 
A productive VHDJH-rearrangement should 
not contain deletions or insertions within the 
VH-gene region that cause a shift in the 
reading frame and consequently generate a 
stop codon downstream in the sequence. We 
used this assumption to investigate the 
frequency of inserts and deletions in 
productive versus non-productive VHDJH-
rearrangements and to verify how few 
forward and reverse sequences would suffice 
in order to secure the creditability of the 
sequences. In the sequences that had at least 1 
forward and 1 reverse sequence we found 
~1.6% of the productive VHDJH-
rearrangements containing inserts or deletions 
(Figure 7). As stated above these insertions 
and deletions are not likely to be biologically 
derived but rather Taq-errors or sequencing 
artifacts. This “noise” was not reduced 
significantly (1%, P=0.27 ) if we only 
accepted sequences that had at least 2 forward 
and 2 reverse sequences, but it caused a 
radical decrease in sample size. Therefore we 
decided to work under the circumstances that 
yielded the larger dataset.  
We further investigated the level of 
substitutions generated by Taq polymerase by 
analyzing the level of substitutions that 
disrupted the open reading frame, changed the 
second conserved cysteine in the VH-gene and 
the conserved tryptophan in the JH-gene. We 
found that these types of substitutions were 
extremely rare in the VHDJH-rearrangement 
considered productive (0.1%), while they 
occurred at a significantly higher frequency 
(16.8%) in the non-productive  VHDJH-
rearrangement. We used the equation below 
to estimate the level of biologically derived 
substitutions in the dataset (>99%). 
 
Frequency 
biological subst. 
 
= 
%Subst.(NP) – %Subst.(P) 
%Subst.(NP) 
 
We could subsequently estimate the fraction 
of substitutions generated by Taq-errors and 
sequencing artifacts to <1% of recorded 
substitutions in mutated sequences.  
 
Statistics. 
We most often used non-parametric statistical 
analysis for analyzing the deep-sequencing 
dataset. These tests do not require data 
belonging to any particular distribution. A 
non-parametric test usually yields a higher P-
value and is thus stricter. The risk of 
acquiring a type I error (false positives) 
should accordingly be reduced. We used 
Mann-Whitney and Kruskal-Wallis Test for 
testing two or more cumulated frequency 
distributions and Spearman’s rank correlation 
test for testing correlations in frequencies. 
These tests were executed in 
GraphPadPrism4.0 along with producing 
figures for the manuscripts. We used the Chi-
square (χ2) and Fishers exact tests for testing 
whether the frequency distributions among 
 
Figure 8. pBudCE4.1 is an eukaryotic expression vector 
with two multiple cloning sites that each are preceded 
by a unique promoter. The vector is equipped with a 
PSV40 that enables extensive plasmid replication in T-
antigen expressing eukaryotic cell lines. 
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categorical groups were equal. For sample 
sizes ≥30 we used χ2-testing and when 
searching for rare events in the human B cell 
receptor repertoire, where the sample size was 
<30, Fisher’s exact test was applied. We 
either used online calculators or excel for 
calculating the Pearson χ2 and P values. The 
computerized statistical technique, Monte-
Carlo simulation, was used when testing 
whether distance between gene segments had 
an effect on rearrangement frequencies and 
when evaluating nucleotide prevalence and 
predicted amino acid content of N regions. 
This technique builds a model of possible 
results of a chosen test parametre under the 
null hypothesis. For example, we generated a 
model for the distribution of sum of squared 
differences of distances between D- and JH 
gene segments randomly selected from the 
dataset. If distance did not have an effect on 
rearrangement frequency we would thus 
expect the observed sum of squared distances 
to be similar to that of the model output. We 
could then estimate a P value for the actual 
value of the sum of squared distances based 
on the distribution of the model.  P<0.05 was 
considered statistically significant. When 
multiple comparisons were done, Bonferroni 
correction of P values was employed. 
 
MOLECULAR CLONING AND CELL 
TRANSFECTION 
 
We used complex molecular cloning in the 
attempt of generating a two-plasmid non-viral 
integration system for targeted gene 
integration in human cell culture. Through 
several steps we succeed in constructing a 
functional vector containing both 
Recombination-Activating Genes (RAG) 1 
and 2 (RAGVec1.0) and the Reporter Vector 
(GeneVec1.0) containing our gene of interest 
(GOI). Here, we go through some of the 
considerations and details of generating the 
RAGVec1.0 and the generation of transgenic 
cell lines.  
  
Preparation for molecular cloning. 
The first step in molecular cloning was 
choosing a plasmid backbone for the gene of 
interest (GOI) to be inserted in. The choice of 
a proper backbone is dependent on the 
purpose of the cloning experiment, whether it 
is library generation or protein expression 
studies in eukaryotic cells. A plasmid usually 
contains all the elements required for plasmid 
replication, gene expression and antibiotic-
selection. We have worked with several 
different backbones during the development 
of the two-plasmid non-viral integration 
system. For the RAGVec1.0 we chose the 
eukaryotic expression vector pBudCE4.1 
which is a dual gene expression vector able to 
express both RAG1 and RAG2 
simultaneously. The inserted genes are driven 
by individual promoters (RAG1 by pCMV 
and RAG2 by pEF-1α) and the vector carries 
resistance against zeocin which is a selective 
antibiotic for both prokaryotes and eukaryotes 
(Figure 8).  
For cloning with pBudCE4.1 we were 
dependent on restriction endonucleases (RE). 
Today hundreds of enzymes are commercially 
available. It is important to know that 
different REs work under different conditions. 
Incubation time, temperature and salt 
concentration are all important factors that 
influence the function of the RE. Some REs 
have unusual requirements, such as multiple 
recognition sites, in order to function properly 
that may complicate the process of cloning 
and therefore has to be considered before 
implementing them. Fortunately, the 
companies are good at providing this 
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information and with the aid of online tools, 
such as WebCutter2.0, it is relatively easy to 
design a molecular cloning experiment. It is 
important to choose REs that are not cutting 
at unwanted sites. We entered the DNA 
sequence of RAG1 and RAG2 into 
WebCutter2.0 and searched for REs that did 
not cut within the genes and that were present 
within the multiple cloning site (MCS) in 
pBudCE4.1.  To increase the chance of 
inserting the gene in the correct orientation, it 
is an advantage to use different REs for 
digestion of the 5’ and 3’ ends, respectively. 
In the case of RAG1, we chose SalI and 
BamHI and for RAG2 NotI and SfiI. By 
designing RAG1 and RAG2 specific primers 
with overhanging restriction sites, we were 
able to generate inserts with flanking 
restriction site. The overhangs were 
dependent on the functional features of the 
respective REs. Most REs require 2-8 
nucleotides on each site of the restriction site.  
 
Digesting with restriction enzymes. 
The efficiency of a digest can be visualized by 
gel electrophoresis (Figure 9). Linearised 
plasmid DNA moves slower in the gel than 
super coiled plasmid DNA. After digestion, 
removing the 5’-end phosphor by phosphatase 
treatment will prevent the plasmid from re-
annealing. It is not possible to visualize the 
digest of the ends of the GOI unless it has 
been excised from another vector.  
Many modern REs are highly efficient 
and can digest 1 µg of DNA in 5 min. In this 
study, however, most of the digestions were 
performed at 37°C for 1-2 hours. If it is not 
possible to stop the digestion reaction by 
increasing the temperature, the reaction-
mixtures should be purified prior to ligation. 
Active enzyme will interfere with annealing. 
Ligation of the GOI and the plasmid is 
executed by the T4 ligase. There should be at 
least three times as much GOI than plasmid in 
the reaction. The T4 ligation reaction was 
incubated for 30 min followed by heat 
inactivation at 65°C for 10 min. 
 
Topo-cloning. 
Topo-vectors are open ready-to-use vectors 
that do not require restriction enzymes or 
ligases for inserting a GOI. The linear vector 
DNA already has the topoisomerase enzyme 
covalently attached to both of its strands' free 
3' ends. The technique exploits the fact that 
Taq-polymerase adds an A-overhang to the 
PCR-product, which then hybridizes with the 
T-overhang of the Topo-vector. Depending on 
the size of the insert, the incubation time may 
take from 5-30 min at room temperature. We 
used Topo-cloning for generating standard 
curves for qPCR and also for routine DNA 
sequencing purposes.      
 
Transforming bacteria. 
We subsequently added 5 µl ligation product 
to 100 µl of chemically competent TOP10 
cells (Invitrogen) and incubated it for 30 min 
 
 
Figure 9. The motility of nicked, linearized and 
supercoiled plasmid DNA during gel 
electrophoresis. Supercoiled plasmids are small and 
compact and they will move faster in the gel. Nicked 
plasmids are large and move slowly in the gel. 
Linearized plasmid moves consistently with the 
molecular marker. In this case, the plasmid is ~4500 
bp. 
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on ice. A brief heat shock of 42°C temporarily 
disrupted the membrane allowing the 
plasmids to enter the cells. 200 µl medium 
was added and the cells were incubated at 
37°C for 1 hour. 50-100 µl bacteria were 
spread out on large antibiotic containing agar 
plates and colonies were allowed to form over 
night. Agar plates were composed of water, 
yeast, salt, tryptophan and agar. After 
autoclaving, the agar was allowed to cool to 
approximately 60°C, before any antibiotics 
were added. The plates were prepared under 
sterile conditions and preferably a few days 
prior to use. The colonies were tested for 
inserts by picking a colony and first dipping it 
into the PCR reaction mix and next into a 10 
ml tube containing medium for overnight 
culture. After PCR, gel-electrophoresis 
identified which colonies contained inserts 
and which did not. Plasmids were purified 
from overnight cultures belonging to positive 
clones. 
 
DNA sequencing. 
SANGER-sequencing was used for 
confirming the sequence of the insert. This 
sequencing technique is based on the selective 
incorporation of chain-terminating ddNTP by 
DNA polymerase.  The ABIPrism 3130 
sequencer uses dye-terminator sequencing, 
where four ddNTP are labeled with distinct 
fluorescent dyes that emit light at different 
wavelengths. This method can sequence 
products up to 700 bp. For each product, a 
forward and a reverse sequence were obtained 
which partially overlapped. Sequences were 
analyzed in the program Chromas. Resulting 
sequences were aligned with the reference 
sequence of the given GOI and clones 
containing Taq-errors were discarded.   
 
Human cell transfection. 
Polyethylinimine (PEI) is a small cationic 
polymer that is used for cell transfection. The 
DNA/PEI complexes are internalized by the 
cell mainly through the endocytic pathway. 
The complexes efficiently absorb the protons 
transported into the endolysosomes ultimately 
leading to an increase n pH which will 
deactivate the degrading enzymes inside the 
vesicle. This prevents the DNA/PEI complex 
from being disintegrated. At the end of the 
endo-lysosomal pathway, the vesicle ruptures 
and the content is emptied into the cytosol. 
We coated plasmids with 2 µl JetPEI/µg of 
pDNA and incubated for 30 min prior to 
pipetting it over the cells. Within 8 hours cells 
became transgenic (Figure 10).  
 
Cell culture and sub-cloning. 
Transgenic cells were either harvested for 
experimental purposes within 3-5 days after 
 
Figure 10. HEK293t cells transfected with a green fluorescent protein. The first transgenic expression can be 
visualized already after 8 hours and it increases over the course of 3 days. If the desire is stabile transfection, 
selection antibiotics should be added to the cultures after 24 hours. 
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transfection or they were grown in the 
presence of selection antibiotics to kill 
untransfected cells and promote growth of 
transgenic cells. In order to obtain high 
transgenic expression of the antibiotic 
selected cells we further sub-cloned the cell 
culture. Approximately 200 cells were plated 
into a large petri dish and colonies were 
allowed to form over the course of 10-14 
days. Cloning discs were used to collect 
colonies and transfer them into 24 well plates 
for further culturing. 
 
Real time PCR. 
Transgenic cell lines were tested for 
transgenic mRNA expression by real time 
PCR. This technique is extremely sensitive 
and may detect even a few mRNA transcripts. 
The template for a real time PCR was cDNA, 
which was prepared from freshly extracted 
RNA. Plasmid DNA interfered with the real 
time PCR results and we therefore added an 
extra step of DNAse I treatment (10 µl of 
DNAseI per sample, 30 min incubation at 
37˚C) prior to RNA purification. No reverse 
transcriptase controls were generated for all 
cDNA samples in order to assess the 
background level of expression. All primer 
pairs amplified products between 80-120 bp 
and had been subjected to temperature 
optimization. We used semi-quantitative real 
time PCR for testing transgenic expression 
and the expression level was estimated based 
on the Ct ratio between the reference gene and 
the target gene. In this case we used FBXL12 
as reference gene.   
 
Enzyme-linked immunosorbent assay 
(ELISA). 
ELISA is a convenient way of screening 
multiple samples for intracellular or secreted 
proteins. The method can however only 
demonstrate the presence and not the size of 
the protein of transgenic protein. We used the 
method for measuring the transgenic 
expression of RAG1 and RAG2 protein in 
whole cell lysate. We used an indirect ELISA 
technique where the primary antibody was 
unconjugated and the secondary was HRP-
conjugated. Indirect ELISA yields a higher 
signal due to the secondary antibody 
compared to direct ELISA which relies on the 
signal from a HRP-conjugated primary 
antibody. Plates were coated with 50 µg 
protein over night and blocked with 1% BSA. 
Primary antibody was incubated at room 
temperature for 1 hour followed by 1 hour 
incubation with secondary antibody. The 
ELISA was developed using an ELISA kit 
from R&D Systems and OD was read on a 
plate reader from Organon Teknika microwell 
system 230S.   
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ABSTRACT  
Rearrangement of the immunoglobulin locus occurs in two steps. First a JH-gene is rearranged 
to a D-gene followed by a VH-gene rearranging to the DJH-rearrangement. By deep 
sequencing, we analyzed 9969 unique DJH-rearrangements and 5919 unique VHDJH-
rearrangements obtained from peripheral blood B cells from 110 healthy adult donors. We 
found that DJH-rearrangements and non-productive VHDJH-rearrangements had many features 
in common but differed significantly in their use of D-genes. During D- to JH-gene 
rearrangement, the D-genes proximal to the JH-locus were rearranged more frequently than 
JH-locus distal D-genes while VH-locus proximal D-genes were observed more frequently in 
non-productive VHDJH-rearrangements than VH-locus distal D-genes. We further 
demonstrated that the distance between VH-, D- and JH-gene segments influence their ability 
to rearrange within the human immunoglobulin locus.  
 
 
INTRODUCTION 
 
The variable part of the immunoglobulin 
heavy chain is generated by rearranging a 
variable (VH), diversity (D) and joining (JH) 
gene segment on the immunoglobulin heavy 
(IgH) chain locus. Rearrangement takes place 
in two consecutive steps: First a JH-gene is 
rearranged to a D-gene and secondly a VH-
gene is rearranged to the DJH-rearrangement. 
VH and JH-genes are flanked by 23-spacer 
RSS and D-genes by 12-spacer RSS. 
Generally, a gene segment flanked by a 12-
spacer RSS is only paired with a gene 
segment flanked by a 23-spacer RSS 1-3. This 
rule ensures that the IgH gene is assembled in 
the correct order. There are, however, 
exceptions to this rule in that direct D-gene to 
DJH rearrangements have been observed in 
3% of non-productive (NP) VHDJH-
rearrangements4. Direct D- to D-gene 
rearrangement are even rarer in productive (P) 
VHDJH-rearrangements (<1.5%) and 
accordingly the contribution of these atypical 
rearrangements to the generation of the B cell 
receptor (BCR) repertoire is considered to be 
insignificant 4, 5. The RAG enzymes cleave 
between the last nucleotide of the heptamer 
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and the first nucleotide of the gene segment. 
The gene segment-end is sealed by a hairpin 
loop while the heptamer-end remains blunt 
and is ligated with the heptamer-end resulting 
from the pairing gene segment creating an 
excision circle. When the rearranging gene 
segments are brought together, the hairpin 
loops are reopened by the Artemis/DNAPK 
complex generating 3’-overhangs6. The two 
3’-overhangs are subjected to exonuclease 
trimming and subsequently terminal 
deoxynucleotidyl transferase (TdT) adds extra 
non-templated (N nucleotides) nucleotides to 
the overhangs7, 8.  Joining of the two gene 
segments are guided by microhomology in the 
3’-overhangs. Depending on the level of 
exonuclease activity a palindromic sequence 
(P nucleotides) will remain after 
rearrangement as a consequence of hairpin 
opening.  
In the late 1980’s and early 1990´s it 
was demonstrated in several mouse studies 
and one study on human fetal liver cells that 
the choice of gene segments during V(D)J 
rearrangement was not merely stochastic. VH-
genes positioned closer to the D-locus 
rearrange more frequently than VH-genes 
positioned more distantly9-12. In humans, it is 
unknown whether this position bias also 
applies during the generation of the adult 
BCR repertoire. It also remains unexplored 
whether D- and JH-gene usage is influenced 
by gene position.  
To our knowledge no studies have yet 
investigated the sequence of sterile DJH-
rearrangement products obtained from human 
peripheral B cells. D-gene usage and the 
somatic hypermutation status of these 
rearrangements are not known. We have 
sequenced 9969 unique DJH-rearrangements 
and 5919 unique VHDJH-rearrangements 
obtained from peripheral B cells from 110 
healthy adults in the attempt to uncover the 
general rearrangement mechanism and 
identify features that are subsequently 
modified by selection. We compared length of 
N regions, level of gene segment trimming, 
presence of P nucleotides and JH-gene usage 
among DJH-, productive (P) and non-
productive (NP) VHDJH-rearrangements. As 
anticipated, most features were similar 
between DJH- and NP VHDJH-rearrangements 
as both of these rearrangements are 
untranslated and thus not prone to selection. 
In DJH-rearrangements, we demonstrate a 
clear rearrangement preference of D-genes 
positioned JH-locus proximal. We further 
found that this position bias shifted during 
VH-gene to DJH rearrangement, indicating a 
VH-gene preference for DJ-rearrangements 
positioned closer to the VH-locus.  
 
MATERIALS AND METHODS  
 
Sample preparation 
A biobank of anonymized buffy coats from 
110 healthy blood donors was used in 
accordance with Danish legislation. PBMCs 
were purified using density gradient 
centrifugation on lymphoprep (Medinor). All 
PBMC suspensions were counted and PBMCs 
from groups of 5 donors were pooled 1:1. The 
pooled samples were then enriched for 
CD19+ cells by anti-CD19 Dynal bead 
purification (Invitrogen). DNA was extracted 
directly from the magnetic bead conjugated 
CD19+ cells using DNA extraction kit 
(QiaAmp). The concentrations of DNA were 
subsequently measured on NanoDrop2000 
(Thermo Scientific). All samples were diluted 
to 50 ng DNA/µl.  
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Preparation of amplicon library 
VHDJH- and DJH-rearrangements were 
amplified using VH-gene and D-gene family-
specific forward primers, respectively, 
combined with a consensus JH-gene reverse 
primer. All forward and reverse primers were 
conjugated with linker sequences (forward 5'-
CGTATCGCCTCCCTCGCGCCATCAG-3', 
reverse 5'-
CTATGCGCCTTGCCAGCCCGCTCAG-3') 
as recommended by the manufacturer 
(Roche). The template-specific parts of the 
primers were: IGHV1: 5’-
TGAGGTGAAGAAGCCTGGG-3’, IGHV2: 
5’-CTCTGGGTTCTCACTCAGC-3’, 
IGHV3: 5’-GTCCCTGAGACTCTCCTGT-
3’, IGHV4: 5’-ACCCTGTCCCTCACCTGC-
3’, IGHV5: 5’-
TGGAGCAGAGGTGAAAAAGC-3’, 
IGHV6, 5’-TTGCTGTTTCCTTTTGTCTCC-
3’, IGHV7: 5’-
GCTTCTGGATACACCTTCAC-3’, IgHD1: 
5’-GATTCTGAACAGCCCCGAG-3’,  
IgHD2: 5’-TTTTGTGGGGGCTCGTGTC-3’, 
IgHD3: 5’-GGTCTGTGTCACTGTGGTAT-
3’,  IgHD4: 5’-
GGCACACTCAGGGGCTTTT-3’, IgHD5: 
5’-ACAGCCCCGCCTCCAGTT-3’, IgHD6: 
5’-GGTTTCTGAAGGTGTCTGTG-3’, 
IGHJ: 5’-CCTGAGGAGACGGTGACC-3’. 
All 7 VH-gene families were analyzed while 
only families 1 to 6 of 7 were analyzed for the 
D-gene family as IgHD7 is located between 
the JH-gene segments JH1 and JH2 and yields a 
conspicuous germ-line PCR product not 
related to rearrangement. A 10 bp multiplex 
identifier (MID) code, unique for each pool of 
DNA, was included between the template-
specific sequence and the linker enabling us 
to discriminate individual PCR reactions. 
Some primers did not match perfectly with all 
VH- and D-genes in the family, but the 
mismatches were centrally positioned in the 
primer and they did not preclude 
amplification of the respective gene segments 
though the efficacy may have been reduced. 
After PCR amplification, all samples were 
purified using AMPure bead purification as 
recommended by the manufacturer (Beckman 
Coulter). PicoGreen dye (Invitrogen) and a 
standard curve based on lambda DNA were 
used for DNA quantification with 
fluorescence estimated on the Light Cycler 
(Roche). PCR products were diluted to 
contain 108 amplicons/µl and pooled 1:1 and 
the concentration and quality was confirmed 
using a High Sensitivity DNA Kit (Agilent 
Technologies) capable of measuring DNA 
concentrations down to 100 pg/band. 
Complete removal of primer dimers in the 
pooled samples were obtained as judged by 
visual inspection. The pooled samples were 
ultimately diluted to 105 amplicons/µl.       
 
Next-generation sequencing 
Sequencing was executed on the GS junior 
system according to the recommendations of 
the manufacturer (Roche). Briefly, 10 µl of 
library (105 amplicons/µl) were added to an 
emulsion PCR that immediately was run on a 
thermocycler for 50 cycles (30 sec of 
denaturing, 4.5 min of annealing and 30 sec 
of extension). The amplicon-covered beads 
were subsequently washed and purified using 
magnetic bead sorting. 500,000 purified beads 
were packed along with packing beads and 
enzymes into a PicoTiterPlate by 
centrifugation and promptly placed in the GS 
Junior instrument. Sequencing of VHDJH- and 
DJH-rearrangements was executed on separate 
chips.  
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Data analysis 
The reads were analyzed by a homemade 
algorithm programmed in Yabasic version 
2.760. First primers and MIDs were identified 
using a Smith-Waterman routine 13 (match=5, 
mismatch=-4; gap penalty=-7) accepting one 
substitution or one delins of one nucleotide 
from the nearest primer sequence. If no 
primers were found the sequence was reverse 
complemented and tested again. Only 
sequences containing two primers, at least one 
MID and no undesignated nucleotides were 
accepted. Next, the sequences between 
primers were analyzed separately for each 
original PCR reaction and identical reads 
(some after reverse complementation) were 
clustered. Clusters without a reasonable 
balance between forward and reverse reads 
were discarded using the following algorithm: 
single sequences were discarded; pairs should 
contain one of each; larger clusters should 
have a number of forward and reverse 
sequences within the 99.9% confidence limits 
for the binomial distribution (p=actual 
frequency in the entire material) or at least not 
be less than 15% of the number of sequences 
in the cluster. Clusters not discarded were 
sorted after declining numbers of sequences. 
The cluster with most members was accepted 
and compared with all smaller clusters from 
the same original PCR using Smith-Waterman 
(match=5, mismatch=-3; gap penalty=-20) 
with the result, nPoint, representing the total 
number of mismatches recorded during the 
back tracing with delins counting by the 
number of positions they represented. 
Clusters deviating only with a small nPoint 
from the accepted cluster were subsequently 
discarded depending on the sizes of the 
accepted cluster (nIndex) and the cluster 
under scrutiny (nCluster). The minimum 
cluster size (nCluster) for any given number 
of differences (nPoint) needed to save a 
cluster from being discarded, was determined 
empirically by analyzing chip data from 
sequencing of a mixture of five PCR products 
of known template sequences. 65% of the 
sequences were identical to the templates, 
nPoint=1 was found in 28% of the sequences, 
nPoint=2 and 3 each in 3%, while larger 
values of nPoint were seen in 0.5 % of the 
sequences. Minimum size for an acceptable 
cluster was fixed by the formula: 
 
MinSize = max[nIndex/10^(nPoint*0.4),2] 
 
The minimum size for nPoint for an 
acceptable cluster was 3 if nCluster<15, 2 if 
nCluster=15-29, while it was one for clusters 
above 29 members. This algorithm was found 
not to discard non-clonally related 
rearrangements from another sequence 
material produced by traditional cloning and 
sequencing assuming a cluster size of 85. 
Rearrangements were analyzed using 
VDJsolver as previously described5 with the 
following modifications (version 2): i) 
improved identification of VH-genes by a 
Smith-Waterman algorithm comparing with a 
database of VH germline genes compiled from 
the international ImMunoGeneTics 
information system (IMGT) 
(http://www.imgt.org) with omission of 
sequences unlikely to be correct (level 5) as 
reported by Wang et al.37 ii) improved 
sensitivity for D-genes by lowering the 
penalty for inclusion of one D gene.  
 
Statistics 
For analysing differences in cumulated 
frequencies we used Mann-Whitney and 
Kruskal-Wallis Test. For testing frequency 
distributions among categorical groups we 
used Pearson’s chi-squared test. Monte-Carlo 
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simulations were applied when testing 
correlations between gene position and usage 
during D- to JH-gene rearrangement and direct 
D- to D-gene rearrangement using squared 
distances as the test parameter. 10,000 
permutations were generated under the null 
hypothesis that rearrangement respected gene 
order but was independent of distance. P< 
0.05 was considered statistically significant.    
 
RESULTS 
 
By next-generation sequencing we obtained in 
total 309,820 reads of DJH-rearrangements 
and 180,370 reads of VHDJH-rearrangements 
that contained both forward and reverse 
primers, one MID and no undesignated 
nucleotides (for more details see materials and 
methods). For each PCR reaction, sequences 
were analyzed by cluster analysis eliminating 
sequences equal to or only slightly deviating 
from an accepted sequence. After cluster 
analysis, we obtained 9969 unique DJH-
rearrangements and 5919 unique VHDJH-
rearrangements. Further, in the case of 
VHDJH-rearrangements, 4876 (82.4%) were 
considered productive and 1043 (17.6%) non-
productive based on whether the reading 
frame was open prior to somatic 
hypermutation of the VH-, D, and JH-
segments. VHDJH-rearrangements containing 
pseudo VH-genes were observed in 34 
VHDJH-rearrangements and these were also 
considered as non-productive. Out of the 4876 
P VHDJH-rearrangements and 1043 NP 
VHDJH-rearrangements, 1104 (23%) and 240 
(23%) (P=0.37), respectively, contained 
somatic hypermutations. A VHDJH-
rearrangement was considered mutated if the 
VH-gene sequence differed in >3 nucleotides 
Table 1. The frequency of delins and substitions that compromise productivity of BCR in rearrangements evaluated 
as mutated. We calculated the frequencies of delins in cluster sizes containing at least one Forward and one reverse 
sequence (≥1F+1R) and also for cluster sizes  ≥2F+2R. The sequence credibility was estimated by subtracting the 
frequency of substitutions found in NP VHDJH-rearrangements with that found in P VHDJH-rearrangements and 
dividing the result by the frequency found in NP VHDJH-rearrangements. 
 Productive Non-productive  
≥1F+1R    
Deletions 0.010 0.222  
Insertions 0.005 0.085  
Delins, total 0.016 0.307  
    
≥2F+2R    
Deletions  0.005 0.189  
Insertions 0.004 0.045  
Delins, total 0.009 0.234  
    
 Frequency of substitutions  
 Productive Non-productive Estimation of 
sequence credibility 
Conserved 2nd cysteine in VH 0.002 0.159 0.988 
Conserved tryptophan in JH 0.000 0.032 1.000 
Mutated to non-productivity 0.002 0.312 0.994 
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compared to the germline sequence. The D-
gene families were almost equally represented 
after data validation, ranging from 14-20% 
representation of each D-gene family. The 
VH1-, VH3- and VH4-families represented 
34.3%, 21.7%, 17.4% of the VH-genes, 
respectively, while VH2 (10.1%), VH5 
(10.4%), VH6 (4.7%) and VH7 (1.4%) were 
represented at substantially lower frequencies. 
 
Data validation. 
The overall validity of the cluster analysis 
was determined by two approaches. First we 
compared the numbers of reading frame 
deleterious insertions and deletions (delins) in 
the VH-gene regions of mutated P and NP 
VHDJH-rearrangements, respectively. Due to 
allelic exclusion, a B cell is assumed only to 
contain one P VHDJH-rearrangement and this 
must be devoid of delins that break the 
reading frame because the B cell depends on a 
functional antigen receptor for survival14. 
Therefore such delins are not likely derived in 
vivo but probably either Taq-errors or 
sequencing artifacts. For the accepted 
sequences, we found that reading frame 
breaking delins occurred at a frequency of 
1.6% in P VHDJH- rearrangements, while this 
frequency was 15-fold higher (24%, P<0.001) 
in NP VHDJH-rearrangements (Table 1). 
Increasing the demand for clusters to contain 
at least two forward and two reverse 
sequences did not improve this ratio 
significantly (P=0.27). Secondly, we 
investigated the presence of substitutions that 
were likely to be incompatible with receptor 
 
Table 2. The frequency of somatic hypermutations in D- and JH segments of DJH-rearrangements and mutated (defined by 
>3 substitutions in the VH region) and unmutated (defined by <3 substitutions in the VH region ) productive and non-
productive VHDJH-rearrangements.  
  Total number 
of bases 
Substitutions Substitutions/base 
DJ D-bases 215785 368 0.0017 
 JH-bases 444354 794 0.0018 
 
Total 660139 1162 0.0018 
     
Mutated P VDJ  D-bases 8961 354 0.0395 
 JH-bases 33505.5 413 0.0123 
 
Total 42466.5 767 0.0181 
     
Mutated NP VDJ  D-bases 2579 98 0.0380 
 JH-bases 7776.5 85 0.0109 
 
Total 10355.5 183 0.0177 
     
Unmutated P VDJ D-bases 39128 70 0.0018 
 JH-bases 142102 243 0.0017 
 
Total 181230 313 0.0017 
     
Unmutated NP VDJ  D-bases 10531 13 0.0012 
 JH-bases 31767.5 40 0.0013 
 Total 42298.5 53 0.0013 
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integrity such as those generating stop codons 
or causing changes in the second conserved 
cysteine of the VH-gene or the conserved 
tryptophan of the JH-gene (Table 1). We only 
found substitutions of the conserved cysteine 
in 0.2% of the mutated P VHDJH-
rearrangements, while this frequency was 80-
fold higher (16%, P<0.001) for NP VHDJH-
rearrangements. In agreement with this, we 
found no substitutions in the conserved 
tryptophan of the VH-gene segment of P 
VHDJH-rearrangements but in 3% (P<0.001) 
of the NP VHDJH-rearrangements. 
Substitutions or delins causing stop codons 
occurred in 0.2% of the P VHDJH-
rearrangements and in 31% of the NP VHDJH-
rearrangements (P<0.001). For each of the 
three analyzed types of deleterious mutations, 
we estimated the fraction of them that was 
prone to negative selection among the P 
VHDJH-rearrangements by subtracting the 
frequency of mutations found in NP VHDJH-
rearrangements with that found in P VHDJH-
rearrangements and dividing the result by the 
frequency found in NP VHDJH-
rearrangements (Table 1). These fractions 
(>98.8%) constituted estimated credibility of 
all mutations in the mutated dataset.  
 
DJH-rearrangements are not exposed to 
somatic hypermutation. 
Somatic hypermutation is dependent on gene 
transcription and induced in activated B cells 
in the secondary lymphoid tissues15. It has 
been demonstrated that DJH-rearrangements 
are transcribed at a low level in murine 
activated splenic B cells and accordingly they 
may be prone to somatic hypermutation16. We 
estimated the level of somatic hypermutation 
in 9428 DJH-rearrangements containing one 
D-gene, based on the level of substitutions 
identified in the D- and JH-gene segments 
divided by the length of the identified D- and 
JH-genes. Three nucleotides were subtracted 
from the length of the D-genes and 1.5 from 
JH-genes as a correction for the fact that 
substitutions in the 1-2 outmost positions in 
the germline segment will lead to a shortening 
of the germline segment and a corresponding 
increase in the N region rather than being 
detected as a substitution.  We found a 
mutation rate of 0.0018 mutations/base in the 
DJH-rearrangements (Table 2). Out of the 720 
P and 182 NP VHDJH-rearrangements 
containing one D-gene and evaluated as being 
mutated based on substitutions in the VH-gene 
segment, we found a 9-fold higher mutation 
rate of the D- and JH-gene segments (0.0181 
and 0.0177 mutations/base, respectively) 
compared to DJH-rearrangements (P<0.0001). 
The mutation rates of the D and JH-gene 
segments in the 2971 P VHDJH-
rearrangements with one D-gene and 
considered as unmutated based on the VH-
gene segment, was similar to that observed in 
DJH-rearrangements (P=0.73) although the 
mutation rate of the 708 unmutated NP 
VHDJH-rearrangements was slightly lower 
(P=0.014). These results thus indicated that 
DJH-rearrangements were not subject to 
somatic hypermutation. 
 
The joint between the D- and JH-gene is 
similar in DJH- and non-productive VHDJH-
rearrangements. 
We examined 9969 DJH-rearrangements, 
4876 P and 1043 NP VHDJH-rearrangements 
for their length of N regions, level of gene 
segment trimming and presence of P 
nucleotides. We found no significant 
difference in any of these features between 
DJH- and NP VHDJH-rearrangements. The 
lengths of the N regions between the D and 
JH-gene segments (entitled N2 in the  
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Figure 1. A) The length of the N region between the D- and JH-gene (N2) was similar for DJH- and NP VHDJH-
rearrangements (P=0.62) but significantly shorter in P VHDJH-rearrangements (P=0.002) B) The frequencies of P 
nucleotides at both untrimmed D-3’-ends and JH-5’-ends we similar for DJH- (22% and 29%) and NP (19% and 28%) 
VHDJH-rearrangements (P>0.41). P nucleotides were less frequent at the D-3’-end in P (12%) compared to NP (19%) 
VHDJH-rearrangements (P<0.029) but not at the JH-gene segments (28% and 29%, respectively) (P=0.89). (C and D) 
The level of trimming of the JH-5’-end and D-3’-end were similar in all three rearrangement types (P>0.05). E) The 
relative usage of JH1, JH3 and JH6 were similar in all three rearrangement types (P>0.05) while JH2 and JH4 differed 
significantly in DJH- and P VHDJH-rearrangements compared to NP VHDJH-rearrangements (P<0.05). JH5 usage 
differed significantly between DJH- and NP VHDJH-rearrangements (P<0.05). Primers matched JH1, JH4, JH5 and JH6 
perfectly, but contained 1 mismatch centrally located in both JH2 and JH3. 
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following) was similar for DJH- and NP 
VHDJH-rearrangements with median lengths 
of 7 nucleotides (P=0.62). N2 in P VHDJH-
rearrangements were significantly shorter 
(median length 5 nucleotides) compared to 
NP VHDJH-rearrangements (P=0.002, Figure 
1A). The extent of gene segment trimming of 
the D- and JH-gene segments was similar for 
all three rearrangement types, with a median 
truncation of 4 nucleotides of the D-gene and 
6 nucleotides of the JH-gene (P=0.81 and 
P=0.38, respectively) (Figures 1C and D). 
The 5’-end of the D-gene segments were 
untrimmed in 17% of the DJH-rearrangements 
which did not differ significantly from NP 
VHDJH-rearrangements (14%) (P=0.16). The 
frequency of untrimmed 3’-end of D-genes 
was however significantly higher in P VHDJH-
rearrangements (18%) compared to the NP 
VHDJH-rearrangements (14%, P<0.002). The  
5’-end of the JH-gene segments were 
untrimmed in 11% of the DJH-rearrangements 
and 10% of the P VHDJH-rearrangements 
which did not differ significantly from that 
observed in NP VHDJH-rearrangements (12%) 
(P>0.15). As P nucleotides are the result of 
hairpin-opening, authentic P nucleotides will 
always follow directly after the end of the 
germline sequence and are thus not identified 
at trimmed gene segments. Accordingly, we 
only analyzed the presence of P nucleotides at 
untrimmed gene segments and did not find a 
significant difference in the frequencies of P 
nucleotides identified at the D-3’-end and JH-
5’-end in DJH- (22% and 29%) and NP (19% 
and 28%) VHDJH-rearrangements (P>0.41). 
There was, however, significantly fewer P 
nucleotides identified at D-genes in P (12%) 
compared to NP (19%) VHDJH-
rearrangements (P=0.029), but not at the JH-
gene segments (28% and 29%, respectively) 
(P=0.89) (Figure 1B).  
We also analyzed the JH-gene usage in 
the three rearrangement types. The use of JH1, 
JH3 and JH6 genes did not differ significantly 
between DJH- (3%, 4%, and 28%), NP (2%, 
3%, and 29%). and P (1%, 4%, and 30%) 
VHDJH-rearrangements, respectively (P>0.05). 
JH2 and JH4 usage differed significantly in 
DJH- (1.3% and 48%) and P VHDJH-
rearrangements (1.6% and 46%) compared to 
NP VHDJH-rearrangements (0.5% and 52%) 
(P<0.05). JH5 only differed significantly 
between DJH- (17%) and NP (13%) VHDJH-
rearrangements (P<0.05) (Figure 1E).  
 
Direct D- to D-gene rearrangement occur 
during D- to JH-gene rearrangement. 
We have previously demonstrated that the 
frequency of direct D-gene to DJH-
rearrangement observed in P VHDJH-
rearrangements is extremely low and 
therefore not contributing significantly to the 
generation of the human BCR repertoire5. 
Here we analyzed the DJH-rearrangements for 
the presence of direct D-gene to DJH 
rearrangement in order to establish whether 
our previous observation was due to selection 
against these atypical rearrangements. Out of 
the 9969 DJH- and 1043 NP and 4876 P 
VHDJH-rearrangements, VDJsolver identified 
a total of 488 rearrangements containing two 
D-genes. An authentic D-gene to DJH 
rearrangement is characterised by having 
rearranged an upstream donor D-gene to a 
downstream acceptor DJH-rearrangement. 
This may be used to validate the allocation of 
two D-genes. A closer look at the identified 
D-D fusions revealed that some of them were 
a result of random hits in the N region. As the 
parameters in VDJsolver were optimised for 
identifying one D-gene per rearrangement, we 
adjusted the penalty for finding two D-genes 
in order to decrease the number of random  
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Figure 2. A) The IgH locus is approximately 1 megabase long. All VH-genes are located within the VH-locus spanning 
positions 1-900,000. All D-genes with known locations, except for D7-27, are located from positions 900,000-950,000. 
The six productive JH-genes are located at the end of the IgH locus from positions 957,000-960,000. B) We divided the 
D-locus into 4 zones that each contains one gene from each D-gene family apart from zone 2 and 4 which contain two 
D3-genes and two D1-genes, respectively. In rearrangements with just one identifiable D-gene, the D-gene usage 
frequency was significantly lower in DJH- (18% and 24% ) and NP (28% and 27%) VHDJH-rearrangements in zones 1 
and 2 (P<0.05). In zone 4, the D-gene usage frequency was significantly higher in DJH- (38%) compared to NP (22%) 
VHDJH-rearrangements (P<0.001). P VHDJH-rearrangements differed significantly from NP VHDJH-rearrangements in 
zones 1 (20%), 2 (31%), and 4 (24%) (P<0.05) but not in zone 3 (25%) (P>0.05). 
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hits. This yielded 339 rearrangements 
containing two D-genes of which 298 were 
identified in the 9969 DJH-rearrangements, 30 
in the 1043 NP VHDJH-rearrangements and 11 
in 4876 P VHDJH-rearrangements. Thus D-
gene to DJH rearrangement occurred at a 
frequency of 3.0% prior to VH-gene 
rearrangement. In NP VHDJH-rearrangements 
they occurred at a frequency of 2.8% which 
did not differ significantly from that observed 
in DJH-rearrangements (P=0.84). In 
productive VHDJH-rearrangements they were 
only present at a frequency of 0.2% which 
was significantly lower compared to both 
DJH- and NP VHDJH-rearrangements 
(P<0.0001). 39 of the rearrangements with 
two D-genes contained D-genes for which the 
position within the IgH locus is unknown. Of 
the 300 rearrangements containing two D-
genes with known locus position, we found 
20 (6%) that did not respect the required order 
for donor and acceptor D-genes. We therefore 
estimated that 87% of D-D fusions identified 
with the novel parameter settings were 
correctly assigned to D-gene position and 
resulted from a true direct D- to D-gene 
rearrangement in vivo.     
 
 
Figure 3. We analyzed 8859 DJH-rearrangements with one D-gene for their usage frequency of D-genes and the 
distance to each of the 6 JH-genes. JH1 is located closest to the D-locus and the closer the D-genes were positioned to 
JH1 the more frequently they were observed (P<0.007). The same was true for JH2 JH3 and JH4 (P<0.0044). 
Interestingly, we found that the more distantly the D-genes were positioned to JH5 and JH6 the more frequently were 
they observed in the DJH- rearrangements (P<0.0001). 
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D-gene position influences D-gene usage.  
We next analyzed the D-gene usage in 9220 
DJH- and 880 NP VHDJH-rearrangements that 
contained one D-gene for which the locus 
localisation was known. The D-gene locus is 
approximately 50,000 bases long and extends 
from nucleotide position 900,000-950,000 
within the IgH locus (Figure 2A). On the D-
locus, the D-genes are arranged into sets 
containing almost one gene segment from 
each D-gene family. We divided the D-locus 
into four zones containing one D-gene from 
each family except for zone 2 which 
contained two D3 genes and zone 4 two D1 
genes. We noticed that differences in D-gene 
usage between DJH- and NP VHDJH-
rearrangements were especially profound in 
zone 1 and zone 4 (Figure 2B). The D-gene 
usage from zone 1 and 2 was significantly 
lower in DJH-rearrangements (18% and 24%) 
compared to NP VHDJH-rearrangements (28% 
and 27%) (P<0.05). In contrast, in zone 4 the 
 
Figure 4. A) Histogram illustrating the frequencies of acceptor and donor D-genes in rearrangements containing two 
D-genes. D2-2 was used as donor D-gene at a significantly higher frequency (44%) than any other D-genes (P<0.05). 
B) The frequencies of acceptor genes in D2-2-DJH-rearrangements compared with the frequency of normal D-gene 
usage in DJH-rearrangements. The acceptor D-genes positioned closer to D2-2 was used more frequently than D-
genes positioned more distal (P=0.014).   
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D-gene usage was significantly higher for 
DJH-rearrangements (38%) compared to NP 
VHDJH-rearrangements (22%) (P<0.001). 
There was no significant difference observed 
between DJH- and NP VHDJH rearrangements 
in zone 3 (20% and 23%, respectively). We 
further found that productive and thus 
selected VHDJH-rearrangements differed 
significantly from NP VHDJH-rearrangements 
in zones 1 (20%), 2 (31%), and 4 (24%) 
(P<0.05) but not in zone 3 (25%) (P>0.05). 
A closer look at the DJH-rearrangements 
revealed that D-gene usage was highly 
dependent on the JH-gene. Thus, we observed 
that the closer positioned the D-genes were to 
JH1, JH2, JH3 and JH4 the more frequently they 
were observed (P<0.0044). Interestingly, for 
JH5 and JH6 we observed the opposite: The 
more distant the D-genes were positioned the 
more frequently they were observed 
(P<0.0001) (Figure 3).  
In the rearrangements containing two 
D-genes we found that D2-2 was significantly 
more often used as donor D-gene than any of 
the other D-genes (44%) (Figure 4B). We 
investigated what preference D2-2 had for 
acceptor D-genes and compared it with the 
normal D-gene usage during D- to JH-gene 
rearrangement and VH-gene to DJ 
rearrangement. As the D-gene families were 
almost equally represented in the 9969 DJH-
rearrangements and each D-gene family 
included 4 (D2, D4, D5 and D6) or 5 (D1 and 
D3) D-genes, we did not discriminate 
between the different D-gene families when 
calculating the frequency distributions of the 
D-gene usage. We found that D-gene position 
and usage frequency also correlated during 
direct D- to D-gene rearrangement for the 
donor D-gene D2-2. The shorter the distance 
between the D2-2 and the acceptor D-gene the 
more frequently the rearrangement occurred 
(P=0.014) (Figure 4A).  
 
DISCUSSION 
 
Within recent years, next-generation 
sequencing has provided new and convincing 
information about the human BCR repertoire 
4, 17-20
. Each of these studies has sequenced 
large numbers of VHDJH-rearrangements and 
both confirmed and elaborated on sequencing 
studies previously executed by SANGER 
sequencing5, 21-26. Large-scale sequence 
analysis is essential for estimating frequencies 
of rare events such as VH-gene replacement 
and direct D- to D-gene rearrangement. To 
our knowlegde all previous studies on the 
human BCR repertoire has relied on  fully 
rearranged IgH loci. In these studies the 
sterile NP VHDJH-rearrangements has 
functioned as negative control for selection. 
Unfortunately, NP VHDJH-rearrangements 
cannot be specifically amplified by PCR and 
therefore these products are not as numerous 
as the P VHDJH-rearrangements. Based on the 
theory that 2 out of 3 rearrangements will be 
out of reading frame27, 60 out of 100 B cells 
obtained from blood will each provide one P 
VHDJH-rearrangement, while 40 will each 
provide one P and one NP VHDJH-
rearrangement. This means that 29% of all 
VHDJH-rearrangements should be NP VHDJH- 
rearrangements. We only obtained 17.6% NP 
VHDJH-rearrangements. Previously, we and 
others have only obtained around 10% NP 
VHDJH-rearrangements5, 28. Why is this? One 
explanation could be that rearrangement is 
simply not resumed quickly enough after 
rearranging non-productively. B cells that do 
not receive survival signals through the BCR 
go into apoptosis. Reluctant rearrangement 
and the lack of NP VHDJH-rearrangement in 
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the BCR repertoire has previously been 
correlated in a case study of Omenn 
syndrome. A child with a mutation within the 
core domain of RAG1 was deficient in T cells 
but displayed nearly normal levels of B cells. 
RAG1 function was thus only partially 
disrupted by the mutation. Interestingly, 
almost none of the peripheral B cells carried 
NP VHDJH-rearrangements. It was suggested 
that the reduced activity of RAG1, delayed 
rearrangement of the second locus for too 
long which forced the B cells into apoptosis29. 
A recent study has however provided 
evidence that normal pro-B cells are capable 
of sensing the difference between a P and a 
NP VHDJH-rearrangements already at the 
transcriptional level. Under normal 
circumstances non-coding mRNA is rapidly 
degraded by the nonsense-mediated mRNA 
decay machinery30, 31. By stabilizing a 
normally non-coding µH mRNA and 
providing it to pro-B cells, further B cell 
development was arrested. This study 
indicated that the pro-B cells were able to 
distinguish between productive  and  non-
productive µH mRNA based on its stability32. 
Perhaps a disadvantage caused by non-coding 
µH mRNA leading to cell death could explain 
why B cells carrying NP VHDJH-
rearrangements are not observed as frequently 
in the periphery as predicted. In contrast to 
NP VHDJH-rearrangements, DJH-
rearrangements can be specifically amplified 
and are therefore an easy accessible source for 
studying the basic D- to JH-gene 
rearrangement event. Further, as we show in 
this paper, DJH-rearrangements are not subject 
to somatic hypermutaions and therefore truly 
mirrors the actual rearrangement mechanism. 
For this study, we developed a method for 
amplifying DJH-rearrangements, which as NP 
VHDJH rearrangements are untranslated 
passive passengers in B cells. 
We have previously found the 
frequency of direct D-gene to D-gene 
rearrangement in 4082 productive VHDJH-
rearrangements to be 1.5%. This frequency 
was similar to the level of two D-genes being 
generated by chance in permutated sequences 
5
. Because of the much higher number of non-
productive sequences available in this paper, 
it was possible for us to optimize the 
VDJsolver algorithm for safe detection of D-
D fusions using the order of D genes in the 
locus to evaluate the parameters. We can 
therefore safely assign D-D fusions to 0.2 % 
of productive VHDJH-rearrangements. We did 
however identify these atypical 
rearrangements at a frequency of 3% in 9969 
DJH-rearrangements, which was similar to the 
frequency found in 1043 NP VHDJH-
rearrangements. CDR1, 2 and 3 are together 
directly involved in antigen binding. In 
neonates and adults P VHDJH-rearrangements 
have generally shorter CDR3s compared to 
NP VHDJH-rearrangements28, 33. We also 
found the median CDR3 length significantly 
longer in NP (48 nucleotides) compared to P 
(55 nucleotides) VHDJH-rearrangements. We 
defined CDR3 as starting after the conserved 
cysteine (C) in the VH-gene and ending before 
the conserved tryptophan (W) in the JH-gene. 
In VHDJH-rearrangements with two D-genes 
the median CDR3 was 66 nucleotides for P 
VHDJH-rearrangements and 81 for NP VHDJH-
rearrangements. As two D-genes significantly 
elongate the CDR3 length these atypical 
rearrangements are probably removed by 
selection explaining the low frequency in P 
VHDJH-rearrangements. 
That D-locus proximal VH-genes are 
rearranged more frequently than D-locus 
distal VH-genes has previously been 
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demonstrated in mice and also in human fetal 
liver cells 11, 22, 34. We have demonstrated that 
position also influences rearrangement of D- 
to JH-genes. During D- to JH-gene 
rearrangement the D-genes positioned closer 
to the JH-locus were rearranged more 
frequently than the JH-locus distal D-genes. 
During VH-gene to DJH rearrangement the 
DJH-rearrangements located closest to the VH-
locus were rearranged more frequently. For 
the P VHDJH-rearrangements we did not find 
this preference. The D-gene frequency from 
zone 1 was significantly lower and zone 4 
significantly higher in P VHDJH-
rearrangements compared to NP VHDJH-
rearrangements.  
During D- to JH-gene rearrangement we 
observed that D-gene usage and position 
correlation was highly dependent on the use 
of JH-gene. The JH-locus is relatively small (3 
kb) compared to the VH-locus (900 kb) and 
the D-gene locus (50 kb). The shorter the 
distance the more frequently the D-genes 
were observed to rearrange to JH1, JH2 JH3 
and JH4. For JH5 and JH6 the correlation was 
opposite, the further away the D-genes were 
positioned the more frequently they were 
observed. This was surprising as JH-genes are 
only separated by a few hundred bases. This 
could, however, be an effect of the 
rearrangement mechanism known as leap-
frogging. Leap-frogging is when a second 
rearrangement takes place across an already 
rearranged locus thus excising the previous 
rearrangement. This mechanism has been 
demonstrated to occur during Ig light chain 
receptor editing, where the VL-genes are 
directly rearranged to the JL-genes 35 and also 
during D- to JH-gene rearrangement in mice36. 
This mechanism could explain why the 
position of the JH-gene has such profound 
effect on the D-gene position correlation. If 
the first DJH-rearrangement has rearranged a 
JH-locus proximal D-gene to JH1, a second 
rearrangement would have to use JH2 to JH6 
combined with a D-gene located further 
upstream of the primary DJH-rearrangement. 
This would cause a shift in the position 
correlation. All JH-genes except for JH6 can 
potentially be replaced by leap-frogging and 
based on our results, leap-frogging may be 
considered to occur rather frequently and 
perhaps even several times during D- to JH-
gene rearrangement.  
We found significant differences in the 
D-gene usage and the level of somatic 
hypermutations between DJH- and NP VHDJH-
rearrangements. Differences in D-gene usage 
must have been generated during and after 
VH-gene to DJH rearrangement. We therefore, 
based on our results, strongly recommend 
using intermediate DJH-rearrangement 
products when studying the first step of V(D)J 
rearrangement.  
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ABSTRACT 
In order to identify structural differences in non-templated (N) regions of rearranged 
immunoglobulin heavy chain genes, we studied the nucleotide composition of N regions 
within 668 unique non-productive and unmutated human VHDJH-rearrangements and 9832 
unique DJH-rearrangements with one D-gene . We provide evidence that N regions are usually 
generated by two concatenating 3’-overhangs and that the enzymatic apparatus preferentially 
adds cytosines to the 3’-overhangs of gene segments. During joint formation this preference 
generates an increasing G/C ratio from left to right across the N regions. Surprisingly, this 
G/C gradient differs between N regions of VH-D and D-JH junctions and is highly dependent 
on gene segment trimming.  
 
 
INTRODUCTION 
 
Terminal deoxynucleotidyl transferase (TdT) 
are along with multiple other enzymes such as 
RAG1/2 and Artemis, involved in the V(D)J 
rearrangement mechanism. During V(D)J 
rearrangement, TdT adds non-templated 
nucleotides, termed N regions, in the 
junctions between the different gene 
segments. The N regions are not essential for 
B cell function but they are required for a 
proper immune response in mice, 
emphasizing the importance of N regions in 
the generation of receptor variety1, 2. One 
short and two long splice variants of TdT 
have been identified in humans and in vitro 
studies on purified human TdT have indicated 
that the short variant executes the transferase 
activity while the two long variants have 3’-5’ 
exonuclease activity3,4. The exonuclease 
activity of TdT is only applicable for 3’-
overhangs and does not progress into double 
stranded DNA. Accordingly, exonuclease 
activity of TdT is thought to complement the 
endonuclease activity of the Artemis/DNA-
PKcs-complex during joint formation5-8. After 
TdT has extended the 3’-ends of the gene 
segments, ligation of the two 3’-overhangs is 
guided by sequence micro-homology9-11. 
Mismatching nucleotides are following 
removed by repair mechanisms and gaps are 
filled by the aid of a DNA polymerase. 
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Early in vitro oligo modification assays 
have demonstrated that purified TdT from calf 
thymus adds G at a significantly higher 
frequency (60-70%), than C (9-17%), T (11-
16%) and A (2-9%)4. It has further been noted 
that TdT has a preference of adding the same 
nucleotide as the primer-terminating 
nucleotide which often results in homo-
polymeric tracts within the N regions in 
human rearrangements12.        
In agreement with that, smaller 
sequencing studies of N regions generated in 
murine and human cell cultures have found an 
excess of G, which has been interpreted as 
TdT primarily adding G to the sense strand 
during joint formation12-14. It remains 
unexplored whether the N region in between 
VH- and D-gene segments (N1) and D- and 
JH-gene segments (N2) are similarly 
constructed. To investigate the exact 
composition of N regions, large datasets of 
unmutated and unselected rearrangements are 
required. In the attempt to clarify this, we 
analyzed the nucleotide composition and 
pattern of N1 and N2 in 668 unique non-
productive and unmutated VHDJH-
rearrangements and correlated findings with 
29802 sequences from international sequence 
repositories. Here we present distinct patterns 
in the N regions generated during V(D)J 
rearrangement. 
 
MATERIALS AND METHODS 
 
Dataset 
We downloaded 67342 VHDJH-
rearrangements from the NCBI repository 
using IgBLAST and excluded entries 
containing the words: musculus, mouse, 
kappa light, lambda light. Out of these, 54145 
VHDJH-rearrangements were classified as 
evaluable meaning they had identifiable VH- 
and JH-genes and a joint length ranging from 
2-200 bp. 35912 of these were evaluated as 
unique after exclusion of sequences with 
same joint length and differing with less than 
5 bases from an accepted sequence. We 
removed 387 sequences containing 
undesignated stretches of nucleotides (letters 
of N or W). In order to determine the 
trimming of the VH gene, it was important to 
know the exact 3’-end of the germline VH-
gene, which only could be certain for those 
VH-gene sequences where part of a 
downstream RSS had been identified. Missing 
information regarding the germline VH-gene 
3’-end led to further removal of 3062 VHDJH-
rearrangements. This yielded 32436 VHDJH-
rearrangements out of which 19568 were 
available in XML-format and linked to a 
NCBI Pubmed article. A total of 303 articles 
were found. Each article was categorized 
manually in eight different categories: anti-
microbial, auto-immunity, allergy, genetic B-
cell diseases, cancerous B-cell diseases, 
acquired B-cell diseases, B-cell biology and 
ontogeny, and involvement in other diseases. 
A total of 277 sequences associated with 32 
articles, were removed from further analysis 
since these sequences were generated in mice 
or in vitro systems. After data-mining, the 
NCBI dataset included a total of 29802 
unique VHDJH-rearrangements. 
668 unique non-productive VHDJH-
rearrangements and 9832 unique DJH-
rearrangements containing one D-gene were 
obtained by 454-sequencing as previously 
described (Manuscript I). 
 
VHDJH-rearrangement analysis 
We analyzed the VHDJH- and DJH-
rearrangements in the program VDJsolver 
version 2.0. VDJsolver aligns VH-, D-, and JH-
gene segments to rearranged sequences using 
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a maximum likelihood method. Version 1.0 is 
publicly available 
(http://www.cbs.dtu.dk/services/VDJsolver/) 
and has been described and benchmarked 
against other publicly available tools15, 16. 
Version 2.0 differs from version 1.0 by: i) 
allowance of D-D fusions in the model, ii) 
improved alignment with VH germline genes 
using a Smith-Waterman-based algorithm17, 
iii) improved sensitivity for D-genes. The 
program finds D-genes in 4% of artificial 
sequences lacking D-gene segments but 
consisting of stochastically assembled joints 
with a base composition similar to N 
additions.  
 
Model15 
Based on the assumption that N regions are 
formed by non-homologous end joining of a 
sense and an anti-sense strand formed by 
TdT, we generated a simple model allowing 
the two last nucleotides upstream of the 
growing 3’-end to influence the probability of 
the next nucleotide to be added. Probabilities 
were estimated from N2 of 9428 DJH-
rearrangements with exactly one D-gene. 
Starting from the last two bases of the D-gene 
segment (including palindromes on 
untrimmed D, if any), the frequency with 
which any specific di-nucleotide (e.g. 5’-AC-
3’) was followed by one of the four possible 
nucleotides forming a tri-nucleotide (e.g. 5’-
ACT-3’) was calculated by enumerating all 
successive tri-nucleotides until the mid of the 
N region. Similarly, a table was made for the 
frequencies on the anti-sense strand starting 
with the last two nucleotides of the JH-gene 
segment (including palindromes on 
untrimmed JH-gene, if any) and propagating 
to the mid of the N region. The probabilities 
after identical di-nucleotide motifs correlated 
strongly (Pearson r=0.88, p<0.0001) and 
average values for each di-nucleotide were 
used in the following. Using unselected, 
unmutated non-productive VHDJH-
rearrangements (n=668) from the chip dataset 
as templates, artificial rearrangements were 
generated by reusing the existing VH-, D-, and 
JH-gene segments. New quasi-random N 
regions were added to the 3’-ends using the 
conditioned probabilities mentioned above. 
Both a forward and a reverse strand were 
made to the full length of the N region where 
after the latter was reverse complemented to 
form an alternative sense strand. The two 
sense strands were concatenated at a random 
position forming a final new N region with 
the alternative strand in the 3’-end of the N 
segment. In order to obtain the G/C gradient 
along the N2 region found for N regions in 
between D- and JH-gene segments (Figure 3) 
it was necessary to increase the C/G ratio by a 
factor of 1.5 by manipulating the probabilities 
for the respective nucleotides using the 
formulas: 
 
PCcorr=PC + 0.5/(1/PC + 1.5/PG) 
PGcorr= PG - 0.5/(1/PC + 1.5/PG) 
 
Fulfilling the equation:  
PCcorr/PGcorr =1.5·PC/PG 
 
To account for the relative surplus of G 
in the sense strands it was necessary to 
assume that only 85% of the N2 segments 
were produced by random concatenation 
while the remaining 15% were produced from 
the JH-gene alone. Similarly, N1 regions 
required 40% contribution from the D-gene 
without concatenation in order to account for 
the extra enrichment of G in this segment. 
In order to generate a realistic repertoire 
of joints representative for natural 
rearrangements prior to selection, the 
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unselected templates were slightly modified at 
one or more of the ends of the VH-, D-, or JH-
gene segment by either removing or adding a 
single germline-encoded nucleotide in all 
possible ways yielding a net change of the 
entire joint of -1, 0, or 1 nucleotides whatever 
necessary to correct the reading frame of the 
JH-gene segment relative to the V H-gene 
segment. 
 
Statistical analysis 
Mann-Whitney was used for testing 
differences in cumulated frequencies. Linear 
regression was applied for testing the G/C 
gradient across the N regions. Monte-Carlo 
simulations were applied when testing the 
differences in G/C and A/T ratios between N1 
and N2 regions and also for testing the 
differences in amino acid composition of N1 
and N2 and differences in amino acid 
composition in selected and unselected 
VHDJH-rearrangements. 10,000 permutations 
were generated under the null hypothesis that 
there was no difference between the groups to 
be compared. Testing of the 21 amino acid + 
stop codon frequency distributions were 
conducted using Bonferroni adjusted alpha 
levels of P<0.0024 (0.05/21).    
 
RESULTS  
 
N1 and N2 generally contained a high G/C 
ratio. 
We investigated the nucleotide composition 
and length of the entire N1 and N2 region in 
668 non-productive VHDJH-rearrangements 
and 9832 unique DJH-rearrangements with 
one D gene, respectively. In N1 we observed 
G at a frequency of 29.5%, C at 25.2%, A at 
23.9% and T at 21% (Figure 1A). In N2 we 
observed G at a frequency of 30.7%, C at 
27.3%, A at 20.8% and T at 21.3%. For both 
 
Figure 1. A) The nucleotide frequency distribution across the entire N1 and N2 regions in 668 non-productive and 
unmutated VHDJH-rearrangements (N1 and N2) and 9832 DJH-rearrangements (N2) with one D-gene obtained from 
blood. N1 was composed of 29.5% G, 23.9% C, 21% A and 22.9% T.  N2 consisted of 30.7% G, 27.4% C, 20.7% A 
and 21.2% T. The G/C ratio was significantly higher in N1 (1.17) compared to N2 (1.13) (P=0.07). The A/T ratio in 
N1 (0.97) and N2 (0.98) did not differ significantly (P=0.66) B) The cumulated frequencies of the length of N1 and 
N2 regions did not differ significantly from each other (P=0.49). The median length of N region was 8 nucleotides. 
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N1 and N2 we observed a high G/C ratio. The 
G/C ratio was not significantly different in N2 
(1.13) compared to N1 (1.17) (P=0.07). The 
A/T ratio did also not differ in N2 (0.98) 
compared to N1 (0.97) (P=0.66). There was 
no significant difference between the length 
of N1 and N2 in non-productive VHDJH-
rearrangements and DJH-rearrangements, 
respectively, which both displayed a median 
length of 8 nucleotides (P=0.94) (Figure 1B). 
 
The composition of N regions are compatible 
with being generated by concatenation of two 
3’-overhangs.  
Previous studies have demonstrated that TdT 
preferentially adds G during N addition12-14. 
Kepler and colleagues18 observed a low G/C 
ratio in the first half of N1 and a high G/C 
ratio in the second half of the N1 region. They 
suggested that this was a result of N1 being 
generated by the 3’-overhang from the D-gene 
alone and thus not by concatenation of two 
3’-overhangs. In order to verify this, we 
investigated the nucleotide composition of the 
first and second half of the N1 region (sense 
strand). If the entire N1 region was generated 
solely by the VH-gene 3’-overhang, we would 
expect the nucleotide composition to be 
similar throughout the N1 region and thus 
generate a positive correlation between the 
two halves of N1 in the 668 non-productive 
and unmutated VHDJH-rearrangements. We 
 
Figure 2. Correlation of the frequencies for which a given nucleotide (T, C, G, or A) followed a given dinucleotide in 
the first and second half of the two N regions, respectively, in 668 non-productive and unmutated VHDJH-
rearrangements (N1 and N2) and 9832 DJH-rearrangements (N2) with one D-gene obtained from blood. The left 
panel illustrates the 64 data points (black dots) representing average frequencies from the sense strand of N1. A 
significant correlation was found (r2=0.37, P<0.0001). However, a considerably (and significantly, P<0.012) higher 
correlation coefficient (r2=0.63, P<0.0001) was found after reverse complementation (RC) of the second half of N1 
(red dots). Right panel shows similar results for the first and second half of N2 (RC). The second half of N2 on the 
sense strand yielded a significant correlation (r2= 0.19, P=0.0003). The reverse complemented sequence did however 
yield a significantly higher (P=0.00014) correlation coefficient (r2=0.77, P<0.0001).  
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indeed found a positive correlation coefficient 
between the first and the second half of the 
N1 region (sense strand) (r2=0.37, P<0.0001) 
(Figure 2). However, if we reverse 
complemented the sequence of the second 
half of the N1 region, the correlation 
coefficient increased considerably (r2=0.63) 
(P=0.012). We found the same tendency to be 
true for N2 in the 9832 unique DJH-
rearrangements. The nucleotide composition 
of the sense strand of the first half of the N2 
region had a weak positive correlation with 
the second half of N2 (r2=0.19, P<0.0003), 
however reverse complementing the second 
half strongly increased the correlation 
coefficient (r2=0.77) (P=0.0001). This 
suggested that the N regions were generated 
by concatenation of two 3’-overhangs with 
similar G/C content rather than by one 3’-
overhang as previously suggested.  
 
TdT preferentially added C during N addition. 
That N regions were generated by 
concatenation suggested that the low G/C 
ratio observed in the first half of N1 and a 
high G/C ratio in the second half of the N1 
region was due to TdT preferentially adding C 
during N addition. In order to confirm this we 
investigated a potential preference of TdT for 
adding C or G in relation to the two primer-
terminating nucleotides in the first half on the 
sense strand and the second half reverse 
complemented (RC) of the N regions in 668 
non-productive and unmutated VHDJH-
rearrangements (N1 and N2) and 9832 DJH-
rearrangements (N2) containing one D-gene. 
Table 1 displays the G/C ratio after a given 
dinucleotide in the first and second half (RC) 
 
Table 1. The G/C ratio after a given dinucleotide in the first and second half of the two N regions in 668 non-
productive and unmutated VHDJH-rearrangements (N1 and N2) and 9832 DJH-rearrangements (N2).  
N1 N2 
Dinucleotide 1st half 2nd half (RC) 1st half 2nd half (RC) 
 
TT 0.95 0.82 1.00 0.67 
TC 0.74 0.71 0.69 0.51 
TG 3.15 2.28 2.11 2.22 
TA 1.29 0.87 1.18 0.77 
CT 0.46 0.56 0.71 0.48 
CC 0.34 0.37 0.47 0.37 
CG 3.11 1.55 1.86 1.67 
CA 0.77 0.55 0.77 0.60 
GT 0.83 0.93 0.68 0.62 
GC 0.58 0.27 0.40 0.38 
GG 2.55 1.87 2.22 1.96 
GA 1.00 0.79 0.91 1.13 
AT 0.81 0.72 0.60 0.53 
AC 0.51 0.47 0.69 0.38 
AG 2.32 2.59 2.59 1.12 
AA 1.03 0.98 1.11 0.92 
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of the two N regions. In the first half of both 
N1 and N2, the G/C ratio was below one in 9 
out of 16 possible dinucleotides. In the second 
half (RC) of N1 and N2 the G/C was below 
one in 12 and 11 out 16 possible 
dinucleotides, respectively. It was generally 
after dinucleotides ending on C, T, and A that 
we observed C more frequently, while G was 
more frequently observed after dinucleotides 
ending on G (Table 1). The frequency of C in 
the first half of N1 was 28.7% which was 
significantly lower compared to G 
(29.8%)(P<0.0001), while in the second half 
of N1 (RC) we found C (32.4%) at a 
significantly higher frequency compared to G 
(25.2%) (P<0.0001) (Table 2). For the first 
half of N2 we also found a significantly 
higher level of C (30.1%) compared to G 
(28.1%) (P=0.016). The same was true for the 
second half of N2 (RC), where C was 
observed at a frequency of 34% and G at 
24.3% (P=0.0005) (Table 2). The general 
surplus of C in the first half and in the second 
half of N regions after reverse 
complementation indicated that TdT 
preferentially added C during N addition and 
not G. This preference further generated a 
clear positive G/C gradient across the N 
region from left to right in both N1 and N2 
(r2=0.48, P=0.03 and r2=0.89, respectively, 
P≤0.026) (Figure 3). The G/C gradients 
across N1 and N2 did however differ 
significantly from each other (P=0.01). 
 
The difference of G/C gradients in N1 and N2 
was not due to footprints after VH-gene 
replacements. 
We investigated whether the difference in 
G/C gradients between N1 and N2 could be 
due to the presence of footprints after VH-
 
 
Figure 3. The G/C ratio across the N region in N1 and 
N2 from 668 non-productive and unmutated VHDJH-
rearrangements (N1+N2) and 9832 DJH-
rearrangements (N2).  We divided the N regions into 
10 sections and plotted the G/C ratio from each 
section. The G/C ratio was close to one in section 1 of 
the N1 region and increased to around 1.4 in section 
10. In the N2 region the G/C ratio was close to 0.80 in 
section 1 of the region and increased to 1.85 in section 
10. We found that the correlation coefficient of the 
G/C gradients in N1 (r2=0.48, P=0.026) and N2 
(r2=0.89, P<0.0001)) differed significantly (P=0.01).  
 
 
Table 2. The nucleotide frequency distribution in the first and second half (RC) of the two N regions in 668 non-
productive and unmutated VHDJH-rearrangements (N1 and N2) and 9832 DJH-rearrangements (N2). 
T C G A 
N1 1st half 0.217 0.287 0.298 0.198 
N1 2nd half (RC) 0.211 0.324 0.252 0.213 
N2 1st half 0.204 0.303 0.281 0.212 
N2 2nd half (RC) 0.199 0.340 0.244 0.217 
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gene replacement in N1 in the 668 non-
productive and unmutated VHDJH-
rearrangements. 80% of all VH-genes contain 
a cryptic recombination signaling sequence 
(cRSS) at their 3’-end followed by 5-10 
nucleotides. It has been demonstrated in 
murine model systems, that the rearrangement 
apparatus is capable of engaging this cRSS 
and thus performing a second rearrangement 
of an upstream VH-gene into the VHDJH-
rearrangement. After VH-gene replacement, 
the 5-10 nucleotides downstream of the cRSS 
may remain as a footprint if gene segment 
trimming has not erased it. We identified all 
available footprints in human germline VH-
gene segments and calculated the frequency 
distribution of G, C, A and T in these 
footprints. We found that footprints were 
primarily composed of A (44%) and G (30%) 
and less frequently of C (16%) and T (3%) 
which yielded a G/C ratio of 1.83 and an A/T 
ratio of 22.7. If the difference in the G/C 
gradient between N1 and N2 was due to 
footprints after VH-gene replacement we 
would expect a higher G/C and also a higher 
A/T ratio in the first half of N1 region 
compared to the first half of N2. We found 
that the G/C ratio in N1 was 1.07 which was 
significantly higher compared to N2 (0.95) 
(P=0.045). If the difference in G/C ratio was 
due to footprints, N1 would have to be 
composed of 21% footprints in order to yield 
a ratio of 1.17. We would however also 
expect a higher A/T ratio, as footprints have 
an A/T ratio of 22.70. If 21% of N1 was 
constituted of a footprint we would expect the 
A/T ratio to be 1.5. We only found an A/T 
ratio of 0.97 in the first half of N1 regions, 
which was similar to the A/T ratio in N2 
regions from the 9832 DJH-rearrangements 
(0.95) (P=0.39). This strongly indicated that 
the difference observed in the G/C gradients 
in N1 and N2 was not due to the presence of 
footprints after VH-gene replacement.  
 
G/C ratios were dependent on gene segment 
trimming. 
We noticed that gene segment trimming 
differed significantly at VH-3’-, D-5’-, D-3’- 
and JH-5’-ends and we therefore investigated 
whether the level of trimming had an effect on 
the G/C ratio and consequently could be 
related to the different G/C gradients 
observed in N1 and N2. In order to obtain a 
larger dataset we combined the 668 unique 
non-productive and unmutated VHDJH-
rearrangements obtained from blood with 
1053 unmutated and non-productive VHDJH-
Table 3. Gene segment trimming and the presence of P nucleotides at untrimmed gene segments in 668 non-
productive and unmutated VHDJH-rearrangements obtained from blood combined with 1053 non-productive and 
unmutated VHDJH-rearrangements downloaded from NCBI (VH-3'-, D-5'-, D-3'- and JH-5'-ends) and 9832 DJH-
rearrangements (D-3'- and JH-5'-ends). 
 
Frequency of untrimmed 
gene segments 
Gene segment trimming 
(Median (bp)) 
Frequency of P nucleotides 
at untrimmed ends 
 
VH-3'-end 0.355 2 0.254 
D-5'-end 0.182 4 0.303 
D-3'-end 0.174 4 0.209 
JH-5'-end 0.115 6 0.290 
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rearrangements downloaded from NCBI. In 
N1 we found that 35.5% of all VH-3’-ends 
were unprocessed which was significantly 
higher compared to D-5’-end (18.2%, 
P<0.0001) (Table 3). The median level of 
gene segment trimming of VH-3’-ends was 2 
nucleotides and 4 nucleotides for D-5’-ends 
(P=0.035). For investigating the level of D-
3’-end and JH-5’-end trimming we further 
included the 9832 DJH-rearrangements and 
found that 17.4% of the D-3’-ends and 11.5% 
of the JH-5’-ends were unprocessed. The 
median level of gene segment trimming was 4 
nucleotides at D-3’-ends and 6 nucleotides at  
Figure 4. The effect of gene segment trimming on the G/C ratio on the sense strand of the nearest half of the N 
region in 668 non-productive and unmutated VHDJH-rearrangements obtained from blood combined with 1053 non-
productive and unmutated VHDJH-rearrangements downloaded from NCBI and 9832 DJH-rearrangements in the 
analysis. The G/C ratio of N2 was significantly higher for untrimmed (1.37) compared to trimmed (0.89) D-3’-ends 
(P<0.0001). For the JH-5’-end we found that trimmed ends had a higher G/C ratio (1.39) than untrimmed ends (0.98) 
(P<0.0001). For testing the effect of gene segment trimming on the G/C ratio on the first and second half of N1 
regions we only analyzed the 668 non-productive and unmutated VHDJH-rearrangements obtained from blood and the 
1053 non-productive and unmutated VHDJH-rearrangements downloaded from NCBI as DJH-rearrangements do not 
have N1 regions. We observed a significant increase in the G/C ratio between trimmed (0.98) and untrimmed (1.21) 
VH-3’-end (P<0.0021). G/C ratio was not significantly influenced by D-5’-end trimming (P=0.19), even though the 
G/C ratio at untrimmed ends (1.19) tended to be lower compared to trimmed (1.30).   
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Figure 5. The nucleotide and amino acid composition of artificial N1 and N2 regions from 48482 Model15 generated 
VHDJH-rearrangements with one D-gene and without stop codons correlated to those of 1053 unmutated and non-
productive VHDJH-rearrangements with one D-gene downloaded from NCBI. The two panels show the correlations 
between the frequencies of individual trinucleotides or encoded amino acids, respectively. The dashed red line 
indicates a perfect correlation (r2=1.00). The trinucleotide composition of Model15-generated N1 (r2=0.84) and N2 
(r2=0.86) did not depart significantly from that of natural rearrangements (P>0.84). Neither did the amino acid 
composition differ significantly (P>0.10) for N1 (r2=0.94) or N2 (r2=0.97). 
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JH-5’-ends which differed significantly from 
each other (P<0.0001). There was no 
significant difference between the gene 
segment trimming of D-5’- and D-3’-ends 
(P=0.99). We further found that P nucleotides 
were only present at 25.4% of untrimmed VH-
3’-ends, 30.3% of untrimmed D-3’-ends and 
28.9% of untrimmed JH-5’-ends (P>0.05), 
while the frequency of P nucleotides was 
significantly lower at the D-5’-end (20.9%) 
(P<0.02) (Table 3). We then investigated the 
effect of VH-3’-, D-5’-, D-3’- and JH-5’-end 
trimming on the G/C ratio and found that the 
G/C ratio was dependent on gene segment 
trimming (Figure 4). The effect of trimming 
of the D-3’-end and JH-5’-ends resulted in a 
significant decrease in G/C ratio in the first 
half of N2 from 1.37 to 0.89 (P<0.0001) and 
an increase in G/C ratio of the second half of 
N2 from 0.98 to 1.39, respectively 
(P<0.0001). We also found that trimming of 
the VH-3’-end yielded a lower G/C ratio 
(0.98) compared to untrimmed VH-3’-ends 
(1.21) in the first half of N1 (P<0.0021). 
Even though the G/C ratio of trimmed D-
5’end (1.30) was slightly higher compared to 
 
Figure 6. We compared the amino acid frequency distributions of 11178 Model15 generated VHDJH-rearrangements 
compared with 1019 non-productive VHDJH-rearrangements obtained from human blood or downloaded from NCBI 
with a joint in reading frame 2 and 3. *Indicates a P value below 0.0024.   
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untrimmed D-5’-end (1.19) the effect of D-5’-
end trimming was not significant (P=0.19). 
These results suggested that the formation of 
the N region generally depended on gene 
segment trimming.  
 
A TdT activity simulating computer algorithm 
confirmed that TdT preferentially added C.  
We used the obtained information regarding 
the ´nucleotide composition of N regions to 
design a computer algorithm (Model15) 
capable of generating artificial N1 and N2 
regions (described in materials and methods). 
We generated 83936 Model15 unselected 
VHDJH-rearrangements with the VH- and JH-
gene segments in the same reading frame.  
35454 (42%) of these rearrangements 
contained stop codons. We compared the 
artificial N regions (N1a and N2a) in the 
48482 rearrangements without stop codons 
with the N regions from 1053 non-productive 
and unmutated VHDJH-rearrangements with 
one D-gene of natural origin downloaded 
from NCBI (See materials and methods). The 
correlation coefficients of the trinucleotide 
composition of N1a (r2=0.84) and N2a 
(r2=0.86) did not differ significantly from 
natural NP VHDJH-rearrangements (r2=1.00) 
(P>0.84) (Figure 5). Neither did the 
correlations of the predicted amino acid 
frequency distributions of N1a and N2a differ 
significantly from that of natural VHDJH-
rearrangements (P>0.91) (Figure 5). Natural 
non-productive VHDJH-rearrangements with a 
joint in reading frame 1 are non-productive 
due to the presence of a stop codon in the 
joint. We wanted to compare the amino acid 
composition of VHDJH-rearrangements which 
were non-productive due to a joint out of 
reading frame and therefore without a bias for 
stop codons in the joint. Therefore we 
compared 1019 non-productive VHDJH-
rearrangements with joints in reading frames 
2 and 3, either downloaded from NCBI or 
obtained from human blood, with N1a and 
N2a in 11178 VHDJH-rearrangements 
randomly picked from the 83936 Model15 
generated VHDJH-rearrangements. We found 
that N1a and N1 did not differ significantly in 
the frequency distribution of any of the 20 
amino acids or stop codons (P>0.0024) 
(Figure 6). The same was found for N2 except 
for one amino acid (tyrosine) (P=0.0003). The 
computer algorithm was thus capable of 
replicating the amino acid composition of 
naturally generated N1 and N2 regions apart 
from the amino acid tyrosine in N2. Using the 
algorithm we generated a 20000 nucleotide 
long N addition. The nucleotide distribution 
in this long N addition showed that Model15 
preferentially added C (39%) during N 
addition, while G was only added at a 
frequency of 20%, A at 22% and T at 20%.  
 
DISCUSSION 
 
One in vitro functional study of purified calf 
TdT has demonstrated that under these 
conditions TdT has a strong preference of 
adding G during N addition. As smaller 
sequence analysis studies in the 1980’s and 
1990’s demonstrated that N regions also 
displayed a surplus of G, it has been 
considered a fact ever since that TdT has a 
preference of adding G during N addition. In 
1996 Kepler and colleagues observed that the 
first half of the N1 region had a slightly 
higher content of C rather than G. Even 
though this observation was not significant 
they did notice a positive G/C ratio gradient 
across the N1 region. They concluded that an 
excess of C in the first half of the N1 region, 
albeit insignificant, must have been a 
consequence of the N region primarily being  
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generated from the D-gene 3’-overhang
not by concatenation of two 3’
With a much larger dataset, we here provide 
evidence that N regions are generated by
A   
 
Figure 7. A sketch of a rearrangement occurring between V
untrimmed (B) VH-gene. The D-gene is in both cases trimmed A) 1. An untrimmed V
hairpin-opening on the non-sense strand. Hairpin
segment 2. A 3’-overhang is generated 
segment 3) The 3’-end of the D-gene segment is dependent on TdT to generate a 3’
will extend beyond the 5’-overhang in order to attack the overhang from 
3’-5’ exonuclease activity of long TdT will remove most of the 3’
generates a new 3’-overhang. 4. Compared to the D
the 3’-overhang of the D-gene to anneal. The mismatching 5’
nucleotides from the VH-gene 3’-overhang are removed by repair mechanisms. The gaps are filled by the aid of DNA 
polymerase. As the N region is mostly generated by the 3’
the VH-gene. B) In the case were both V
region formation. Accordingly the G/C ratio is symmetr
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suggest that the low G/C ratio that we also 
observed in the first half of both N1 and N2 
was due to TdT having a preference of adding 
            B 
H3-23 and D2-2 gene segments for trimmed
H-gene may be generated by 
-opening executed on the sense strand will yield a trimmed D
by the VH-gene segment and a 5’-overhang is generated by the D
-overhang
the VH-gene segment. Most commonly the 
-overhang of the VH-gene segment and TdT then 
-gene segment TdT is only required to add enough nucleoti
-overhang at the D-gene segment and the mismatching N 
-overhang of the D-gene the G/C ratio is skewed towards 
H and D-gene segments are trimmed they both contribute equally to the N 
ical around the center of the N region.  
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C rather than G during in vivo N addition. We 
further noticed that the correlation coefficient 
of the G/C gradient was significantly steeper 
for N2 (r2=0.89) compared to N1 (r2=0.48) 
(P=0.012). The difference in G/C ratio 
between the first half of N1 and N2 did not 
have anything to do with footprints after VH-
gene replacement. Footprints are A- (44%) as 
well as G-rich (30%) and would therefore in 
addition to a higher G/C ratio also yield a 
higher A/T ratio in N1 compared to N2. In 
fact if footprints were the cause of the 
difference in G/C ratio we would expect the 
A/T ratio to be 1.5. Instead we observed an 
A/T ratio of 0.92 in N1 which was similar to 
that observed in N2 (0.95) (P=0.39). The 
difference in G/C ratio across the N region 
could however be caused by a difference in 
gene segment trimming between the VH-gene 
and the D- and JH-genes as we found the G/C 
ratios being dependent on trimmed or 
untrimmed gene segments. We found that the 
levels of exonuclease activity executed on the 
VH-3’-ends were significantly lower 
compared to the D-5’-, D3’- and JH-ends. We 
postulate that the length of N additions tend to 
be longer at trimmed than untrimmed gene 
segments prior to concatenation and that this 
influence how much the sense and non-sense 
strands contribute to the generation of the N 
region. This may be the underlying 
mechanism responsible for the difference that 
we observed in the G/C gradients in N1 and 
N2 regions. During V(D)J rearrangements the 
RAG-complex cleaves at the gene segments 
and seals the double stranded DNA break 
with a hairpin loop. If the hairpin loop on the 
VH-gene segment is opened on the non-sense 
strand this will leave a 3’-overhang composed 
of P nucleotides (Figure 7A). If a 3’-overhang 
from the pairing gene segment is available 
this may attack the P nucleotides directly. We 
only found P nucleotides (>2 nucleotides) at 
21% of untrimmed VH-3’-ends, 25% D-5’, 
22% D-3’ and 29% of JH-gene ends (P>0.05). 
Trimming of P nucleotides by 3’-5’ 
exonuclease activity of long TdT is thus quite 
common (>70%). TdT may even remove the 
entire 3’-overhang which additionally leads to 
trimming of the gene segment. In this 
situation, joining of VH- and D gene segments 
are dependent on TdT generating a new 3’-
overhang on the VH-gene segment. Only a 
few nucleotides are however required in order 
for the D-gene 3’-overhang to anneal. The 
resulting N region will in this case be 
primarily composed of the C-rich D-gene 3’-
overhang which will generate a surplus of G 
on the sense strand in the resulting N region. 
If Artemis/DNA-PKcs-complex however 
engages in hairpin-opening on the sense 
strand of the VH-3’-end, a 5’-overhang is 
generated (Figure 7B). TdT is incapable of 5’-
3’ exonuclease processing3 and joining of 
gene segments are thus dependent on TdT-
generated 3’-overhangs that extend beyond 
the length of the 5’-overhang. This will lead 
to a longer N addition on the VH-3’-end and if 
the 3’-overhang from the D-5’-end is 
generated similarly this will lead to an equal 
contribution of 3’-overhangs in the generation 
of the N region. 35.3% of the VH-genes have 
not been subjected to exonuclease activity 
while this frequency was 17% for the 5’-end 
of the D-gene. Only 16.5% of the 3’-end of 
D-genes were intact after exonuclease 
trimming, while this frequency was 
significantly lower for JH-genes (11.2%). We 
found that untrimmed VH- and D-3’-ends had 
a significant higher G/C ratio compared to 
untrimmed VH- and D-3’-ends. As expected 
we found the effect of gene segment trimming 
to have the opposite effect on the G/C ratio as 
the D- and JH-5’-ends provided non-sense 
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overhangs. Trimmed D-5’- and JH-5’-ends 
had a higher G/C ratio compared to 
untrimmed ends. This effect was however 
only significant for the JH-5’-ends. Steric 
hindrance may explain why VH-genes are less 
frequently trimmed compared to D- and JH-
gene trimming. D-genes may be completely 
removed by exonuclease activity while VH-
genes did not seem to be trimmed more than 9 
nucleotides. This could be correlated with the 
presence of a cRSS located 5-10 nucleotides 
upstream from the 3’-end of 80% of all VH-
genes. This site could potentially be occupied 
by the RAG-complex thus hindering 
exonuclease activity from passing this point. 
Future studies on protein-protein and DNA-
protein interactions may provide an 
explanation for the trimming bias observed 
among gene segments and the subsequent 
difference in the G/C ratio gradients of N1 
and N2 regions.  
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ABSTRACT 
Mouse studies have suggested that autoreactive B cells or B cells that have rearranged both 
their immunoglobulin heavy chain loci non-productively may be rescued from apoptosis by 
performing a secondary rearrangement known as VH-gene replacement. This is possible due 
to the presence of a cryptic RSS (5’-TACTGTG-3’) located at the 3’-end of 80% of the VH-
genes. After VH-gene replacement an identifiable 5 to 10 nucleotide footprint may remain as a 
remnant from the previous VH-gene. Studies regarding the role of VH-gene replacement in the 
generation of the human B cell receptor repertoire have been controversial ranging from non-
existent to 5%. Here we have revisited the question and investigated 29802 unique human 
VHDJH-rearrangements for the presence of footprints after VH-gene replacement. With a new 
analysis approach and large-scale dataset we did not find any proof of footprints remaining 
after VH-gene replacements in the human B cell receptor repertoire.  
 
 
INTRODUCTION 
 
Due to imprecise annealing during VHDJH-
rearrangement two out of three 
rearrangements end up with a VHDJH-
rearrangement out of reading frame1. The 
majority of immunoglobulin genes are thus 
never translated into protein and as B cell 
survival is dependent on signalling through a 
B cell receptor (BCR) these cells will go into 
apoptosis2. B cells that express a BCR will be 
subject to negative selection in the bone 
marrow in order to prevent highly self-
reactive B cells from entering into the 
peripheral blood to lymph circulation and 
cause autoimmune disease. Accordingly, 
excessive numbers of developing B cells 
never reach maturity and just dissipate within 
the bone marrow.  
B cells with self-reactive BCRs 
however, have the opportunity of escaping 
negative selection by changing the 
specificities of their BCRs. This process is 
referred to as receptor editing and occurs 
early during B cell development in the bone 
marrow3-5. Editing of the µL chain may occur 
multiple times on either the kabba of the 
lambda allele as unused upstream VL-genes 
may rearrange to unused downstream JL-
genes6-8. In the mid 1980’s it was however, 
discovered that B cells obtained from murine 
bone marrow were capable of editing the 
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specificity of their BCR by editing the µH 
chain as well. A new further upstream 
positioned VH-gene was rearranged to an 
already fully rearranged IgH locus thus 
replacing the previous VH-gene segment9-11. 
This secondary rearrangement mechanism 
was termed VH-gene replacement. This 
editing mechanism is facilitated through a 
cryptic recombination signalling sequence 
(cRSS) located at the 3’-end of 80% of all 
VH-gene segments. Following the cRSS is a 
short stretch of 5-10 nucleotides. These 
nucleotides may remain, as a footprint after a 
VH-gene replacement has occurred if they are 
not removed by gene segment trimming 
during joint formation or obscured by somatic 
hypermutation after B cell activation12. VH-
gene replacement has been demonstrated to 
rescue highly self-reactive12 or non-
productive B cells13, 14 in mouse models. 
Evidence that VH-gene replacement is 
contributing to the generation of the human 
BCR repertoire has been controversial 15-17. 
Searching for footprints in the human BCR 
repertoire has previously been carried out in a 
smaller sample consisting of 343 productive 
VHDJH-rearrangements obtained from 
infants18. In that study they compared the 
number of footprints identified in the N 
region between the VH- and D-gene segment 
(N1) and D- and J-gene segment (N2). They 
found that approximately 5% of the mature B 
cells contained a pentameric footprint 
consistent with VH-gene replacement17. In 
contrast, we have previously not been able to 
find any proof of footprints after VH-gene 
replacement in approximately 6000 
productive VHDJH-rearrangements15. With a 
new analysis approach  and a large-scale 
dataset of nearly 30,000 VHDJH-
rearrangements downloaded from NCBI we 
attempted to settle the controversy of whether 
VH-gene replacements contribute to the 
generation of the human BCR repertoire or 
not.   
 
MATERIALS AND METHODS 
 
VHDJH –rearrangements 
29,802 unique VHDJH-rearrangements were 
obtained from the National Center for 
Biotechnology Information (NCBI) repository 
using IgBLAST (December 2011) and 5919 
unique human VHDJH-rearrangements were 
obtained from 110 healthy adult blood donors 
as previously described (Manuscript I). 
VHDJH-rearrangements were analyzed by the 
VDJsolver algorithm (version 3.0) which is 
described in detail elsewhere15 (Manuscript I). 
Version 1.0 of the algorithm is available at 
http://www.cbs.dtu.dk/services/VDJsolver/ 
 
Footprint analysis 
We identified all VH-genes containing a cRSS 
and catalogued the 5-10 nucleotide footprints 
positioned downstream thereof into an index 
file. This yielded a footprint repertoire of 138 
footprints. We generated an algorithm that 
searched for fragments of at least 5 
nucleotides from each of the 138 index 
footprints within the N-additions found 
between VH and D (N1) and D and JH (N2) 
regions of the VHDJH-rearrangements. Only 
unmutated (<3 substitutions in the VH region) 
rearrangements with one identifiable D-gene 
and an N1 region ranging from 5 to 20 
nucleotides in length were subject to footprint 
analysis. As control, we used artificially 
generated N-additions (N1a) derived from a 
model of natural VH, D JH rearrangements as 
they appear prior to antigen selection 
(Model15). The model uses experimentally 
found frequencies for gene segments, levels 
of trimming and lengths of N-additions, and 
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generates the latter by applying 
experimentally found frequencies for adding 
of specific nucleotides after a given 
dinucleotide. The model assumes 
asymmetrical concatenation in N1a and N2a 
to account for minor differences in nucleotide 
composition of the two segments. The model 
is described and evaluated in reference 
(Manuscript II) 
 
Statistical analysis 
We tested the odds ratios of finding a 
footprint in N1 and N1a at each length of the 
N region by 2x2 χ2-testing or Fisher’s exact 
testing for expected values <5. Tests of the 
fifteen priori hypotheses were conducted 
using Bonferroni adjusted alpha levels of 
0.003 (0.05/15). 
 
RESULTS 
 
No evidence of VH-gene replacement in N 
regions of 5-15 nucleotides in length in large-
scale dataset. 
We have previously demonstrated that the 
A/T and G/C ratios of N1 and N2 are 
significantly different (Manuscript II). 
Accordingly, we decided to use artificially 
generated N1 as negative control instead a 
N2, for identifying footprints after VH-gene 
replacement. These artificial N regions (N1a 
and N2a) were generated stochastically by the 
computer algorithm (Model15) based on the 
gene segment usage of 668 non-productive 
and unmutated VHDJH-rearrangements and 
observations regarding N1 and N2 region 
structure from these sequences as well as of a 
large database of DJH rearrangements 
(Manuscript I). The nucleotide and amino 
acid composition of the resulting N1a and 
N2a did not differ significantly from that 
observed in N1 and N2 found in non-
productive VHDJH-rearrangements in the 
NCBI dataset (Manuscript II).  
We downloaded 29,802 unique human 
VHDJH-rearrangements from NCBI and 
selected those that were productively 
rearranged, unmutated and contained one D-
gene and an N1 region ≥5 nucleotides. Out of 
the 29,802 VHDJH-rearrangements, 5,140 
passed those criteria and out of 48,482 
Model15-generated VHDJH-rearrangements 
we identified 32,096 passing those criteria. 
The frequencies of pentameric footprints 
identified in N1 were compared with the 
frequencies of pentameric footprints identified 
in N1a in N regions ranging from 5-15 
nucleotides in length (Table 1). With 
increasing length of the N region, the number 
of footprints identified increased. We did, 
however, not find any significant difference in 
the frequencies of identified footprints 
between N1 and N1a for each length 
individually or for all lengths combined 
(P>0.003).  
In order to deal with the possibility  that 
footprints could be removed by steric- or 
antigen-dependent selection during B cell 
development, we further investigated their 
presence in 2,132 non-productive VHDJH-
rearrangements identified in the NCBI dataset 
(Table 2). We identified 764 non-productive 
VHDJH-rearrangements with an N1 region ≥5 
nucleotides and one D-gene, which we 
compared with the 32,096 identified N1a 
regions in Model15 complying to the same 
criteria. We did not find any significant 
difference in the frequencies of footprints 
identified in N1 or N1a regions of individual 
lengths or combined from non-productive 
VHDJH-rearrangements  (P>0.003).  
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Table 1. The frequency of footprints identified in N1 productive VHDJH-rearrangements from the NCBI dataset and 
N1a from the Model15 generated VHDJH-rearrangements. We found no significant difference in the frequency of 
footprints in N1 compared to N1a. 
 
N1 N1a 
Length of                        
N-addition   Footprints No footprints Footprints No footprints Odds ratio P * 
5 38 (6%) 652 156 (5%) 3210 0.009 0.327 
6 55 (8%) 621 236 (7%) 3117 0.011 0.315 
7 83 (14%) 510 318 (10%) 2790 0.038 0.007 
8 70 (14%) 440 380 (13%) 2480 0.004 0.791 
9 73 (16%) 393 438 (16%) 2237 -0.007 0.699 
10 73 (18%) 335 435 (18%) 1927 -0.005 0.801 
11 80 (21%) 296 500 (22%) 1779 -0.007 0.777 
12 60 (22%) 211 429 (23%) 1452 -0.007 0.862 
13 56 (24%) 178 454 (26%) 1266 -0.025 0.420 
14 72 (33%) 146 361 (27%) 1001 0.065 0.045 
15   53 (34%) 103 334 (29%) 805 0.047 0.233 
Total 713 (16%) 3885 4041(15%) 22064 0.0003 1.000 
 
 
Table 2. The frequency of footprints identified in N1 non-productive VHDJH-rearrangements from the NCBI 
dataset and N1a from the Model15 generated VHDJH-rearrangements. We found no significant difference in the 
frequency of footprints in N1 compared to N1a. 
 
N1 N1a 
Length of    N-
addition   Footprints No footprints Footprints No footprints Odds ratio P * 
5 3 (4%) 67 156 (5%) 3210 -0.003 1.000 
6 4 (7%) 55 236 (7%) 3117 -0.003 1.000 
7 8 (12%) 61 318 (10%) 2790 0.014 0.708 
8 8 (14%) 48 380 (13%) 2480 0.010 0.823 
9 7 (11%) 55 438 (16%) 2237 -0.051 0.284 
10 8 (16%) 43 435 (18%) 1927 -0.027 0.617 
11 13 (25%) 40 500 (22%) 1779 0.026 0.655 
12 13 (27%) 36 429 (23%) 1452 0.037 0.538 
13 5 (13%) 34 454 (26%) 1266 -0.136 0.056 
14 11 (37%) 19 361 (27%) 1001 0.102 0.213 
15   3 (19%) 29 334 (29%) 805 -0.199 0.014 
Total 83 (15%) 487 4041 (15%) 22064 -0.01 0.559 
 
*Bonferroni adjustment requires P>0.003 for significance 
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Table 3. The frequency of footprints identified in N1 productive VHDJH-rearrangements from healthy adult 
blood donors and N1a from the Model15 generated VHDJH-rearrangements. We found no significant difference 
in the frequency of footprints in N1 compared to N1a. 
 
 
N1 N1a 
Length of                        
N-addition   Footprints No footprints Footprints No footprints Odds ratio P * 
5 8 (3%) 238 156 (5%) 3210 -0.014 0.315 
6 11 (4%) 243 236 (7%) 3117 -0.027 0.010 
7 26 (12%) 189 318 (10%) 2790 0.019 0.386 
8 25 (12%) 176 380 (13%) 2480 -0.008 0.729 
9 19 (12%) 135 438 (16%) 2237 -0.040 0.186 
10 23 (16%) 122 435 (18%) 1927 -0.026 0.439 
11 23 (17%) 112 500 (22%) 1779 -0.049 0.180 
12 32 (35%) 60 429 (23%) 1452 0.120 0.008 
13 16 (21%) 61 454 (26%) 1266 -0.056 0.273 
14 17 (30%) 40 361 (27%) 1001 0.033 0.578 
15   14 (30%) 33 334 (29%) 805 0.005 1.000 
Total 214(13%) 1409 4041(15%) 22064 -0.023 0.013 
 
 
Table 4. The frequency of footprints identified in N1 non-productive VHDJH-rearrangements from healthy 
adult blood donors and N1a from the Model15 generated VHDJH-rearrangements. We found no significant 
difference in the frequency of footprints in N1 compared to N1a. 
 
N1 N1a 
Length of                        
N-addition   Footprints No footprints Footprints No footprints Odds ratio P * 
5 4 (8%) 46 156 (5%) 3210 0.045 0.294 
6 5 (10%) 46 236 (7%) 3117 0.104 0.406 
7 7 (15%) 40 318 (10%) 2790 0.103 0.327 
8 3 (9%) 30 380 (13%) 2480 0.167 0.612 
9 6 (17%) 30 438 (16%) 2237 0.121 1.000 
10 12 (29%) 29 435 (18%) 1927 0.184 0.077 
11 7 (22%) 25 500 (22%) 1779 0.250 1.000 
12 6 (21%) 23 429 (23%) 1452 0.261 0.791 
13 9 (41%) 13 454 (26%) 1266 0.294 0.126 
14 6 (25%) 18 361 (27%) 1001 0.250 0.862 
15   7 (44%) 9 334 (29%) 805 0.118 0.268 
Total 72 (19%) 309 4041(15%) 22064 0.034 0.068 
 
* Bonferroni adjustment requires P>0.003 for significance 
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No evidence of VH-gene replacement in 
VHDJH-rearrangements obtained from healthy 
blood donors. 
In order to exclude that our results were 
biased due to concealed factors within the 
NCBI dataset, we additionally ran an analysis 
on a smaller dataset acquired within our group 
by 454-sequencing. This dataset consisted of 
2,949 unique unmutated productive and 668 
unique unmutated non-productive VHDJH-
rearrangements obtained from 110 healthy 
adult blood donors. Out of the 2,949 
productive VHDJH-rearrangements we 
identified 1,794 with an N1 region ≥5 
nucleotides and one D-gene. Again, we 
compared the frequencies of footprints 
identified in N1 with that identified in N1a. 
We found no significant difference between 
the two groups, supporting the results 
obtained from the NCBI dataset (P>0.003) 
(Table 3). Likewise, we identified 479 non-
productive VHDJH-rearrangements with an N1 
region ≥5 nucleotides and one D-gene. We 
did not find any significant difference 
between the frequencies of footprints in N1 
regions from non-productive VHDJH-
rearrangements and N1a (P>0.003) (Table 4).  
 
Exonuclease activity may destroy footprints 
after VH-gene replacement. 
Under the assumption that every cRSS was 
equally efficient during VH-gene replacement, 
the factors influencing whether a footprint 
will remain after joint formation will be the 
length of the footprint, its distribution within 
the footprint index and the level of trimming 
during joint formation. We observed four 
different lengths of footprints within the 
index. 25.5% of the footprints were 
pentameric, 65.6% heptameric, 7.3% 
nonameric and 1.8% decameric. Hexameric 
and octameric footprints did not exist in the 
footprint index. We investigated the level of 
gene segment trimming of VH- and D-gene 
segments during primary rearrangement. 35% 
of VH-genes in 5273 unmutated VHDJH-
rearrangements with one D-gene and an N1 
region ≥5 nucleotides from the NCBI dataset 
were untrimmed after joint formation, while 
20% were trimmed one nucleotide, 15% two 
nucleotides, 11% three nucleotides etc. (Table 
5). During VH-gene replacement the RAG-
complex cleaves at the 3’-end of the cRSS 
and the footprint will subsequently be sealed 
by a hairpin-loop. The level of D-gene 
trimming during primary rearrangement will 
during VH-gene replacement be applied on the 
5’-end of the footprint (Table 5). 16% of D-
genes in the VHDJH-rearrangements were 
untrimmed after joint formation, while 8% 
were trimmed one nucleotide, 14% two 
nucleotides, 10% three nucleotides etc. (Table 
5). We therefore only expect 6% of the 
pentameric footprints to remain after a second 
rearrangement (Table 6). As pentameric 
footprints only represented 25.5% of the 
footprint repertoire, this yielded an actual 
chance of remaining after VH-gene 
replacement of 1.4%. The additive rule of 
probabilities was applied for calculating the 
probability of finding a heptameric footprint 
after a VH-gene replacement, which was 
20.6% (Table 6). Combined with the 
frequency distribution of heptameric 
footprints in the footprint index, this yielded 
an actual chance of finding a heptameric 
footprint after VH-gene replacement of 13.5% 
(Table 6). The actual chance of finding a 
footprint after nonameric and decameric 
footprints were 2.9% and 0.9%, respectively. 
Based on the entire footprint index and the 
level of gene segment trimming during 
primary rearrangement and VH-gene 
replacement the actual chance of finding any  
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footprint after VH-gene replacement was 
18.7%. This indicated that if VH-gene 
replacement does occur at a low level, >80% 
of footprints will be lost due to trimming. 
 
DISCUSSION 
 
VH-gene replacement has been demonstrated 
to take place in transgenic mice engineered to 
only express either a highly self-reactive12 or 
non-productive antibody13. Under these 
conditions where the immune system is 
forced to find a loophole out of immune 
deficiency, VH-gene replacement occurs at 
rather high frequencies. As the contribution of 
VH-gene replacement in the generation of the 
human BCR repertoire has been controversial 
we wanted to resolve this by executing large-
scale analysis of footprints in a dataset 
containing 29,802 human VHDJH-
rearrangements downloaded from NCBI. In 
order to detect a 5 percentage point 
difference, with a power of at least 90%, in 
footprints identified in N1 compared to the 
negative control N1a, a minimum of 1,210 
VHDJH-rearrangements was required per 
group. We investigated the presence of 
footprints in 5,140 productive unmutated 
Table 5. The effect of nuclease activity on the trimming 
of VH-3’-end and D-5’-end respectively in 5273 
unmutated VHDJH-rearrangements with one D-gene and 
an N1 region ≥5 nucleotides from the NCBI dataset. The 
negative numbers indicate truncation of gene segments.  
 
 Frequency of trimming 
Truncation of   
gene segment (bp) VH-3'-end D-5'-end 
0 0.35 0.16 
-1 0.20 0.08 
-2 0.15 0.14 
-3 0.11 0.10 
-4 0.05 0.12 
-5 0.04 0.09 
-6 0.02 0.08 
-7 0.01 0.06 
-8 0.01 0.04 
-9 0.06 0.03 
-10 0.00 0.03 
-11 0.00 0.02 
-12 0.00 0.01 
-13 0.00 0.01 
-14 0.00 0.01 
-15 0.00 0.01 
-16 0.00 0.01 
-17 0.00 0.00 
-18 0.00 0.00 
-19 0.00 0.00 
 
Table 6. The chance of finding a footprint of length 5 or longer after joint formation. Four lengths of footprints exist 
in the footprint index at different distribution frequencies. We calculated the chances of finding footprints based on 
the level of gene segment trimming during primary rearrangement (Table 5). The actual chance of finding a footprint 
was estimated by the additive rule of probabilities. 
 
Germline footprint 
Distribution in 
footprint index 
Chance of any footprint 
after trimming 
 
Actual chance 
  
   
Pentamer 0.255 0.06 0.015 
Heptamer  0.655 0.21 0.135 
Nonamer 0.073 0.40 0.029 
Decamer 0.018 0.49 0.009 
    
 Total   0.187 
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VHDJH-rearrangements with 1 D-gene and 
length of N1 ≥5, which was markedly above 
the required sample size in order to prevent a 
false negative result. Under these conditions 
we were unable to detect any footprints after 
VH-gene replacement in productive VHDJH-
rearrangements (P>0.003). We further 
demonstrated that this was not due to 
selection against VHDJH-rearrangements 
containing footprints as they were also absent 
in 2,131 non-productive VHDJH-
rearrangements. We additionally subjected a 
smaller dataset of 2,949 unmutated productive 
and 668 unmutated non-productive VHDJH-
rearrangements obtained from 110 healthy 
adult blood donors to the footprint analysis 
which supported the outcome from the NCBI 
dataset. We thus conclude, if VH-gene 
replacement is a mechanism involved in the 
generation of the human BCR repertoire, the 
frequency must be extremely low. In order to 
detect such a marginal difference between N1 
and N1a as significant, the sample size would 
have to be increased even further. It is thus 
questionable whether VH-gene replacement is 
of any importance for the shaping of the 
normal human BCR repertoire.  
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ABSTRACT 
The occurrence of vector-related side effects in gene therapeutic trials has emphasized the 
requirement of improved vector designs. We have explored the opportunity of using the 
naturally occurring recombinases, RAG1 and RAG2, to introduce a transgene into the human 
immunoglobulin heavy chain locus. These enzymes recognize specific recombination 
signalling sequences, RSS, which could act as integration sites for transgenes. We have 
designed and generated a prototype of a non-viral two-plasmid-targeted gene integration 
system consisting of a RAG1 and RAG2 expression vector (RAGVec1.0) and a vector with a 
gene of interest encoding red fluorescent protein (RFP)  flanked by RSS. (GeneVec1.0). We 
have used the model cell line HEK293T to demonstrate the expression potential of both 
plasmids and measured high RAG1 and RAG2 mRNA expression and high RAG1 protein 
expression. We further verified the expression and function of RFP in the GeneVec1.0 
integration vector.  The advantages and limitations of stable, locus-specific, long-term 
integration with a gene of interest with the current vector design are hereby presented.   
 
 
INTRODUCTION 
 
Up until today, the preferred clinical strategy 
for performing gene therapy has relied on the 
mechanism of viral systems. By incorporating 
the desired gene into the viral genome it is 
possible to utilize the viral integration 
mechanism to integrate a gene into the host 
cell’s genome (retrovirus, lentivirus, adeno-
associated virus etc.1-6). In recent years, it has 
been demonstrated that viral integration does 
not occur sporadically throughout the host 
genome as initially thought. There is a bias 
towards integrating the genes into already 
active transcriptional sites, and this generates 
a high risk of mutagenesis7-9. Despite the 
vector-related complications, viral vectors 
have been used in almost 70% of the 
approximately 1700 gene therapeutic trials 
that have been approved since 198910. There 
are, however, alternative ways of delivering 
and integrating DNA into cells that are much 
less risky for the patients, based on non-viral 
gene delivery and integration techniques.  
Mammalian cells carry a net negative 
surface charge11 which appears to play a key 
role in the mediation of cell-to-cell interaction 
and cell-to-substrate adhesion. By wrapping 
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DNA molecules, that are either linear or 
circular, with lipopolyamines, 
polyamidoamines or polyethylenimine (PEI), 
it is possible to stimulate the transport and 
uptake of DNA across the cell membrane into 
the cells. Once within the cytoplasm, the 
DNA has the opportunity of entering the 
nucleus and integrate stably into the genome, 
either by random integration (homologous 
recombination12, 13) or by the aid of 
integrational enzymes14-17. Homologous 
recombination (HR) is one of the mechanisms 
used by both prokaryotic and eukaryotic cells 
to repair double stranded DNA breaks (DSBs) 
that occurs from exposure to damaging agents 
or as intermediates during normal cellular 
processes. HR leads to accurate repair of 
DSBs as it takes advantage of the homologous 
DNA sequence of a sister-chromatid (allelic 
recombination) or another homologous 
chromosome (ectopic recombination) thus 
transferring the genetic information from one 
DNA molecule to the other. The commonly 
accepted model for HR is the Szostak 
model18. This model suggests that at the DSB 
the 5’-ends at the break are trimmed back 
leaving a long single stranded 3’- overhang. 
This overhang will combine with a 
homologous DNA sequence. The homologous 
DNA strand will separate at the site of DNA 
invasion and allows both of the 3’-overhangs 
to anneal to their homologous sequences on 
opposite strands. DNA synthesis will be 
primed by the 3’-overhang and ligation leads 
to the formation of a double Holliday-
junction19. The intertwined DNA strands 
depend on resolution of the Holliday-
junctions in order to segregate and the 
mechanism involved in this remains an 
enigma. Utilizing homologous recombination 
for targeted gene integration has a major 
potential, however, the frequency by which 
spontaneous homologous recombination 
occurs is rather low (10-6)20.  
An example of an enzyme-based 
integrational system is represented by 
transposable elements which are capable of 
carrying large size genes and contribute to 
stably integrating them into the genome. The 
integrational-based system depends on two 
components for action: The transposable 
element and the transposase enzyme that 
catalyzes transposition. The transposase 
recognizes specific inverted terminal repeats 
(ITR) flanking the transposon. The ITR 
contains two binding motifs separated by 
~200 bp21. Neutral evolution has led to the 
accumulation of mutations within vertebrate 
transposons over the course of time, rendering 
the natural transposons inactive. In one study, 
Ivics and colleagues reconstructed a dormant 
transposon found in the genome of eight 
different fish species, by sequence alignment. 
Based on the consensus sequence from this 
alignment, they re-created the Sleeping 
Beauty (SB) transposon22. Further genetic 
engineering of the transposon resulted in an 
increase in the activity of the initial Sleeping 
Beauty transposition by 100-fold, thus 
obtaining a hyperactive version potentially 
useful for gene integration in clinical trials23. 
In 2008, a phase I trial using the Sleeping 
Beauty system was approved for generating 
CD19-specific chimeric antigen receptors 
(CARs) on T cells. These CAR-expressing T 
cells targeted cells expressing the B cell 
specific marker CD19+. SB containing the 
CAR was delivered to T cells obtained from 
patients with advanced CD19+ lymphoid 
malignancies and infused back into the 
patients24. The CAR-expressing T cells will 
then kill all B cells but because the 
hematopoietic stem cells that can give rise to 
new B cells are CD19-, there is an 
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opportunity to overcome the treatment. The 
trial is still ongoing and thus, its outcome 
remains unknown.  
The two-step hydrolysis/transesterification 
mechanism mediated by the two 
recombination-activating genes (RAG) 1 and 
2 that occurs during V(D)J-rearrangement,  
strongly resembles that of transposable 
elements25-27. The secondary and tertiary 
structure of the RAG-complex is similar to 
transposases28 and the RAG-complex’s ability 
to carry out intermolecular transposition of a 
DNA fragment flanked by RSS favours the 
theory of transposon origination25. Further, 
the two RAG genes are intron-less just as 
other genes of microbial descent. Here, we 
hypothesize that the transposition property of 
RAG1 and RAG2 can be utilized for locus-
specific gene integration. We have attempted 
to design a non-viral, two-plasmid-targeted 
integrational system composed of a vector 
containing both RAG1 and RAG2 and a 
vector containing the gene of interest (GOI) 
e.g. the gene RFP encoding red fluorescent 
protein, flanked by 23-spacer RSS. We have 
measured high transgenic RAG1 and RAG2 
mRNA expression as well as high transgenic 
RAG1 protein expression in the non-
lymphoid cell line HEK293T, a modified 
human embryonic kidney cell capable of 
high-recombinant protein expression used as a 
model system in this study29, 30. Taking the 
so-far accumulated data together, it has not 
been possible to demonstrate targeted gene 
integration using the current vector design. In 
this report, we discuss the several reasons that 
could account for the lack of gene integration 
and what future approaches should be made in 
order to achieve a successful outcome.   
 
 
 
MATERIALS AND METHODS 
 
Cell culture 
The adherent human embryonic kidney cell, 
HEK293T, was cultured in DMEM 
supplemented with 10% FBS, 2 mM 
glutamine and Pen/S-strep. Medium was 
changed and cultures split 1:4 every third day. 
The B cell lymphoma lines, Daudi and 
Farage, were cultured in RPMI supplemented 
with 10% FBS, 4 mM glutamine and 
Pen/Strep. For the B cell lines, medium was 
changed and cultures split every fourth day. 
All cell lines were maintained at 37 °C at 21% 
O2 and 5 % CO2.  
 
DNA Sequencing  
DNA sequencing was performed using 
BigDye terminator v3.1 cycle sequencing kit 
according to the instructions of the 
manufacturer (Life Technologies). Forward 
and reverse primers were designed to anneal 
to the template with approx. 400 nucleotides 
apart and the assay was run on ABIprism 
3130 (Life Technologies) and analyzed in 
Chromas and ClustalW.  
 
Generation of transgenic HEK293T 
Transfection was achieved by non-viral 
means using the polyethylenimine reagent 
JetPEI from PolyPlus. RAG transgenic 
HEK293T cells were treated with 500 ng/ml 
zeocin 24 hours after transfection, and 
continued up to 10 weeks, after which cell 
clones were isolated. Subcloning was 
achieved by seeding approximately 200 cells 
in 150 mm cell culture dishes. Colonies were 
allowed to develop within 7-10 days. After 
removing the medium, 3mm cloning discs 
(Sigma-Aldrich) were submerged into pre-
warmed 37ºC trypsin and placed on top of the 
colonies and left to incubate for 5 min at room 
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temperature. The membranes were 
subsequently transferred to individual wells in 
a 12-well culture plate. Transfection with the 
RAGVec1.0 and GeneVec1.0 vectors was 
performed as described above. However, 
GeneVec1.0 transfectants were not subject to 
antibiotic selection. Immunofluorescence 
pictures were taken each day within the first 
72 hours. Transfection frequency and 
corrected total cell fluorescence (CTCF) 
levels were estimated in ImageJ software.  
 
Sample preparation    
DNA and RNA were extracted using DNA 
and RNeasy mini kits, as described by the 
manufacturer (Qiagen). RNA extraction of 
transfected cell lines required an extra DNAse 
I (Promega) treatment for 30 min at 37˚C in 
order to completely eliminate plasmid DNA. 
cDNA was synthesised using the RevertAid H 
Minus First strand cDNA synthesis kit  
(Fermentas-Thermo Scientific).  
Protein extraction was achieved by collecting 
cells by centrifugation (1500g), washed twice 
with PBS (w/o Ca2+,Mg2+), and 
resuspending cell pellets in RIPA buffer 
(Sigma-Aldrich) containing protease inhibitor 
cocktail (Sigma-Aldrich). Protein 
concentration was determined by the method 
of Lowry using the DC protein assay 
(Biorad). 
 
Construction of a two-plasmid integration 
system 
To construct the vector containing RAG1 and 
RAG2 (RAGVec1.0), the dual gene 
expression vector, pBudCE4.1 (Life 
Technologies) (4600bp), was used as a 
backbone (Figure 1). The two multiple 
cloning sites (MCS) are preceded by two 
different promoters (PCMV and PEF-1α). In 
addition, the vector contains a gene encoding 
resistance against the antibiotic zeocin and the 
SV40 promoter that enables excessive 
replication of the plasmids once inside the T-
antigen-expressing HEK293T cell line. 
Unless specified, all restriction endonucleases 
(RE) and accompanying cloning reagents 
were purchased from New England Biolabs. 
Reference sequences of RAG1 (NM_000448: 
3200bp) and RAG2 (NM_000536: 1600bp) 
were obtained from GenBank. Suitable 
endonucleases were identified in the online 
available program, WebCutter2.0, to allow for 
insertion of amplified RAG sequences into 
compatible sites in pBudCE4.1. Template-
specific primers were generated for full-
length amplification of RAG1 and RAG2 
with overhanging restriction sites (RS). 
(RAG1-forward-Sal I: 5’-
TTTGTCGACCAGCATGGCAGCCTCTTT
C-3’, RAG1-reverse-BamHI: 5’-
TTGGATCCTGGTTGCCCTACTTAAAAT
TC-3’, RAG2-forward-NotI: 5’- 
CCCCGCGGCCGCCTACGTACCATCAGA
AACTAT-3’, RAG2-reverse-SfiI: 5’-
AACCGGCCCAGCCGGCCTCCATACACC
TGAATCTGAAA-3’). RAG1 and RAG2 
were amplified from genomic DNA obtained 
from PBMCs with primers containing 
restriction sites (Figure 1). PCR products 
were purified prior to restriction enzyme 
digestion. Initially, pBudCE4.1 and RAG1 
fragments flanked by SalI and BamHI RS 
were separately digested with SalI and 
BamHI (1x NEBbuffer3, 10 units SalI, 10 
units BamHI, 2 µg vector or RAG1 fragment) 
for two hours at 37ºC. Digestion of the vector 
was confirmed by gel-electrophoresis and the 
RE’s were subsequently inactivated at 65°C 
for 20 min. To prevent re-ligation of the 
vector, the reaction was further incubated 
during 30 min with Antarctic phosphatase at 
37°C followed by heat inactivation at 65°C  
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Figure 1. Construction scheme of the RAGVec1.0 vector. The RAGVec1.0 was generated in four steps: The first 
step consisted of adding RS’s to RAG1 and RAG2. RAG1 and RAG2 were amplified from genomic DNA obtained 
from PBMCs. In the second step,  RAG1 and RAG2 were inserted into pBudCE4.1 and Topo-pCR2.1, respectively. 
In the third step, RAG2 was excised from Topo-pCR2.1. In the fourth step RAG2 was inserted into the second MCS 
of pBudCE4.1 which produced the RAGVec1.0. 
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for 10 min. Ligation of the insert and vector 
was performed at room temperature for 30 
min (2000 units of T4 ligase, 1X ligase 
buffer, 1 µl vector, 3 µl insert). Ligation 
products were transformed into chemically 
competent TOP10 E.coli (Life Technologies). 
Transformed cells were cultured for ~16 
hours at 37ºC on low sodium Luria-Bertani 
(LB) agar plates containing 25 µg/ml Zeocin. 
Positive colonies were identified using vector 
primers and overnight cultures were prepared 
from positive colonies. Plasmids were 
subsequently purified and the RAG1 sequence 
was confirmed by DNA sequencing. It was 
more efficient to digest the RAG2 fragments 
flanked by SfiI and NotI RS from an 
intermediate vector rather than digesting the 
PCR product directly. This is probably due to 
SfiI’s requirement of two adjacent RSs in 
order to cleave. We therefore inserted an 
oligonucleotide containing the SfiI and NotI 
RS flanking the RAG2 fragment into a 
pCR2.1 TOPO-vector (Life Technologies). 
The RAG1-containing pBudCE4.1 and the 
pCR2.1-TOPO-containing RAG2 were 
separately incubated with SfiI (1X 
NEBbuffer2, 20 units SfiI and 6 µg backbone 
vector and 30 µg vector containing RAG2, 
respectively) for 2 hours at 50ºC. SfiI 
digestion was confirmed by gel-
electrophoresis. Prior to NotI digestion (50 
mM NaCl and 2.5 units NotI), the samples 
were cooled. NotI was incubated at 37ºC for 2 
hours. As SfiI cannot be heat inactivated, the 
samples were purified prior to ligation using 
an Illustra GFX DNA/gel band purification 
kit (GE Health Sciences). The RAG1-
containing pBudCE4.1 was again subjected to 
phosphatase treatment prior to ligation. 
Ligation, transformation, plasmid purification 
and DNA sequence confirmation were 
performed as mentioned above. For 
convenience, we named the RAG1 and 
RAG2-containing pBudCE4.1 expression 
vector as RAGVec1.0 (Figure 1). 
 To construct the vector containing the 
GOI, the eukaryotic expression vector 
pCMV-Script (4300bp) (Stratagene) was used 
as a backbone. This vector contains a gene 
encoding resistance against neomycin and a 
SV40 promoter. The GOI chosen in this study 
was RFP, the gene encoding red fluorescent 
protein31, 32. First, a double-stranded 
oligonucleotide  containing a new multiple 
cloning site (MCS) composed of three RS, 
AscI, PacI and FseI,  flanked by two 23-
spacer RSS (5’-
GGTTTTTGTACACACTCAGGATGTGGT
TGCAACACTGTG-3’) on each side was 
synthesized (GenScript) (Figure 2A). The 23-
spacer MCS cassette flanked by AatII and 
EcoRI restriction sites, respectively, was 
introduced into the pUC57 expression vector 
(GenScript) (Figure 1B). We obtained RFP 
from the expression vector pcDNA3-TagRFP-
T (kind gift from Dr. Robert Tsien, UCSD, 
USA). Primers for full-length RFP including 
its promoter region were designed with 
overhanging AscI and PacI RS, respectively.  
RFP-Forward-AscI: 5’-
ATTAGGCGCGCCGCGTTGACATTGATT
ATTGACT-3’, RFP-Reverse-PacI: 5'-
TATATTAATTAAGCTGGTTCTTTCCGCC
TCA-3’. RFP flanked by AscI and PacI RSs 
and the 23-spacer-RSS-containing pUC57 
vector were incubated separately with both 
PacI and AscI for 1 hour at 37°C (1X 
NEBbuffer4, 10 µg BSA, 10 units PacI, 10 
units AscI, 25 µg insert or vector). The 
digested 23-spacer RSS fragment was 
incubated for 30 min with Antarctic 
phosphatase at 37°C followed by heat 
inactivation at 65°C for 10 min. Ligation of 
PCR-amplified RFP into the 23-spacer RSS- 
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containing-pUC57 vector, transformation, 
plasmid purification and DNA sequence 
confirmation were performed as mentioned 
above. The gene cassette including RFP and 
the pCMV-Script vector was digested with 
AatII and EcoRI by first incubating the 
digestion with AatII at 37°C for 2 hours (1X 
NEBbuffer4, 20 units AatII, 3 µg insert or 
A
B 
 
Figure 2. Construction scheme of the GeneVec1.0 vector. A) Design of the 23-spacer cassette: In between two 23-
spacer RSS, a multiple cloning site (MCS) was positioned which was composed of AscI, PacI and FseI recognition 
sites. Two other recognition sites for the AatII and EcoRI enzymes were placed flanking on each side of the entire 
gene cassette. B) GeneVec1.0 construction workflow: 1) RFP was amplified using template specific primers with 
AscI and PacI RS overhangs, respectively. The 23-spacer RSS was introduced into the expression vector pUC57.  The 
23-spacer RSS cassette vector was digested by AscI and PacI REs. The excised RFP was subsequently ligated into the 
23-spacer RSS cassette vector. 2) The pCMV-Script vector and the pUC57-containing 23-spacer RSS flanked RFP 
plasmid were digested by AatII and EcoRI RE’s. The pCMV-Script digest helped to remove the purposeless Pcmv 
promoter. 3) Ligation of the 23-spacer RSS flanked RFP into pCMV-Script yielded GeneVec1.0.   
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vector) until full-linearization was achieved. 
The samples were purified with Illustra GFX 
DNA/gel band purification kit (GE Health 
sciences) and incubated  with EcoRI at 37°C 
for 2 hours in (1X NEBbufferU, 20 units 
EcoRI). EcoRI was heat inactivated for 20 
min at 65°C prior to ligation, and vector 
digestion was confirmed by gel-
electrophoresis. pCMV-Script was thereafter 
incubated with Antarctic phosphatase at 37°C 
followed by heat inactivation at 65°C for 10 
min. Ligation of the gene cassette including 
RFP and pCMV-Script, transformation, 
plasmid purification and DNA sequence 
confirmation was performed as mentioned 
above. For convenience, we named this vector 
GeneVec1.0 (Figure 2B).     
 
Semi-quantitative real-time and standard 
PCR 
The following primers were designed to 
detect RAG1 and RAG2 expression levels. 
RAG1-forward: 5’ 
CAGCATGGCAGCCTCTTTC 3’, RAG1-
reverse: 5’ 
TCTGAAAATTTAATATGTGGGTG 3’, 
RAG2-forward: 5’ 
CTACGTACCATCAGAAACTAT 3’, 
RAG2-reverse: 5’ 
TGTCCATCAAATTCATCAGTG 3’. 
Quantitative real-time PCR was performed 
using SYBR PCR Master-mix (Life 
Technologies) with 25 ng cDNA template per 
PCR reaction. For detection of targeted gene 
integration the following primers were 
designed. IgHD1-forward: 5’-
GATTCTGAACAGCCCCGAG-3’, IgHD2-
forward: 5’-TTTTGTGGGGGCTCGTGTC-
3’, IgHD3-forward: 5’-
GGTCTGTGTCACTGTGGTAT-3’, IgHD4-
forward: 5’-GGCACACTCAGGGGCTTTT-
3’ , IgHD5-forward: 5’-
ACAGCCCCGCCTCCAGTT-3’, IgHD6-
forward: 5’-
GGTTTCTGAAGGTGTCTGTG-3’, IgHD6-
19-forward: 5’-
GGTTTCTGAAGCTGTCTGTA-3’ IgHD7-
forward: 5’-
GAGAACCACTGTGCTAACTG-3’, RFP-
correct-reverse: 5’-
GCTATGAACTAATGACCCCG-3’, RFP-
inverse-reverse: 5’-
GGTGGGCTCTATGGCTTCT-3’. 100 µg 
genomic DNA was added per PCR reaction. 
 
ELISA 
96-well clear flat bottom MaxiSorp plates 
(Nunc) were coated over night at 4°C with 
total protein extracts from HEK293T cells 
expressing transgenic RAG1 and RAG2 
(RAGVec1.0). Plates were blocked at room 
temperature for 1 hour in PBS + 1% BSA. 
The primary rabbit anti-human RAG1 
antibody (Cell Signaling Technologies) was 
diluted 1:250 in 1% BSA, added to the plates 
and incubated for 1 hour at room temperature. 
HRP-conjugated secondary antibody against 
rabbit immunoglobulins (Cell Signaling 
Technologies) was diluted 1:10,000, and 
added to the corresponding wells followed by 
1 hour of incubation at room temperature. 
Protein detection was obtained using ELISA 
reagents from R&D Systems according to the 
manufacturer’s protocol. OD was 
subsequently measured at 450 nm (Organon 
Teknika microwell system 230S).      
 
RESULTS 
 
RAGVec1.0 transfection results in high-level 
RAG1 and RAG2 expression in HEK293T 
cells.  
We first introduced RAGVec1.0 into 
HEK293T cells by polyethylenimine-
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mediated transfection. The mRNA expression 
levels increased 60-fold for RAG1 and 10-
fold for RAG2 compared to sham within the 
first 72 hours of culture (Figure 3). Thus, 
RAG1 mRNA levels were 8-fold higher than 
a naturally expressing RAG+ cell line such as 
the B-cell line Daudi (Figure 3). Even though 
RAG2 mRNA expression was higher 
compared to sham, it was 16-fold lower 
compared to Daudi. After two weeks of 
antibiotic treatment, cultures were subjected 
to sub-cloning in order to obtain clones with a 
higher and more homogenous transgenic 
expression (Figure 3b). We obtained three 
 
Figure 3. RAG1 and RAG2 mRNA and protein expression in transgenic and established cell lines. A) RAG expression 
is significantly different in the two B-cell lines Daudi (RAG+) and Farage(RAG-). RAG1 expression is 400-fold and 
RAG2 3000-fold higher in Daudi than in Farage.  B) Transgenic RAG expression 72 hours after transfection with 
Sham and RAGVec1.0. The copy number of transgenic RAG1 and RAG2 is significantly increased with more than 
1000-fold. When compared to the two B cell lines Daudi and Ramos that are positive and negative for RAG 
expression, respectively, it becomes evident  that the level of transgenic RAG expression is above the level of Ramos 
and almost as high as Daudi. Transfection of sham does not result in detectable RAG expression Within 72 hours after 
transfecting RAGVec1.0 into HEK293T, we obtained a 60-fold increase in RAG1 expression and 10-fold in RAG2 
expression (R1R2) compared to sham. Further subcloning increased RAG1 expression up to 55000-fold and RAG2 up 
to 123500-fold compared to sham. C) We measured RAG1 protein expression in subclones cultured for >10 weeks. 
SC1 expressed RAG1 protein 7-fold higher than sham (T-test, P<0.05). SC2 and SC3 only displayed 2-fold higher 
RAG1 expression and only SC3 was significantly different from Sham (T-test, P<0.05).   RAG2 protein expression 
could not be analyzed due to the lack of a reliable antibody. 
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high RAG mRNA expressing subclones: SC1, 
SC2 and SC3. Compared to sham, the RAG1 
mRNA level was increased 2000-fold in SC1, 
55000-fold in SC2 and 9000-fold in SC3.  As 
regards RAG2, its mRNA expression was 
increased 81000 fold in SC1, 4000-fold in 
SC2 and 123500-fold in SC3. However, over 
the course of 10 weeks, we noticed that 
RAG1 mRNA expression had decreased with 
85% in SC1, 84% in SC2 and 98% in SC3. 
Also, RAG2 mRNA expression had decreased 
78% in SC1, 95% in SC2 and 94% in SC3 
(data not shown). These inconsistencies in 
expression level between passages made it 
complicated to obtain independent replicates 
for statistical verification. We measured the 
RAG1 protein expression levels in sub clones 
cultured for >10 weeks and found that SC1 
had 7-fold higher RAG1 protein expression 
compared to sham (P<0.05) and both SC2 and 
SC3 had 2-fold higher RAG1 expression. It 
was only SC3 that was significantly different 
from sham (P<0.05) (Figure 3C). 
Since only RAG1, but not RAG2, 
antibodies suitable for immunoblotting were 
available to confirm expression of the RAG 
proteins; functional assays involving the RAG 
proteins were attempted. We tested the 
functionality of RAG1 and RAG2 by 
transfecting subclones with a rearrangement 
substrate, DelVec33, kindly lent to us by Dr. 
Gina Scott from the University of Leeds, UK. 
 
 
 
 
Figure 4. Functional test to assess expression of RFP from the GeneVec1.0 vector. RFP expression was clearly 
detectable 72 hours after transfection. Transfection efficiency was approximately 25% and RFP expression was highly 
variable among RFP expressing cells, ranging from nearly invisible to extremely bright. Un-transfected HEK293T 
was negative for RFP expression. 
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Five days after transfection, plasmid DNA 
was purified from the transgenic cells and 
analyzed for excision both by conventional 
and real time PCR. We did not detect any 
excision events (data not shown). 
 
Visual RFP expression 72 hours after 
transfection of GeneVec1.0 in HEK293T cells. 
We tested the functionality of RFP in 
HEK293T. GeneVec1.0 was introduced into 
cells by polyethylenimine-mediated 
tranfection and 72 hours after transfection we 
found that approximately 25% of the cells 
were positive for RFP expression (Figure 4). 
The expression of RFP in individual cells was 
rather heterogeneous ranging from hardly 
visible (CTCF=1,500) to extremely bright 
(CTCF=100,000). Non-transfected cells did 
not display any RFP expression (CTCF=0).    
 
RFP integration in the IgH locus of RAG 
transgenic 293T lines was negative.  
Real time PCR is an extremely sensitive 
method capable of detecting as little as one 
 
Figure 5. A) Real time PCR expression results. We designed forward primers for all IgH D-gene families and reverse 
primers capable of detecting both sense and anti-sense inverted integrated RFP. B) and D) Amplification of a hybrid 
product between a D-gene and a sense or inverted RFP was significantly lower in SC1 compared to sham (2-way 
ANOVA, P<0.0001). C) and E) In the RAGVec1.0 and GeneVec1.0 double transfectants, amplification of a hybrid 
product was non-existent and significantly lower than HEK293T transfected with sham and GeneVec1.0 alone (2-way 
ANOVA, P<0.0001). 
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template copy per cell.  We designed forward 
primers matching all D-genes within the IgH 
locus and two RFP internal reverse primers 
capable of detecting sense and antisense 
inserted RFP, respectively (Figure 5A). We 
transfected SC1 cells that were grown and 
selected with zeocin antibiotic for >10 weeks 
with GeneVec1.0 and also co-transfected 
RAGVec1.0 and GeneVec1.0 into HEK293T. 
Five days after transfection, we extracted 
genomic DNA. We included genomic DNA 
from approximately 17,000 cells in the PCR 
reaction. Compared to sham, we did not find 
any detectable RFP integration in either SC1 
or in double-transfected HEK293T (Figure 
5B-E). 
 
DISCUSSION 
 
The hypothesis. 
Based on functional and structural similarities 
to the transposon-systems used in gene 
therapeutic trials today (Sleeping Beauty), we 
hypothesized that RAG1 and RAG2 could be 
applied in similar ways. RAG1 and RAG2 
can only bind and cleave site-specifically 
within the immunoglobulin loci (heavy chain 
locus on chromosome 14; kappa locus on 
chromosome 2; and lambda locus on 
chromosome 22) and T-cell receptor loci 
(alpha and delta chain loci on chromosome 
14, beta and gamma chain loci on 
chromosome 7). By flanking a GOI with 23-
spacer RSSs we speculated that it could be 
possible to integrate the gene in between two 
D-genes on the immunoglobulin locus on 
chromosome 14 or the orphon D-locus on 
chromosome 15. The advantage of targeting a 
construct to one specific location reduces the 
likelihood of negative side effects resulting 
from integration events. 
Non-viral gene delivery would be 
employed to deliver the plasmids into the 
cells and as a result, transgenic RAG1 and 
RAG2 were expressed transiently. Within the 
first days of transfection, RAG1 and RAG2 
would contribute to integrate the GOI. In 
theory, RAG1 and RAG2 would first bind to 
the 23-spacer RSS on one side of the GOI and 
pair it with a complementary 12-spacer RSS 
within the D-locus (Figure 6). Secondly, the 
23-spacer RSS on the other side of the GOI 
would be paired with another 12-spacer RSS 
within the D-locus. The RAG complex would 
then cleave in between the gene segment and 
the heptamer of the RSS. The gene-end is 
thereafter sealed by a hairpin loop, while the 
heptamer-end would remain blunt. During 
normal V(D)J rearrangement the heptamer-
end from a gene segment is ligated with a 
heptamer-end from another gene segment 
creating an excision circle. In the hypothetical 
situation of a gene-integration event, we 
predict that two situations may occur: 1) 
RAG1 and RAG2-mediated cleavage occurs 
simultaneously on both sides of the GOI 
generating an excision circle consisting of the 
backbone of GeneVec1.0 and the intervening 
DNA between the two D-genes (Figure 6a), 
or 2) The two sides are integrated 
asynchronously generating a linear excision 
product (Figure 6b). The hairpins that are 
generated at the D-gene segments and the 
GOI would be reopened by the enzyme 
Artemis, which also is responsible for 
trimming the 3’-overhang produced by 
hairpin opening34. If terminal 
deoxynucleotidyl transferase (TdT) is 
expressed normally in the cell line, non-
template nucleotides may also be added to the 
overhangs35. Micro-homology between the 
overhang from the D-gene and the overhang 
from the GOI would guide the annealing 
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process36, 37. DNA polymerase 
subsequently repair the remaining gaps
the GOI would then be positioned in between 
two D-genes on the Ig locus.   
A 
B 
Figure 6. Schematic representation of the RAG
integration system is composed of a plasmid expressing both RAG1 and RAG2 and a plasmid containing the GOI 
flanked by 23-spacer RSS. The two vectors are transfected using a non
formulation  into the target cells B) After cell entry, the RAG enz
RAG1 and RAG2 function as a hetero-
in the IgH locus. Recombination will subsequently integrate the GOI in between two D
product may either be circular or linear depending on the integration order.
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 and  
We assume that integration in this 
location will not affect the physiology of the 
cell and therefore constitutes a safe harbour 
for a transgene. Accordingly, tumour 
suppressor inactivation and oncogene 
-based gene integration. A) The two-plasmid non
-viral delivery method such as a cationic lipid 
ymes are transcribed and translated into protein. 
dimer that recognizes the 23-spacer RSS flanking the GOI and 12
-gene segmen
 
MARCH 2013 
 
 
-viral targeted 
-spacer RSS 
ts. The excision 
SECTION 3.4 RESULTS MARCH 2013 
104 
 
activation should be prevented. An open issue 
regarding epigenetic effects necessary during 
the integration process are an issue of 
concern. It remains to be clarified whether the 
immunoglobulin loci are repressed by 
chromatin structures in non-lymphoid cells 
and are therefore inactive and unavailable for 
gene integration. However, the RAG-complex 
has been shown to have E3-ligase activity 
enabling the complex to mediate the removal 
of chromatin structures39-41. Accordingly, we 
envisioned that the E3-ligase activity of 
transgenic RAG would be able to disintegrate 
chromatin structures at the e.g. IgH loci and 
thus enable gene integration. We initially 
attempted to transfect B cells with the two-
plasmid-targeted integration system, but this  
turned out to be highly inefficient (<5%). For 
convenience, we therefore used the cell line 
HEK293T which is a human embryonic 
kidney cell line expressing the SV40 T-
antigen constitutively. This cell line as 
previously been used successfully for RAG 
expression studies40, 42-44.  
 
Is HEK293T a suitable model system for 
RAG-mediated gene integration studies? 
HEK293T cells (originally known as 
293tsA1609neo) are non-lymphoid cells that 
have been genetically altered and therefore 
already contain a neomycin resistance-
encoding gene in a gene cassette together with 
the SV40 Large T-antigen gene30. As the 
GeneVec1.0 vector contains a neomycin 
resistance-encoding gene this meant that 
selection of GeneVec1.0 positive cells would 
be a very difficult task. 
If untransfected cells were not removed 
by antibiotic selection, they would soon 
outgrow the cells that were successfully 
transfected. We were therefore limited by 
time and the process of gene integration could 
only be conducted for a few days prior to 
DNA extraction. If we had been able to grow 
the transgenic cultures for longer time, to 
allow for selection (see below) we might have 
obtained a proof of concept for RAG-
mediated integration. However, even in 
HEK293T cells transfected with RAGVec1.0 
alone, further selected and subcloned, it 
resulted in cultures initially expressing high 
levels of transgenic RAG1 and 2 mRNA’s, 
but  their  mRNA expression was drastically 
reduced after 10 weeks of culturing. The ideal 
way to tackle this roadblock is to perform 
simultaneous co-transfection of GeneVec1.0 
and RAGVec1.0 and select from the 
beginning (after transfection) with both 
zeocin and neomycin antibiotics that would 
allow selection of the RAGVec1.0 and 
GeneVec1.0 vectors, respectively. Co-
transfection efficiency has a tendency to be 
lower than transfection of any single vector, 
but it is not an uncommon event. The major 
issue is that the two vectors, GeneVec1.0 and 
RAGVec1.0 need to be functional to the 
extent that they can allow recombination with 
its genomic targets.     
In cells where V(D)J rearrangement is 
unnecessary, such as in some lymphoid as 
well as non-lymphoid cells, the IgH locus 
may be inaccessible due to chromatin 
structures45, 46. Even though primary V(D)J 
rearrangement only occur in pro- and pre-B 
cells it has been demonstrated that RAG1 and 
RAG2 are expressed to some extent in mature 
peripheral B cells, presumably due to receptor 
editing47, 48. We therefore suspected that 
chromatin structures in B cells may be more 
easily disintegrated after reintroduction of 
transgenic RAG1 and RAG2 and therefore a 
more suitable model system for testing our 
hypothesis. The highly efficient transfection 
approach that we used for HEK293T could 
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not be directly applied to B cells. We only 
succeeded transfecting single vectors into one 
B-cell line at a low frequency (<5%), which 
was the RAG+ B-cell line Daudi. Studying 
our gene integration system in B cells is 
therefore dependent on developing a gene 
delivery approach suitable for B cells.  
At present, it is not possible to assess if 
gene silencing by chromatin in the IgH locus 
may have had a role in the lack of detectable 
gene integration. That would require 
knowledge of the epigenetic status of the IgH 
locus in HEK293T cells.  Use of chromatin-
modifying chemicals could perhaps contribute 
to improve the gene-targeting process.  
 
Are transgenic RAG1 and RAG2 functional? 
Even though mRNA expression of both RAG 
proteins was clearly detectable, we lacked 
definitive evidence for their protein 
expression throughout time. In vitro and in 
vivo functional studies of proteins are highly 
dependent on protein solubility49, 50. 
Recombinant proteins tend to accumulate in 
insoluble aggregates known as inclusion 
bodies and in this state the proteins are often 
rendered inactive51. Therefore most functional 
studies on RAG1 and RAG2 have been 
performed on truncated RAG1 and RAG2, as 
full length RAG1 and RAG2 are less 
soluble42, 43, 52-55. In the early 1990’s it was 
demonstrated that the function of RAG1 and 
RAG2 were entirely addressed to their core 
domains42, 52. We used unmodified full-length 
RAG1 and RAG2 and accordingly we cannot 
exclude that the enzymes may have been 
forming IBs in the cytosol and therefore were 
non-functional.  
 
Reconsidering the GeneVec1.0 design. 
We hypothesized that in order to target a gene 
specifically to the e.g. IgH locus on 
chromosome 14, we could flank the GOI by 
23-spacer RSSs. Hypothetically, the 23-spacer 
RSS would then pair with the 12-spacer RSS 
flanking the D-gene segments. This design 
may however not be ideal. The GOI could in 
fact be flanked by any combination of 12- and 
23-spacer RSS. Designing the GeneVec1.0 
with two 12-spacer RSS, would target the gene 
to either the VH- or the JH-loci inserting it in 
between two VH-genes or two JH-genes, 
respectively. Flanking the GOI by a 12-spacer 
RSS on one side and 23-spacer RSS on the 
other side would insert the GOI in between a 
VH- and a D-gene segments or a D- and JH-
gene segments. This situation would better 
mirror the natural sequential mechanism of 
rearrangement. With this design there is, 
however, a risk of rearrangement that could 
occur within the plasmid as seen for other 
rearrangement substrates33, 56. Another 
concern, independent of the combination of 
flanking RSS, is the endogenous 
rearrangement of the IgH locus. Transgenic 
RAG1 and RAG2 may initiate rearrangement 
at the IgH locus and if a gene is integrated into 
any place within the IgH-locus it may as well 
be excised by a rearrangement between an 
available VH-, D- and JH-gene segment. 
However, this was not the reason for the lack 
of detectable integration, as we did not 
observe rearrangements at the IgH locus in 
transgenic HEK293T cells (data not shown).   
The GeneVec1.0 vector requires an antibiotic-
resistance gene other than neomycin, such as 
hygromycin or blasticidin that would allow its 
use in cell lines with gene cassettes containing 
T cell antigen-neoR. Unless RAG1 and RAG2 
remains bound to the ends and somehow 
protect the linearised DNA from being 
degraded, it will not persist as linear DNA. 
Including a resistance gene, along with the 
GOI, will further enable us to select for cells 
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that have integrated the gene into the genome 
(Figure 6).  
 
Using other techniques for detecting gene 
integration.  
Five days after setting up the gene integration 
study we extracted genomic DNA. As 
mentioned earlier we were unable to prolong 
the incubation time as it was not possible to 
select with antibiotics. Our hypothesis 
envisioned targeted integration of GOI in 
between two D-genes at the IgH locus. We 
therefore designed a real time-PCR 
specifically for detecting targeted integration 
in this location that would amplify a ~100 bp 
hybrid product between all seven D-gene 
families and both correct and inverse 
integrated RFP. We added template DNA 
equivalent to 17,000 cells. If only 1:17,000 
cells had integrated an RFP in between two D-
genes, this copy would have been amplified 
239 during the course of 40 cycles and yielded 
a signal.  No integration events were 
detectable in the GeneVec1.0-transfected SC1 
or the GeneVec1.0 and RAGVec1.0 double 
transfectants compared to sham. This implied 
that RFP had not been integrated into the D-
locus at frequencies higher than 1:17,000. We 
cannot exclude that RFP was integrated into 
another location within the genome. 
Unauthorized RAG1 and RAG2 cleavage does 
occur and is in fact involved in chromosomal 
translocation leading to leukemia57-59. 
Investigating RFP integration in other 
genetic locations can be achieved by either A) 
whole genome sequencing by next-generation 
sequencing (NGS), B) inverse PCR or C) 
Splinkerette PCR. Today companies offer 
quick solutions for whole genome sequencing 
at affordable prices and a technique like NGS 
would provide the DNA sequence of the 
entire genome including all potential 
integration sites. Inverse PCR allows to 
conduct PCR when the only sequence 
information available is that of the GOI. The 
genomic DNA of the target cells is digested 
by a RE, not targeting the GOI. The resulting 
fragments are brought to self-ligate into 
circular DNA. The circular DNA molecules 
are then linearised using an RE that cuts 
within the GOI. The linearised fragments that 
contain the GOI will have the first half of the 
GOI at the 5’-end and the second half at the 
3’-end. It is now possible to amplify these 
fragments by PCR and identify the location of 
insert by DNA sequencing. Splinkerette PCR 
is a recently developed technique that also 
relies on RE digestion60. However, this 
technique does not require circularization of 
the digested DNA fragments. The genomic 
DNA of the target cells are digested using an 
RE that generates sticky ends. A primer 
targeting the center of the GOI and a 
splinkerette primer with a compatible sticky 
end and a stable hairpin loop (sense strand) 
opposite a 5’-overhang (non-sense) is 
annealed to the fragments. The splinkerette 
conjugated fragments are then subjected to 
two rounds of nested PCR with a primer 
matching the 5’-overhanging strand. The 
integration site is subsequently identified by 
sequencing of the nested PCR products. The 
two PCR techniques are rather complex and 
require extensive optimization before 
implemented and since whole-genome 
sequencing has become fast and affordable 
this technique is therefore more readily 
approachable.      
 
Efficiency of gene integration. 
It took nearly 10 years to re-construct the 
Sleeping Beauty transposon until its approval 
for clinical trial in 200822-24, 61. Molecular 
cloning and gene expression studies are 
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laborious and time consuming processes. If 
we obtain a proof of concept for RAG-
mediated integration, the efficiency of the 
RAG-enzymes would subsequently have to be 
increased by genetic engineering. Directed 
evolution has been employed in improving or 
altering the function of various enzymes 
including the Sleeping Beauty system23, 62, 62-
66
.   
We believe that gene integration 
facilitated by RAG1 and RAG2 is still 
plausible if the model cell line, the 
GeneVec1.0 design, confirmation of 
transgenic RAG protein function originating 
from RAGVec1.0, and the technical approach 
for detecting gene integration mentioned 
above are re-evaluated. Clearly, more 
experiments will be necessary to address all 
these issues. 
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Concluding Remarks and Future Perspectives 
 
Recently, next-generation sequencing has provided excessive information regarding fully 
rearranged IgH loci1-5. The innovative idea of sequencing sterile DJH-rearrangements and analyzing 
their structural composition has led to the discoveries of novel features in the basic mechanism of 
V(D)J rearrangement presented in this thesis. D-gene usage and somatic hypermutation status of 
fully and partially rearranged IgH loci differed significantly which implied that the initial D- to JH-
gene rearrangement should be studied in DJH-rearrangements exclusively. Previously, it has been 
demonstrated that purified TdT primarily adds guanine during N addition in vitro; we did however 
find evidence for the opposite in vivo, namely that the N region is generated by concatenation of 
two TdT elongated 3’-overhangs predominated by cytosine. Thus, we found that the sense-strand in 
the first half of the N region had a low G/C ratio while the sense-strand on the second half had a 
higher G/C ratio. Because TdT adds nucleotides to the 3’ end, elongation from the VH-gene will  
generate the sense strand and the D-5’-end overhang generates the non-sense strand. Increasing G/C 
ratio gradient from VH to D is thus a result of TdT primarily adding cytosine during N addition, 
either from VH to D (sense strand), from D to VH (non-sense strand), or both. We found that the 
G/C ratio gradient was significantly different in N1 compared to N2. We excluded that this 
difference was due to footprints after VH-gene replacement but found that the G/C ratio was 
dependent on the status of gene segment trimming. Based on a simple model of N-additions being 
the result of concatenation of two TdT synthesized strands produced with a low G/C ratio, we were 
able to explain the fine structure of N1 and N2 rather closely assuming asymmetrical contributions 
from the two ends. We propose that the effect of trimming relates to an influence on the relative 
contribution from the two sites. 
Studying steric- and antigen dependent-selection of amino acids have been complicated as it 
is not possible to specifically amplify non-productive and thus unselected VHDJH-rearrangement to 
compare productive and selected VHDJH-rearrangement with. Only 10-20% of VHDJH-
rearrangements obtained from peripheral B cells are considered to be non-productive. We therefore 
used the newly obtained information on N region structure and combined it with known information 
regarding the mechanism of V(D)J rearrangement and generated a computer program that could 
generate new unselected productive VHDJH-rearrangements. This program fabricated ~100 new 
productive VHDJH-rearrangements based on a single known non-productive VHDJH-rearrangement. 
The N regions of these artificial, unselected VHDJH-rearrangements displayed the same features as 
authentic non-productive VHDJH-rearrangements apart from the reading frame which had been 
shifted into open. The open reading frame allows for studies of the amino acid distribution of the 
unselected repertoire. In this thesis we have used these artificial rearrangements as negative control 
for studying the presence of footprints after VH-gene replacement but in the future we further plan 
to use them for providing solid information regarding selection trends initiated by steric- and 
antigen-dependent selection  
We have direct access to blood from patients diagnosed with rare immune disorders. In the 
future, we plan to use next-generation sequencing for studying the effect of these immune disorders 
on the rearrangement mechanism. We have previously investigated the effect of a RAG1 core-
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domain mutation on the generation of the B cell receptor repertoire6. The patient was deficient in T 
cells but had nearly normal levels of B cells. The effect of the mutation on V(D)J rearrangement 
was demonstrated by sequence analysis. 78 VHDJH-rearrangements was sequenced by conventional 
SANGER-sequencing and it was revealed that non-productive VHDJH-rearrangements were almost 
non-existent. Other studies have demonstrated that the frequency of non-productive VHDJH-
rearrangements is around 10-20% in the normal B cell receptor repertoire7, 8 (Manuscript II). The 
generation of productive VHDJH-rearrangements explained that the mutation only partially 
obstructed RAG1 function and caused a delay in the rearrangement mechanism. This delay had 
consequences for the B cells that rearranged non-productively on the first locus, as these cells 
would go into apoptosis before rearrangement was resumed on the second locus.  
We also plan to characterize thousands of VHDJH-rearrangements obtained from a known 
source of poly-reactive B cells. A poly-reactive B cell is characterized by binding a variety of 
different self and non-self antigens. The structural details about VH-, D- and JH-gene composition, 
joint formation and somatic hypermutation status of these poly-reactive B cells have only been 
sparsely explored in smaller VHDJH-rearrangement materials9, 10.  We hope to elaborate on these 
studies with large datasets obtained by next-generation sequencing. 
We had the ambitious goal of obtaining a proof of concept of targeted gene integration 
mediated by RAG1 and RAG2. Inspired by the Sleeping Beauty transposon system11, we designed a 
non-viral two-plasmid targeted gene integration system, consisting of one vector expressing RAG1 
and RAG2 and another vector containing the gene of interest flanked by 23-spacer RSS. We 
obtained high mRNA expression of both RAG1 and RAG2 and further demonstrated that RAG1 
was translated into protein. The gene of interest, RFP, was translated into protein within the first 72 
hours. We did, however, not obtain a proof of concept with the initial vector design. The current 
vector design has several flaws and we believe that with major revisions, a proof of concept 
integration may be provided in the future. We are however also aware that this task is time 
consuming and laborious and in order to keep progressing we will have to collaborate with other 
research teams who are specialized in this area. 
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